
<html lang="en"     class="pb-page"  data-request-id="9e0ce5f2-8147-434d-a432-b15d3ded6e88"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-5;article:article:10.1021/acs.jmedchem.9b01547"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Isolation, Structural Identification, Synthesis, and Pharmacological Profiling of 1,2-trans-Dihydro-1,2-diol Metabolites of the Utrophin Modulator Ezutromid" /></meta><meta name="dc.Creator" content="Maria  Chatzopoulou" /></meta><meta name="dc.Creator" content="Tim D. W.  Claridge" /></meta><meta name="dc.Creator" content="Kay E.  Davies" /></meta><meta name="dc.Creator" content="Stephen G.  Davies" /></meta><meta name="dc.Creator" content="David J.  Elsey" /></meta><meta name="dc.Creator" content="Enrico  Emer" /></meta><meta name="dc.Creator" content="Ai M.  Fletcher" /></meta><meta name="dc.Creator" content="Shawn  Harriman" /></meta><meta name="dc.Creator" content="Neil  Robinson" /></meta><meta name="dc.Creator" content="Jessica A.  Rowley" /></meta><meta name="dc.Creator" content="Angela J.  Russell" /></meta><meta name="dc.Creator" content="Jonathon M.  Tinsley" /></meta><meta name="dc.Creator" content="Richard  Weaver" /></meta><meta name="dc.Creator" content="Isabel V. L.  Wilkinson" /></meta><meta name="dc.Creator" content="Nicky J.  Willis" /></meta><meta name="dc.Creator" content="Francis X.  Wilson" /></meta><meta name="dc.Creator" content="Graham M.  Wynne" /></meta><meta name="dc.Description" content="5-(Ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole (ezutromid, 1) is a first-in-class utrophin modulator that has been evaluated in a phase 2 clinical study for the treatment of Duchenne muscular..." /></meta><meta name="Description" content="5-(Ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole (ezutromid, 1) is a first-in-class utrophin modulator that has been evaluated in a phase 2 clinical study for the treatment of Duchenne muscular..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 10, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01547" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01547" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01547" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01547" /></link>
        
    
    

<title>Isolation, Structural Identification, Synthesis, and Pharmacological Profiling of 1,2-trans-Dihydro-1,2-diol Metabolites of the Utrophin Modulator Ezutromid | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01547" /></meta><meta property="og:title" content="Isolation, Structural Identification, Synthesis, and Pharmacological Profiling of 1,2-trans-Dihydro-1,2-diol Metabolites of the Utrophin Modulator Ezutromid" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0006.jpeg" /></meta><meta property="og:description" content="5-(Ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole (ezutromid, 1) is a first-in-class utrophin modulator that has been evaluated in a phase 2 clinical study for the treatment of Duchenne muscular dystrophy (DMD). Ezutromid was found to undergo hepatic oxidation of its 2-naphthyl substituent to produce two regioisomeric 1,2-dihydronaphthalene-1,2-diols, DHD1 and DHD3, as the major metabolites after oral administration in humans and rodents. In many patients, plasma levels of the DHD metabolites were found to exceed those of ezutromid. Herein, we describe the structural elucidation of the main metabolites of ezutromid, the regio- and relative stereochemical assignments of DHD1 and DHD3, their de novo chemical synthesis, and their production in systems in vitro. We further elucidate the likely metabolic pathway and CYP isoforms responsible for DHD1 and DHD3 production and characterize their physicochemical, ADME, and pharmacological properties and their preliminary toxicological profiles." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01547"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01547">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01547&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01547&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01547&amp;href=/doi/10.1021/acs.jmedchem.9b01547" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2547-2556</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01506" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01561" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Isolation, Structural Identification, Synthesis, and Pharmacological Profiling of 1,2-<i>trans</i>-Dihydro-1,2-diol Metabolites of the Utrophin Modulator Ezutromid</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Maria Chatzopoulou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maria Chatzopoulou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Oxford, Chemistry Research Laboratory, Mansfield Road, Oxford OX1 3TA, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maria++Chatzopoulou">Maria Chatzopoulou</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1886-7705" title="Orcid link">http://orcid.org/0000-0003-1886-7705</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Tim D. W. Claridge</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tim D. W. Claridge</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Oxford, Chemistry Research Laboratory, Mansfield Road, Oxford OX1 3TA, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tim+D.+W.++Claridge">Tim D. W. Claridge</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5583-6460" title="Orcid link">http://orcid.org/0000-0001-5583-6460</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Kay E. Davies</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kay E. Davies</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Physiology, Anatomy and Genetics, MDUK Oxford Neuromuscular Centre, University of Oxford, Oxford OX1 3PT, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kay+E.++Davies">Kay E. Davies</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Stephen G. Davies</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephen G. Davies</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Oxford, Chemistry Research Laboratory, Mansfield Road, Oxford OX1 3TA, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+G.++Davies">Stephen G. Davies</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3181-8748" title="Orcid link">http://orcid.org/0000-0003-3181-8748</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">David J. Elsey</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David J. Elsey</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Summit Therapeutics plc, 136a Eastern Avenue, Milton Park, Abingdon OX14 4SB, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+J.++Elsey">David J. Elsey</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Enrico Emer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Enrico Emer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Oxford, Chemistry Research Laboratory, Mansfield Road, Oxford OX1 3TA, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Enrico++Emer">Enrico Emer</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Ai M. Fletcher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ai M. Fletcher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Oxford, Chemistry Research Laboratory, Mansfield Road, Oxford OX1 3TA, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ai+M.++Fletcher">Ai M. Fletcher</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Shawn Harriman</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shawn Harriman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Summit Therapeutics plc, One Broadway, 14th Floor, Cambridge, Massachusetts 02142, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shawn++Harriman">Shawn Harriman</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Neil Robinson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Neil Robinson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">S.H.B. Enterprises Ltd., 55 Station Road, Beaconsfield HP19 1QL, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Neil++Robinson">Neil Robinson</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jessica A. Rowley</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jessica A. Rowley</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Oxford, Chemistry Research Laboratory, Mansfield Road, Oxford OX1 3TA, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jessica+A.++Rowley">Jessica A. Rowley</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Angela J. Russell</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Angela J. Russell</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Oxford, Chemistry Research Laboratory, Mansfield Road, Oxford OX1 3TA, United Kingdom</div><div class="loa-info-affiliations-info">Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3PQ, United Kingdom</div></div><span class="conrtib-corresp"><strong>*</strong>Tel.: +44 (0) 1865 275 643 (Chemistry) or +44 (0) 1865 271 883 (Pharmacology). E-mail: <a href="/cdn-cgi/l/email-protection#0869666f6d6469267a7d7b7b6d6464486b606d6526677026696b267d63"><span class="__cf_email__" data-cfemail="06676861636a672874737575636a6a46656e636b28697e28676528736d">[emailÂ protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Angela+J.++Russell">Angela J. Russell</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3610-9369" title="Orcid link">http://orcid.org/0000-0003-3610-9369</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jonathon M. Tinsley</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jonathon M. Tinsley</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Summit Therapeutics plc, 136a Eastern Avenue, Milton Park, Abingdon OX14 4SB, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jonathon+M.++Tinsley">Jonathon M. Tinsley</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Richard Weaver</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard Weaver</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">XenoGesis Ltd., BioCity Nottingham, Pennyfoot Street, Nottingham NG1 1GF, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Weaver">Richard Weaver</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Isabel V. L. Wilkinson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Isabel V. L. Wilkinson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Oxford, Chemistry Research Laboratory, Mansfield Road, Oxford OX1 3TA, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Isabel+V.+L.++Wilkinson">Isabel V. L. Wilkinson</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Nicky J. Willis</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nicky J. Willis</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Oxford, Chemistry Research Laboratory, Mansfield Road, Oxford OX1 3TA, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nicky+J.++Willis">Nicky J. Willis</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Francis X. Wilson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Francis X. Wilson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Summit Therapeutics plc, 136a Eastern Avenue, Milton Park, Abingdon OX14 4SB, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Francis+X.++Wilson">Francis X. Wilson</a></span></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Graham M. Wynne</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Graham M. Wynne</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, University of Oxford, Chemistry Research Laboratory, Mansfield Road, Oxford OX1 3TA, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Graham+M.++Wynne">Graham M. Wynne</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01547&amp;href=/doi/10.1021%2Facs.jmedchem.9b01547" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2547â2556</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 10, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 September 2019</li><li><span class="item_label"><b>Published</b> online</span>10 October 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 March 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01547" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01547</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2547%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMaria%2BChatzopoulou%252C%2BTim%2BD.%2BW.%2BClaridge%252C%2BKay%2BE.%2BDavies%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D5%26contentID%3Dacs.jmedchem.9b01547%26title%3DIsolation%252C%2BStructural%2BIdentification%252C%2BSynthesis%252C%2Band%2BPharmacological%2BProfiling%2Bof%2B1%252C2-trans-Dihydro-1%252C2-diol%2BMetabolites%2Bof%2Bthe%2BUtrophin%2BModulator%2BEzutromid%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2556%26publicationDate%3DMarch%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01547"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">783</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">7</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01547" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Isolation, Structural Identification, Synthesis, and Pharmacological Profiling of 1,2-trans-Dihydro-1,2-diol Metabolites of the Utrophin Modulator Ezutromid&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Chatzopoulou&quot;},{&quot;first_name&quot;:&quot;Tim&quot;,&quot;last_name&quot;:&quot;D. W. Claridge&quot;},{&quot;first_name&quot;:&quot;Kay&quot;,&quot;last_name&quot;:&quot;E. Davies&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;G. Davies&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;J. Elsey&quot;},{&quot;first_name&quot;:&quot;Enrico&quot;,&quot;last_name&quot;:&quot;Emer&quot;},{&quot;first_name&quot;:&quot;Ai&quot;,&quot;last_name&quot;:&quot;M. Fletcher&quot;},{&quot;first_name&quot;:&quot;Shawn&quot;,&quot;last_name&quot;:&quot;Harriman&quot;},{&quot;first_name&quot;:&quot;Neil&quot;,&quot;last_name&quot;:&quot;Robinson&quot;},{&quot;first_name&quot;:&quot;Jessica&quot;,&quot;last_name&quot;:&quot;A. Rowley&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;J. Russell&quot;},{&quot;first_name&quot;:&quot;Jonathon&quot;,&quot;last_name&quot;:&quot;M. Tinsley&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Weaver&quot;},{&quot;first_name&quot;:&quot;Isabel&quot;,&quot;last_name&quot;:&quot;V. L. Wilkinson&quot;},{&quot;first_name&quot;:&quot;Nicky&quot;,&quot;last_name&quot;:&quot;J. Willis&quot;},{&quot;first_name&quot;:&quot;Francis&quot;,&quot;last_name&quot;:&quot;X. Wilson&quot;},{&quot;first_name&quot;:&quot;Graham&quot;,&quot;last_name&quot;:&quot;M. Wynne&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;2547-2556&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01547&quot;},&quot;abstract&quot;:&quot;5-(Ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole (ezutromid, 1) is a first-in-class utrophin modulator that has been evaluated in a phase 2 clinical study for the treatment of Duchenne muscular dystrophy (DMD). Ezutromid was found to undergo hepatic oxidation of its 2-naphthyl substituent to produce two regioisomeric 1,2-dihydronaphthalene-1,2-diols, DHD1 and DHD3, as the major metabolites after oral administration in humans and rodents. In many patients, plasma levels of the DHD metabolites were found to exceed those of ezutromid. Herein, we describe the structural elucidation of the main metabolites of ezutromid, the regio- and relative stereochemical assignments of DHD1 and DHD3, their de novo chemical synthesis, and their production in systems in vitro. We further elucidate the likely metabolic pathway and CYP isoforms responsible for DHD1 and DHD3 production and characterize their physicochemical, ADME, and pharmacological properties and their preliminary toxicological profiles.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01547&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01547" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01547&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01547" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01547&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01547" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01547&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01547&amp;href=/doi/10.1021/acs.jmedchem.9b01547" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01547" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01547" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01547%26sid%3Dliteratum%253Aachs%26pmid%3D31599580%26genre%3Darticle%26aulast%3DChatzopoulou%26date%3D2020%26atitle%3DIsolation%252C%2BStructural%2BIdentification%252C%2BSynthesis%252C%2Band%2BPharmacological%2BProfiling%2Bof%2B1%252C2-trans-Dihydro-1%252C2-diol%2BMetabolites%2Bof%2Bthe%2BUtrophin%2BModulator%2BEzutromid%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D5%26spage%3D2547%26epage%3D2556%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/jmcmar.2020.63.issue-5/20200312/jmcmar.2020.63.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/medium/jm9b01547_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01547&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">5-(Ethylsulfonyl)-2-(naphthalen-2-yl)benzo[<i>d</i>]oxazole (ezutromid, <b>1</b>) is a first-in-class utrophin modulator that has been evaluated in a phase 2 clinical study for the treatment of Duchenne muscular dystrophy (DMD). Ezutromid was found to undergo hepatic oxidation of its 2-naphthyl substituent to produce two regioisomeric 1,2-dihydronaphthalene-1,2-diols, DHD1 and DHD3, as the major metabolites after oral administration in humans and rodents. In many patients, plasma levels of the DHD metabolites were found to exceed those of ezutromid. Herein, we describe the structural elucidation of the main metabolites of ezutromid, the regio- and relative stereochemical assignments of DHD1 and DHD3, their de novo chemical synthesis, and their production in systems in vitro. We further elucidate the likely metabolic pathway and CYP isoforms responsible for DHD1 and DHD3 production and characterize their physicochemical, ADME, and pharmacological properties and their preliminary toxicological profiles.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/63/5"><issue-title>Women in Medicinal Chemistry</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54336" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54336" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Duchenne muscular dystrophy (DMD) is one of the most prevalent neuromuscular disorders and is caused by mutations in the dystrophin gene that result in loss of the key structural protein dystrophin. This is an essential component of the dystrophin-associated protein complex that connects the actin cytoskeleton to the basal lamina. Loss of dystrophin results in chronic inflammation and a vicious cycle of muscle necrosis and regeneration that leads to the eventual replacement of muscle by adipose and connective tissue. The gradual muscle degeneration causes loss of ambulation in adolescence and ultimately respiratory and cardiac failure, significantly reducing the life expectancy of DMD patients.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a></div><div class="NLM_p">Dystrophin is the largest gene known in humans and shows high susceptibility to spontaneous mutations.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> As a result, DMD patients can have different mutations, and this has created a challenge in the design of disease-modifying therapeutics, as many are targeted to a specific mutation and thus a subpopulation rather than all patients.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Until recently, patients could only be treated with symptomatic therapies like corticosteroids to reduce inflammation; however, this is now changing with the conditional approval of ataluren (PTC Therapeutics) for nonsense mutations by the European Medicines Agency (EMA), although it is not yet approved by the U.S. Food and Drug Administration (FDA). An exon skipping drug, eteplirsen (Sarepta Therapeutics) has also been granted conditional approval by the U.S. FDA. Other disease modifying approaches that are currently under clinical investigation include gene therapy and exon skipping candidates for mutations other than those related to exon 51. For many years we have pursued an alternative disease-modifying approach in DMD: replacing defective dystrophin with utrophin, an approach in principle applicable to all DMD patients irrespective of their mutation.</div><div class="NLM_p">Utrophin is a structural paralogue of dystrophin discovered and characterized over two decades ago.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Initial proof of principle studies in <i>mdx</i> mice<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> and DMD dogs<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> were encouraging, and this data supported the initiation of drug discovery programs from a number of companies.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The most advanced small molecule utrophin modulator to date is ezutromid (formerly SMT C1100, Summit Therapeutics plc),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> a first-in-class utrophin modulator that progressed to a Phase 2 clinical trial in DMD boys (PhaseOut DMD). Encouraging interim 24 week data demonstrated reduced muscle fiber damage and increased levels of utrophin following ezutromid treatment, providing the first evidence of target engagement and proof of mechanism. However, ezutromid failed to meet its primary or secondary end points after 48 weeks of treatment, and further development was discontinued.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a><named-content content-type="anchor" rid="fig1" type="simple"></named-content></div><div class="NLM_p">Ezutromid (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) bears a naphthalene moiety and is extensively metabolized after oral administration.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13â15)</a> Naphthalene moieties commonly undergo oxidative metabolism: glutathione adducts and naphthols were the first isolated metabolites, both postulated to arise from a common reactive intermediate later identified as the 1,2-naphthalene oxide.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> Several CYP isoforms (CYP1A1, CYP1A2, CYP2E1, CYP2F1, CYP3A4, and CYP2A6) have been found to produce this intermediate.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21">(18â21)</a> 1-Naphthol can be produced by rearrangement of 1,2-naphthalene oxide, whereas 1,2-dihydro-1,2-diol formation can proceed either by enzymatic or nonenzymatic hydrolysis.<a onclick="showRef(event, 'ref20 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref22">(20,22)</a> In an in vitro study in pooled human liver microsomes (HLM), naphthalene was metabolized to predominantly 1,2-dihydrodiol along with 1-naphthol and 2-naphthol, a transformation subsequently found to be mediated predominantly by CYP1A2.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Similar metabolic pathways have also been observed for 1-naphthalene-containing drugs or investigational drugs such as setipiprant, cinacalcet, and terbinafine, but to the best of our knowledge, there are no similar reports of 2-naphthalene-containing drug candidates.<a onclick="showRef(event, 'ref23 ref24 ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref23 ref24 ref25 ref26">(23,24,23â26)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/medium/jm9b01547_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structure of ezutromid and isolated major metabolites DHD1 and DHD3 (in each case, one of two possible enantiomers is drawn, as absolute configuration was not determined).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01547&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Clinical studies of ezutromid in healthy volunteers and pediatric DMD patients demonstrated two major abundant metabolites in plasma, accounting for >90% of total drug exposure on day 1 and approximately 70% on day 11.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13â15)</a> These were tentatively assigned as regioisomeric 1,2-dihydrodiols and named DHD1 and DHD3 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) on the basis of the order of elution in the analytical procedure employed. In urine, species assigned as hydroxylated metabolites of ezutromid and their respective <i>O</i>-glucuronides were found. Although the plasma concentration of ezutromid varied significantly between subjects, the relative ratios between ezutromid and metabolites were very similar.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Furthermore, exposure to ezutromid was observed to decrease with repeated dosing, whereas metabolite levels increased. It was therefore important to determine the major route of metabolism of ezutromid and consequent potential CYP induction in order to better understand the compoundâs PK/PD profile.</div><div class="NLM_p last">Herein, we detail ezutromidâs metabolic profile in in vitro and in vivo systems, together with the structural elucidation and pharmacological characterization of the major dihydrodiol metabolites, DHD1 and DHD3.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16683" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16683" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Ezutromidâs metabolism was investigated using a human in vitro model. A preliminary study in human liver microsomes (HLM) showed that after incubation for 45 min, an 81:19 mixture of parent (A) and a single metabolite was observed (B, <i>T</i><sub>R</sub> = 5.7 min, [M + H]<sup>+</sup><i>m</i>/<i>z</i> 372, <a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Figures S1 and S3</a>). Mass spectrometry analysis showed this metabolite corresponded to an increase of 34 mass units, which indicated addition of either H<sub>2</sub>O<sub>2</sub>, H<sub>2</sub> and CH<sub>3</sub>OH, or H<sub>2</sub>S. MS/MS fragmentation analysis (<i>m</i>/<i>z</i> 354, 344, 326, 279, and 261) demonstrated a loss of <i>m</i>/<i>z</i> 18 (H<sub>2</sub>O, <i>m</i>/<i>z</i> 354), suggesting formal addition of H<sub>2</sub>O<sub>2</sub>. Key fragments of ezutromid (<i>m</i>/<i>z</i> 310, âC<sub>2</sub>H<sub>4</sub>, and 245, âC<sub>2</sub>H<sub>5</sub>SO<sub>2</sub>) were visible as 344 (âC<sub>2</sub>H<sub>4</sub>) and 279 (âC<sub>2</sub>H<sub>5</sub>SO<sub>2</sub>) within the MS/MS fragmentation of the metabolite (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Figures S2âS4</a>), suggesting that this metabolite may be a dihydroxylated benzoxazole or a dihydronaphthalenediol (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/medium/jm9b01547_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Proposed fragmentation pathway of (A) ezutromid and (B) its main metabolite in human liver microsomes (HLM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01547&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A more comprehensive investigation of ezutromid metabolism was accomplished using a single oral administration of a radiolabeled sample of [<sup>14</sup>C-1]ezutromid in mice. Metabolites and their relative proportions were measured in plasma, urine, feces, and liver over 3 days. A total of 16 metabolites were observed in plasma, up to 19 were observed in excreta and liver, and the identities of 14 of them were discerned from a combination of accurate mass measurements and diagnostic MS<sup><i>n</i></sup> fragments (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Figures S5âS9 and Tables S1 and S2</a>). Consistent with the observations in human samples, the most prominent metabolites in excreta were consistent with two isomeric dihydrodiol derivatives of ezutromid (M4 and M8) and their corresponding glucuronide adducts (M2 and M5) (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Figure S5 and Tables S1 and S2</a>).</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Production of Metabolites Using In Vitro Systems</h3><div class="NLM_p">A route to larger quantities of ezutromidâs metabolites was required in order to elucidate their structures and investigate their pharmacological profiles. Ezutromidâs stability was investigated in a range of in vitro systems in an attempt to identify an appropriate system for production of the DHDs. Ezutromidâs metabolism was found to vary significantly among different species in vitro (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Table S3</a>).</div><div class="NLM_p">MicroCyp enzymes, a recombinant human cytochrome P450, and a microbial biocatalyst panel all failed to produce the desired metabolites in sufficient quantities. Several attempts at a biomimetic approach based on epoxidation followed by hydrolysis also gave only trace quantities of the desired metabolites.</div><div class="NLM_p">The optimal, most cost-effective and scalable conditions for the synthesis of the major metabolites were found to be by metabolic conversion of ezutromid with induced rat S9 fractions (Î²-naphthoflavone/phenobarbital) (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Table S4</a>). UVâvis spectroscopy showed conversion to a 18:77:5 mixture of ezutromid, dihydrodiol-1 (<b>D1</b>), and dihydrodiol-2 (<b>D2</b>) after 4 h of incubation (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Figure S10</a>). Although this procedure was low yielding for diol <b>D2</b>, it was found to be amenable to scale-up: scaling up to 200 mL incubation volume gave similar levels of conversion to <b>D1</b> and <b>D2</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Table S5 and Figure S11</a>). The isolated sample of <b>D1</b> was compared with the samples produced from the radiochemical study in mice and was found to have similar retention times to M4 (<i>T</i><sub>R</sub> = 26.7 and 27.5 min, respectively) and identical fragmentation by MS/MS, suggesting these had the same composition (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Figures S12 and S13 and Table S6</a>).</div><div class="NLM_p">Moreover, the analytical data of dihydrodiol metabolites DHD1 and DHD3 from human plasma samples were compared with those from induced rat S9 <b>D1</b> and <b>D2</b> using LC-MS/MS (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). <b>D1</b>, eluting at <i>T</i><sub>R</sub> = 8.2 min with <i>m</i>/<i>z</i> 372.0898, matched the sample of DHD1 from human patients (M372a, <i>T</i><sub>R</sub> = 8.1 min with <i>m</i>/<i>z</i> 372.0899). <b>D2</b>, eluting at <i>T</i><sub>R</sub> = 9.0 min with <i>m</i>/<i>z</i> 372.0899, matched the sample of DHD3 from human patients (M372b, <i>T</i><sub>R</sub> = 8.9 min with <i>m</i>/<i>z</i> 372.0898). Further accurate mass measurements of both samples gave identical fragmentation for the two samples, supporting the same composition (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Table S7 and Figures S14âS17</a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/medium/jm9b01547_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cumulative accurate mass summed ion chromatograms for (A) equimolar mixture of ezutromid, <b>D1</b>, and <b>D2</b> reference standards and (B) plasma following multiple oral doses of ezutromid (1.0 g, BID) in pediatric DMD subjects 8 h after the a.m. dose on day 7.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01547&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> De Novo Synthesis of Dihydrodiols DHD1 and DHD3</h3><div class="NLM_p">In order to assign the correct regio- and relative stereochemistries to the dihydrodiols DHD1 and DHD3, we carried out de novo chemical synthesis. Several previous studies on 1-naphthyl-containing molecules report preferential formation of 7,8-dihydrodiol or 5,6-dihydrodiol as the major (or only) metabolites.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30 ref31 ref32">(27â32)</a> On the basis of the proposed two-step epoxidationâtransdiaxial ring opening mechanism of 1,2-dihydrodiol formation,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> it was envisaged that the relative stereochemistries in both dihydrodiols were likely to be <i>trans</i>. Thus, authentic samples of <i>trans</i>-dihydrodiols <b>9</b> and <b>10</b>, reasoned to be the major metabolites from ezutromid, were synthesized from the corresponding naphthalenes (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/medium/jm9b01547_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route to <i>trans</i>-1,2-Dihydrodiols <b>9</b> and <b>10</b><sup>a</sup><sup>,</sup><sup>b</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01547&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label"><sup>a</sup></span>For each, one of two possible enantiomers is depicted, as absolute configuration was not unambiguously determined.</p><p class="last"><span class="fn-label"><sup>b</sup></span>Reagents and conditions: (a) (1) SOCl<sub>2</sub>, DMF, 1,4-dioxane, 80 Â°C, 1 h; (2) 2-amino-4-(ethylsulfonyl)phenol, MsOH, <i>p</i>-xylene, 140 Â°C, 48 h. (b) BBr<sub>3</sub>, DCM, 0â40 Â°C, 24 h. (c) IBX, DMF, rt, 90 min. (d) LiBH<sub>4</sub>, O<sub>2</sub>, rt, 24 h. (e) <i>o</i>-Chloranil, DMF, rt, 24 h.</p></p></figure><div class="NLM_p last">Regioisomeric 6-methoxy-2-naphthoic acid (<b>1</b>) and 7-methoxy-2-naphthoic acid (<b>2</b>) were treated sequentially with thionyl chloride, 2-amino-4-(ethylsulfonyl)phenol, and BBr<sub>3</sub> to afford naphthols <b>5</b> and <b>6</b> in good yields (67â84% over three steps). Oxidation of <b>5</b> and <b>6</b> with IBX gave 5,6-diketo and 7,8-diketo species <b>7</b> and <b>8</b>, respectively. Initial attempts to scale up the production of <b>9</b> resulted in partial oxidation of <b>5</b> to naphthalene diol <b>7a</b> or to a mixture of <b>7</b> and <b>7a</b>. However, treatment of <b>7a</b> with <i>o</i>-chloranil gave complete conversion to the diketo species <b>7</b>. Reduction of the diketo species to the final dihydrodiol products <b>9</b> and <b>10</b> was attempted under a range of conditions, including NaBH<sub>4</sub>, KBH<sub>4</sub>, Pd/C, LiAlH<sub>4</sub>, LiAlH(OtBu<sub>3</sub>)<sub>3</sub>, REDAL, DIBAL, in air, under oxygen, and in an inert atmosphere. Optimal conditions were found to be treatment with LiBH<sub>4</sub> under an oxygen atmosphere. The final products, <b>9</b> and <b>10</b>, were isolated as racemic mixtures after chromatography (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Supporting Information</a>). Compounds <b>9</b> and <b>10</b> were resolved into single enantiomers following chiral chromatography.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Metabolite Structure Determination and Verification</h3><div class="NLM_p">Unambiguous structure elucidation of <b>D1</b> (DHD1) and <b>D2</b> (DHD3) was achieved with full NMR assignment and comparison with the authentic samples obtained from chemical synthesis. Overlaying of the <sup>1</sup>H NMR spectra of <b>9</b> and <b>D1</b> showed complete overlap; similarly, overlaying of the spectra of <b>10</b> and <b>D2</b> also showed complete overlap (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Figures S18 and S19</a>). Full assignments were based on COSY for <i>J</i>-coupled pairs of protons and edited HSQC and HMBC correlations for the assignment of aromatic and aliphatic carbon-13 chemical shifts and their attached protons. The regiochemistry of both dihydrodiols was assigned by NOESY. For <b>D1</b>, determined to be the 6-benzoxazol-2-yl regioisomer, characteristic NOE correlations were observed between H<sub>8</sub> and H<sub>1</sub> and between alkene proton H<sub>4</sub> and naphthalene proton H<sub>5</sub> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a). In <b>D2</b>, determined to be the 7-benzoxazol-2-yl regioisomer, characteristic NOE correlations were observed between H<sub>8</sub> and H<sub>1</sub> and between H<sub>5</sub> and alkene proton H<sub>4</sub> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>b). In both regioisomers, a NOE correlation was observed between H<sub>2</sub> and H<sub>3</sub>, and no strong NOE correlation was observed between H<sub>1</sub> and H<sub>2</sub>, consistent with <i>trans</i> relative stereochemistry in both cases. The observed H<sub>1</sub>âH<sub>2</sub> cross peak was dominated by scalar coupling effects, with evidence of only a very weak NOE between the protons contributing to it. The assignment of <i>trans</i> relative stereochemistry was further supported by analysis of vicinal coupling constants in the <sup>1</sup>H NMR spectra: for both <b>D1</b> and <b>D2</b>, <sup>3</sup><i>J</i><sub>(H1,H2)</sub> = 10.5 Hz (<sup>3</sup><i>J</i><sub>(H2,H3)</sub> = 2.4 Hz). This is consistent with data for other reported <i>trans</i>-dihydrodiols,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> whereas <i>cis</i>-dihydrodiols have much lower recorded <i>J</i> values (i.e., 4.8 Hz).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/medium/jm9b01547_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. NOESY spectra and NOE correlations for structure elucidation of (a) <b>D1</b> and (b) <b>D2</b>. In each, one of two possible enantiomers is shown, as absolute configuration was not determined.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01547&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Determination of CYP-Mediated Metabolism of Ezutromid</h3><div class="NLM_p">Naphthalene has been shown to be predominantly metabolized by human CYP1A2 into the <i>trans</i>-1,2-dihydrodiol and to the 1-naphthol. CYP3A4 has also shown to induce metabolism to the 2-naphthol.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> To identify the main CYP isoforms involved in ezutromidâs metabolism, two approaches were employed. First, a panel of eight recombinant CYP isoform expression systems (bactosomes) were incubated with ezutromid (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Table S8</a>). Second, CYP isoform specific chemical inhibitors were used to determine their effects on ezutromid metabolism in HLM (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Table S9</a>).</div><div class="NLM_p">The shortest half-life for ezutromid was observed in the presence of the CYP1A1 (<i>T</i><sub>1/2</sub> = 2.16 min) and CYP1A2 (<i>T</i><sub>1/2</sub> = 2.62 min) bactosomes (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Table S8</a>). Turnover of ezutromid in the CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 bactosomes was minimal (<i>T</i><sub>1/2</sub> â¥ 180 min). Formation of DHD1 was observed upon incubation of ezutromid with CYP1A2, CYP2B6, and CYP2D6, although peak area ratios were small. Formation of DHD3 was not observed under any conditions.</div><div class="NLM_p">In HLM, turnover of ezutromid was decreased in the presence of inhibitors of CYP1A (CL<sub>int</sub> = 5.06 Î¼L/min/mg), CYP2B6 (CL<sub>int</sub> = 21.37 Î¼L/min/mg), and CYP2D6 (CL<sub>int</sub> = 35.1 Î¼L/min/mg) compared with that of the control (CL<sub>int</sub> = 50.67 Î¼L/min/mg) (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Table S9</a>). Ticlopidine was used as an FDA recommended inhibitor for CYP2B6; however, it has been shown to inhibit other CYP isoforms, including CYP1A2, at the concentration used in this study. It was therefore plausible and consistent with our observations of CYP1A1/2-mediated metabolism of ezutromid in bactosomes that the decrease in turnover of ezutromid in the presence of ticlopidine might result from CYP1A2 inhibition rather than CYP2B6 inhibition. This was further supported by the observation that decreased formation of both DHD1 and DHD3 was observed only in the presence of inhibitors of CYP1A (6 and 11% of control) and to a lesser extent CYP2D6 (65 and 66% of control). The CYP2D6 inhibitor used, quinidine, has been reported to be a relatively selective inhibitor, inhibiting CYP3A4 only at higher concentrations (IC<sub>50</sub> = 28 Î¼M);<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> thus, CYP2D6 appears to also be involved in ezutromidâs metabolism but to a lesser extent than CYP1A1/2.</div><div class="NLM_p last">In summary, the CYP1A1 and CYP1A2 enzymes appear to be the main P450 isoforms mediating ezutromidâs metabolism and the formation of DHD1 and DHD3 in vitro. On the basis of the methods used, CYP2C8, CYP2C9, CYP2C19, and CYP3A4 do not appear to be involved in the metabolism of this molecule, but CYP2D6 may also contribute to a lesser extent.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Ezutromid Metabolite Profiling upon Repeated Dosing</h3><div class="NLM_p">As there was a marked decrease in exposure after repeated dosing of ezutromid in DMD patients,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> the metabolic profile of ezutromid was investigated in rats after 1 and 28 days (2000 mg/kg). Consistent with the results from DMD patients, it was found that ezutromidâs clearance was higher after 28 days of dosing compared with that at day 1. After 24 h, notable levels of ezutromid (38â89%) were found in plasma (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Table S10</a>). A large variation in the extent of ezutromid metabolism was observed between animals. The most abundant metabolite observed (<i>T</i><sub>R</sub> = 4.57â4.61 min, 8â44%) was a dihydrodiol (<b>I</b>), followed by an isomeric dihydrodiol (<b>II</b>) (<i>T</i><sub>R</sub> = 4.98â5.00 min, 3â14%).</div><div class="NLM_p last">After 28 days of dosing, more extensive metabolism of ezutromid was observed (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Table S11</a>). Ezutromid was detected at low levels, and the two main metabolites were found in similar proportions to those at day 1 (<i>T</i><sub>R</sub> = 4.57â4.61, 50â70%, and <i>T</i><sub>R</sub> = 4.98â5.00 min, 10â12%, for dihydrodiols <b>I</b> and <b>II</b>, respectively). Two other metabolites were also present in significant amounts: a glucuronide conjugate of a dihydrodiol and the <i>O</i>-glucuronide conjugate of an aromatized diol. In urine, the composition of metabolites changed significantly, with dihydrodiol glucuronides being the most abundant (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Table S12</a>). The relative proportions of the remaining metabolites varied significantly between male and female rats.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> CYP Induction</h3><div class="NLM_p">As exposure to ezutromid was observed to decrease over time with concurrent increases in the levels of metabolites in both humans and rodents,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> the propensity of ezutromid and its two major metabolites, DHD1 and DHD3, to induce CYP expression was investigated. No significant induction of CYP1A1/2 was observed using in vitro systems where only a single dose was administered: after 48 h incubation of ezutromid (0.1â10 Î¼M) with rat hepatocytes, no significant difference in CYP1A1/2 mediated enzyme activity was observed (data not shown). Similarly, in human hepatocytes, incubation with ezutromid for 48 h did not result in significant induction of CYP1A2 (data not shown). However, ezutromid was observed to inhibit CYP1A2 enzymic activity in HLM with an IC<sub>50</sub> of 5.4 Î¼M.</div><div class="NLM_p">Although no evidence in support of CYP induction in vitro was observed, a marked elevation in 7-ethoxyresorufin <i>O</i>-deethylase (EROD) activity was observed after treatment with ezutromid (2000 mg/kg/day, po) for 28 days in rats. EROD enzyme activity was elevated 17â18-fold per milligram of protein, 21â22-fold per gram of liver, and 13â18-fold per nanomole of P450 (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Table S13</a>). No significant changes were observed in microsomal proteins or total P450 concentration. EROD activity is used as a proxy for induction of the CYP1A subfamily (CYP1A1 and CYP1A2);<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> thus, these data suggest that repeated oral administration of ezutromid in rats can result in induction of CYP1A, which are the principal enzymes responsible for mediating metabolism of ezutromid.</div><div class="NLM_p last">A similar trend was observed after administration of ezutromid (500 mg/kg/day) for 39 weeks in minipigs. No evidence of significant increases in microsomal protein concentrations and total cytochrome P450 content were observed (data not shown), but small increases in EROD and 7-pentoxyresorufin <i>O</i>-depentylase (PROD) activity (2.1- and 2.0-fold, respectively) were observed in female minipigs (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Table S14</a>). The magnitude of this effect was very low in comparison with that observed with other CYP1A and CYP2B inducers. The marked gender difference between the basal levels of CYP1A activity in minipigs (CYP1A2 and CYP2B activities are higher in female minipigs by 4- and 3.8-fold, respectively)<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> could account for the observed lack of increased EROD and PROD activity in male minipigs. No effect was observed on testosterone hydroxylase activity or lauric acid 11- or 12-hydroxylase activity, suggesting no induction of CYP3A, CYP2E1, or CYP4A, respectively.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Pharmacological Characterization and In Vitro PK Profiling of DHD1 and DHD3</h3><div class="NLM_p">As the two major metabolites, DHD1 and DHD3, were produced in significant amounts in vivo, and exposure exceeded that of ezutromid in some patients,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> a systematic analysis of the pharmacological activities, physicochemical properties, and pharmacokinetic and toxicological profiles of DHD1 and DHD3 was undertaken.</div><div class="NLM_p">Although both metabolites appeared to show comparable levels of activity to ezutromid in the H2K-<i>mdx</i> utrnA-luc assay,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> a luciferase reporter gene assay using a human muscle specific utrophin A promoter in mouse <i>mdx</i> myoblasts, differences were observed in the homogenous time-resolved fluorescence (HTRF) assay quantifying human utrophin protein in cell lysates of iDMD cells (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). In the latter assay, no increase in utrophin protein was observed upon treatment with DHD1 up to the highest concentration tested (10 Î¼M), whereas DHD3 was found to increase utrophin protein but with an approximately 6-fold reduction in potency compared with that of ezutromid. The molecular target of ezutromid and the mechanism through which it increases utrophin protein levels is not yet known, and so it is unclear at this stage whether DHD3 and ezutromid act through a common molecular target or distinct pathways leading to increases in utrophin protein. Studies are ongoing to resolve this question.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Assay Data for Monitoring Utrophin Upregulation by DHD1 and DHD3 Metabolites of Ezutromid</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="2" align="center" char="Â±">EC<sub>50</sub>Â Â±Â SEM<a class="ref internalNav" href="#t1fn2" aria-label="a">a</a>Â (Î¼M)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char="Â±">H2K<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="Â±">HTRF<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">DHD1</td><td class="colsep0 rowsep0" align="char" char="Â±">0.37Â Â±Â 0.08</td><td class="colsep0 rowsep0" align="char" char="Â±">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">DHD3</td><td class="colsep0 rowsep0" align="char" char="Â±">0.12Â Â±Â 0.03</td><td class="colsep0 rowsep0" align="char" char="Â±">8.35Â Â±Â 0.62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">ezutromid</td><td class="colsep0 rowsep0" align="char" char="Â±">0.11Â Â±Â 0.01</td><td class="colsep0 rowsep0" align="char" char="Â±">1.28Â Â±Â 0.24</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn2"><div class="footnote" id="t1fn2"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values were calculated using nonlinear regression (curve fit) from two biological replicates (three technical replicates each).</p></div><div class="footnote" id="t1fn1"><sup><sup>b</sup></sup><p class="last">Firefly luciferase reporter gene assay in H2K-<i>mdx</i> utrnA-luc cells.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">HTRF, homogeneous time-resolved fluorescence assay.</p></div></div></div><div class="NLM_p">Physicochemical and in vitro PK properties were also determined for DHD1 and DHD3 (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Both metabolites had measured log <i>D</i> values of around 2, with increased solubility and permeability, and higher unbound fractions to mouse and human plasma proteins compared with that of ezutromid (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Metabolic stability was measured in vitro in mouse and human S9 fractions and hepatocytes. DHD3 was found to be the more stable of the two metabolites in both mouse and human hepatocytes (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Physicochemical Profile and Plasma Protein Binding (100% Plasma) of DHD1 and DHD3 Metabolites of Ezutromid<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="rowsep1 colsep0" colspan="2" align="center">PPBÂ <i>F</i><sub>b</sub>Â (%)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">logÂ <i>D</i>Â (pHÂ 7.4)</th><th class="colsep0 rowsep0" align="center" char=".">KinSolÂ (Î¼M)</th><th class="colsep0 rowsep0" align="center" char=".">PAMPA<sub>pH7.4</sub> (Ã10<sup>â6</sup>Â cm/s)</th><th class="colsep0 rowsep0" align="center">mouse</th><th class="colsep0 rowsep0" align="center">human</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">DHD1</td><td class="colsep0 rowsep0" align="center">2.04</td><td class="colsep0 rowsep0" align="char" char=".">96</td><td class="colsep0 rowsep0" align="char" char=".">33.3</td><td class="colsep0 rowsep0" align="center">highly unbound</td><td class="colsep0 rowsep0" align="center">63.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">DHD3</td><td class="colsep0 rowsep0" align="center">1.95</td><td class="colsep0 rowsep0" align="char" char=".">210</td><td class="colsep0 rowsep0" align="char" char=".">34.4</td><td class="colsep0 rowsep0" align="center">92.3</td><td class="colsep0 rowsep0" align="center">87.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">ezutromid</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char=".">1â2</td><td class="colsep0 rowsep0" align="char" char=".">9.5</td><td class="colsep0 rowsep0" align="center">99.5</td><td class="colsep0 rowsep0" align="center">99.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">KinSol, kinetic aqueous solubility; PAMPA, parallel artificial membrane permeability assay; PPB, plasma protein binding; <i>F</i><sub>b</sub>, bound fraction.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Metabolic Stability of DHD1 and DHD3 Metabolites of Ezutromid in Mouse and Human Microsomes (S9 Fraction) and Hepatocytes (Hep)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="4" align="center" char="Â±"><i>T</i><sub>1/2</sub>Â Â±Â SDÂ (min)</th><th class="rowsep1 colsep0" colspan="4" align="center" char="Â±">CL<sub>int</sub>Â Â±Â SDÂ (Î¼L/min/mg)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="2" align="center" char="Â±">mouse</th><th class="rowsep1 colsep0" colspan="2" align="center" char="Â±">human</th><th class="rowsep1 colsep0" colspan="2" align="center" char="Â±">mouse</th><th class="rowsep1 colsep0" colspan="2" align="center" char="Â±">human</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char="Â±">S9</th><th class="colsep0 rowsep0" align="center" char="Â±">Hep</th><th class="colsep0 rowsep0" align="center" char="Â±">S9</th><th class="colsep0 rowsep0" align="center" char="Â±">Hep</th><th class="colsep0 rowsep0" align="center" char="Â±">S9</th><th class="colsep0 rowsep0" align="center" char="Â±">Hep</th><th class="colsep0 rowsep0" align="center" char="Â±">S9</th><th class="colsep0 rowsep0" align="center" char="Â±">Hep</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">DHD1</td><td class="colsep0 rowsep0" align="char" char="Â±">39Â Â±Â 1.8</td><td class="colsep0 rowsep0" align="char" char="Â±">7Â Â±Â 0.7</td><td class="colsep0 rowsep0" align="char" char="Â±">>138</td><td class="colsep0 rowsep0" align="char" char="Â±">85Â Â±Â 8.2</td><td class="colsep0 rowsep0" align="char" char="Â±">35Â Â±Â 1.3</td><td class="colsep0 rowsep0" align="char" char="Â±">98Â Â±Â 9.9</td><td class="colsep0 rowsep0" align="char" char="Â±"><10</td><td class="colsep0 rowsep0" align="char" char="Â±">8Â Â±Â 0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">DHD3</td><td class="colsep0 rowsep0" align="char" char="Â±">112Â Â±Â 26.2</td><td class="colsep0 rowsep0" align="char" char="Â±">143Â Â±Â 16.3</td><td class="colsep0 rowsep0" align="char" char="Â±">>138</td><td class="colsep0 rowsep0" align="char" char="Â±">142Â Â±Â 10.3</td><td class="colsep0 rowsep0" align="char" char="Â±">13Â Â±Â 3.1</td><td class="colsep0 rowsep0" align="char" char="Â±">5Â Â±Â 0.6</td><td class="colsep0 rowsep0" align="char" char="Â±"><10</td><td class="colsep0 rowsep0" align="char" char="Â±">5Â Â±Â 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">ezutromid</td><td class="colsep0 rowsep0" align="char" char="Â±">74Â Â±Â 7.8</td><td class="colsep0 rowsep0" align="char" char="Â±">Â </td><td class="colsep0 rowsep0" align="char" char="Â±">101Â Â±Â 4.5</td><td class="colsep0 rowsep0" align="char" char="Â±">Â </td><td class="colsep0 rowsep0" align="char" char="Â±">19Â Â±Â 2.0</td><td class="colsep0 rowsep0" align="char" char="Â±">Â </td><td class="colsep0 rowsep0" align="char" char="Â±">14Â Â±Â 0.6</td><td class="colsep0 rowsep0" align="char" char="Â±">Â </td></tr></tbody></table></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Preliminary Toxicology and Safety Assessment of Metabolites</h3><div id="sec2_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> UGT Turnover and UGT Inhibition by Ezutromid Metabolites</h4><div class="NLM_p last">No detectable turnover of DHD1 and DHD3 was observed in any of the uridine glucuronate transferase (UGT) incubations (<i>T</i><sub>1/2</sub> > 240 min). The CL<sub>int</sub> values for both DHD1 and DHD3 with all UGT enzymes were determined to be <5.8 Î¼L/min/pmol, and for UGT1A4, they were determined to be <2.9 Î¼L/min/pmol. The propensities of DHD1 and DHD3 to act as UGT inhibitors were also investigated. DHD1 was found to be an inhibitor of UGT1A9 and UGT1A3 (12 and 62% residual activity, respectively, at 10 Î¼M for DHD1); DHD3 was found to be a weak inhibitor of UGT1A9, UGT1A3, and UGT1A4 (45, 79, and 84% residual activity, respectively, at 10 Î¼M for DHD3, <a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Table S15</a>).</div></div><div id="sec2_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Interactions of Ezutromid Metabolites with Liver Transporter Proteins</h4><div class="NLM_p last">The potential of DHD1 and DHD3 to cause drug-induced liver injury was evaluated by screening them against a panel of hepatic transporters in vitro (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Table S16</a>). Both metabolites were found to inhibit the breast cancer resistance protein (BCRP) efflux transporter, with IC<sub>50</sub> values in the low micromolar range, and the organic anion transporter protein (OATP) uptake receptors OATP1B1 and OATP1B3, with IC<sub>50</sub> values in the mid micromolar range. DHD1 was also observed to inhibit the multidrug and toxic compound extrusion (MATE) transporter 1, with an IC<sub>50</sub> value of 10 Î¼M (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Table S16</a>). No other interactions were observed. DHD1 and DHD3 were also assessed as substrates for BCRP, MDR1, MDR4, OAT1B1, and OAT1B3. No evidence of transport or uptake was observed for either metabolite (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Table S16</a>).</div></div><div id="sec2_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Secondary Pharmacology of Ezutromid Metabolites</h4><div class="NLM_p last">DHD1 and DHD3 were screened at 10 Î¼M against a panel of 87 receptors and enzymes (CEREP). No significant interactions were noted with DHD3, but DHD1 was found to inhibit monoamino oxidase B (MAO-B) and the adenosine transporter (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Graph S1 and Table S17</a>). In a follow up study, DHD1 was found to inhibit MAO-B and the adenosine transporter, with IC<sub>50</sub> values of 4.0 and 3.9 Î¼M, respectively.</div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78665" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78665" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The metabolic fate of ezutromid was evaluated using in vitro and in vivo systems. Hepatic clearance was found to be the main route of ezutromidâs metabolism. Oxidative metabolism, predominantly mediated by CYP1A, led to the formation of 1,2-dihydrodiols DHD1 and DHD3, produced as the two major metabolites in mice, rats, and minipigs, consistent with observations in human plasma. Comparison of analytical and spectroscopic data of DHD1 and DHD3, the dihydrodiol metabolites produced from mice and authentic samples accessed through chemical synthesis allowed the regio- and stereochemical assignment of the structures of both metabolites. Although the metabolic fates of 1-substituted-naphthalene-containing drugs have been profiled, this study provides an insight into the metabolic fate of a 2-substituted naphthalene in mammals and humans, which are less well exemplified in the literature.</div><div class="NLM_p last">The pharmacological, pharmacokinetic, and toxicological profiles of the two metabolites, DHD1 and DHD3, were investigated. Both appear to be equipotent to ezutromid in the luciferase reporter gene assay; however, DHD3 was found to be 6-fold less potent than ezutromid in an HTRF assay monitoring increases in utrophin protein levels. DHD1 was inactive in the HTRF assay. The physicochemical and in vitro pharmacokinetic properties of DHD1 and DHD3 were shown to be more favorable than those of ezutromid; they showed improved solubility, permeability, metabolic stability, and reduced plasma protein binding. DHD1 or DHD3 were found to have acceptable toxicological profiles: no significant interactions with hepatic transporters or other receptors, ion channels, or enzymes were observed for either metabolite.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51657" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51657" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedures</h3><div class="NLM_p">All reactions involving moisture-sensitive reagents were carried out under a nitrogen or argon atmosphere using standard vacuum line techniques and glassware that was flame-dried and cooled under nitrogen before use. Water was purified by an Elix UV-10 system. All other reagents were used as supplied (analytical or HPLC grade) without prior purification. Thin layer chromatography was performed on aluminum plates coated with 60 F254 silica. Flash column chromatography was performed either on Kieselgel 60 silica on a glass column or on a Biotage SP4 automated flash column chromatography platform. Melting points were recorded on a EZ-Melt Automated Melting Point Apparatus (EZ Melt) and are uncorrected. NMR spectra were recorded on Bruker Avance III spectrometers (at 400 or 500 MHz) using the deuterated solvent stated at room temperature. The field was locked by external referencing to the relevant deuteron resonance. Optical rotations were recorded on a PerkinElmer 241 polarimeter with a water-jacketed 1 cm cell. Specific rotations are reported in 10<sup>â1</sup> deg cm<sup>2</sup> g<sup>â1</sup>, and concentrations are reported in grams per 100 mL. Accurate mass measurements were run on either a Bruker MicroTOF internally calibrated with polyalanine, or a Micromass GCT instrument fitted with a Scientific Glass Instruments BPX5 column (15 m Ã 0.25 mm) using amyl acetate as a lock mass. Purities of the compounds were determined by high performance liquid chromatography (HPLC) and were 95% or higher in all cases. The instrument used was a Waters Acquity H-Class consisting of an Acquity UPLC PDA Detector, an Acquity Quaternary Solvent Manager, and an Acquity QDa mass detector. The columns and conditions varied. For chemical purity determination, the column was an Acquity BEH C18 1.7 Î¼m particle size (50 Ã 2.1 mm); eluent A was 0.1% TFA, and eluent B was 0.1% TFA in MeCN; the gradient is provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Supporting Information</a>; the flow rate was 0.6 mL/min; the column temperature was 40 Â°C; and the injection volume was 1.0 Î¼L. Enantiopurities were determined on the same instrument with a Lux iC5 particle size 5 Î¼M (4.6 mm Ã 250 mm) and a Lux iC5 particle size 5 Î¼M (4.6 mm Ã 250 mm) column for <b>D1</b> (<b>9</b>) and <b>D2</b> (<b>10</b>), respectively; the eluent was 50:50 EtOH (or MeOH)/CO<sub>2</sub> (0.2%, v/v, NH<sub>3</sub>), isocratic; the flow rate was 4 mL/min; the column temperature was 40 Â°C; and the injection volume was 1.0 Î¼L. An EnVision 2103 Multilabel plate reader (PerkinElmer) with 620 and 665 nm emission filters was used for the HTRF assay. Experiments conducted in CROs used their standard equipment.</div><div class="NLM_p last">The 28 day oral (gavage) administration of ezutromid study in rats and the 39 week oral (gavage) administration of ezutromid study in minipigs were designed to meet the known requirements of European Directive 2001/83/EC and all subsequent amendments, together with any relevant International Conference on Harmonisation (ICH) guidelines.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Materials</h3><div class="NLM_p last">The starting material for DHD1 (7-methoxy-2-naphthoic acid) was provided by Synthesis Med Chem Pty Ltd.; [<sup>14</sup>C]ezutromid was synthesized at Covance Laboratories Ltd. (the synthetic scheme and analytical data are reported in <a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Scheme S1</a>). Liver and intestine microsomes for intrinsic clearance of ezutromid were obtained from Xenotech and included the following: human microsomes (pooled, mixed gender), monkey microsomes (cynomolgus, pooled male), dog microsomes (Beagle, pooled male), and rat microsomes (Sprague-Dawley, pooled male); pooled human liver microsomes (pooled male and female) for the in vitro metabolite identification study in human liver microsomes were prepared at Cyprotex. Microsomes were stored at â80 Â°C prior to use. Î²-Naphthoflavone/phenobarbital induced rat S9 was obtained from Xenotech (Product No. R1081.S9, Lot No. 710507 for day 1 and Lot No. 1510257 for days 2â5). UltraPool human liver microsomes 150 were used in the P450 time-dependent inhibition and UGT phenotyping and inhibition studies.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Metabolite Extractions from Induced Rat S9</h3><div class="NLM_p">In brief, ezutromid (100 Î¼g/mL) was incubated with Î²-naphthoflavone/phenobarbital induced rat S9 (0.5 mg/mL protein concentration) and NADPH (3 mM) for 7 h. The mixture was then quenched with ice-cold methanol and centrifuged to remove excess protein, and the solvents were removed. After chiral separation (Reach separations, complete method described in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Supporting Information</a>), 120 mg of <b>D1</b> and 11 mg of <b>D2</b> were obtained from 188 mg of ezutromid.</div><div id="sec4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <b>D1</b></h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) Î´ 8.29 (dd, <i>J</i> = 1.8, 0.6 Hz, 1H), 8.18 (dd, <i>J</i> = 8.0, 1.8 Hz, 1H), 8.01 (dd, <i>J</i> = 7.2, 1.8 Hz, 1H), 7.98 (d, <i>J</i> = 1.8 Hz, 1H), 7.94 (dd, <i>J</i> = 8.5, 0.7 Hz, 1H), 7.79 (dd, <i>J</i> = 7.9, 1.2 Hz, 1H), 6.59 (dd, <i>J</i> = 9.9, 2.3 Hz, 1H), 6.08 (dd, <i>J</i> = 9.8, 2.4 Hz, 1H), 4.77 (dd, <i>J</i> = 10.5, 1.2 Hz, 1H), 4.43 (dt, <i>J</i> = 10.5, 2.4 Hz, 1H), 3.29 (q, <i>J</i> = 7.4 Hz, 2H), 1.26 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (125.5 MHz, MeOH-<i>d</i><sub>4</sub>) Î´ 166.8, 155.2, 143.7, 136.9, 135.1, 134.2, 128.2, 127.4, 126.8, 126.7, 126.3, 121.5, 112.9, 75.5, 73.7, 51.6, 7.7. [Î±<sub class="stack">D</sub><sup class="stack">25</sup> ] â46.8 [<i>c</i> 0.1, MeOH].</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <b>D2</b></h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, MeOH-<i>d</i><sub>4</sub>) Î´ 8.48 (d, <i>J</i> = 1.6 Hz, 1H), 8.33â8.27 (m, 1H), 8.17 (ddd, <i>J</i> = 7.9, 1.9, 0.8 Hz, 1H), 7.98 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 7.94 (dd, <i>J</i> = 8.5, 0.6 Hz, 1H), 7.34 (d, <i>J</i> = 7.9 Hz, 1H), 6.56 (dd, <i>J</i> = 9.8, 2.3 Hz, 1H), 6.13 (dd, <i>J</i> = 9.8, 2.5 Hz, 1H), 4.78 (dd, <i>J</i> = 10.5, 1.3 Hz, 1H), 4.45 (dt, <i>J</i> = 10.5, 2.4 Hz, 1H), 3.29 (s, 2H), 1.26 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (125.5 MHz, MeOH-<i>d</i><sub>4</sub>) Î´ 166.9, 155.2, 143.8, 140.0, 138.3, 136.9, 135.6, 128.6, 128.0, 127.6, 126.7, 126.1, 121.5, 112.8, 75.2, 73.9, 51.6, 7.7. [Î±<sub class="stack">D</sub><sup class="stack">25</sup> ] â177.5 [<i>c</i> 0.1, MeOH].</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Chemistry</h3><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> General Method for the Synthesis of Naphthols</h4><div class="NLM_p last">To a solution of <b>1</b> or <b>2</b> (3.0 g, 14.8 mmol) in 1,4-dioxane (20 mL), DMF (0.1 mL) and SOCl<sub>2</sub> (2.0 mL, 26.4 mmol) were added dropwise and refluxed for 1 h. The solvents were evaporated, and the crude material was used in the next step.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 6-Methoxy-2-naphthoyl Chloride</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, C<i>D</i>Cl<sub>3</sub>) Î´ 8.67 (d, <i>J</i> = 2.0 Hz, 1H), 8.03 (dd, <i>J</i> = 8.7, 1.9 Hz, 1H), 7.90 (d, <i>J</i> = 9.0 Hz, 1H), 7.79 (d, <i>J</i> = 8.7 Hz, 1H), 7.24 (s, 1H), 7.17 (d, <i>J</i> = 2.5 Hz, 1H), 3.97 (s, 3H).</div></div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 7-Methoxy-2-naphthoyl Chloride</h4><div class="NLM_p"><sup>1</sup>H NMR (400 MHz, C<i>D</i>Cl<sub>3</sub>) Î´ 8.64 (dt, <i>J</i> = 1.8, 0.7 Hz, 1H), 7.92 (dd, <i>J</i> = 8.6, 1.9 Hz, 1H), 7.84 (d, <i>J</i> = 8.7 Hz, 1H), 7.80 (d, <i>J</i> = 8.8 Hz, 1H), 7.33 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 7.28 (d, <i>J</i> = 2.5 Hz, 1H), 3.96 (s, 3H).</div><div class="NLM_p last">A solution of the crude naphthoyl chloride (14.8 mmol) and 2-amino-4-(ethylsulfonyl)phenol (1.5 g, 14.8 mmol) was refluxed in <i>p</i>-xylene for 1 h. Then, MsOH (0.15 mL) was added and refluxed for 2 days. The reaction was cooled to room temperature, partitioned between EtOAc (2 Ã 100 mL) and saturated aqueous NaHCO<sub>3</sub>(100 mL), washed with brine (100 mL), and dried over MgSO<sub>4</sub>. The crude material was used in the next step.</div></div><div id="sec4_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 5-(Ethylsulfonyl)-2-(6-methoxynaphthalen-2-yl)benzo[<i>d</i>]oxazole (<b>3</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, C<i>D</i>Cl<sub>3</sub>) Î´ 8.73â8.69 (m, 1H), 8.33 (d, <i>J</i> = 1.6 Hz, 1H), 8.26 (dd, <i>J</i> = 8.5, 1.7 Hz, 1H), 7.93 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 7.88 (t, <i>J</i> = 9.0 Hz, 2H), 7.75 (d, <i>J</i> = 8.4 Hz, 1H), 7.24 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 7.19 (d, <i>J</i> = 2.5 Hz, 1H), 3.97 (s, 3H), 3.19 (q, <i>J</i> = 7.4 Hz, 2H), 1.31 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (125.5 MHz, C<i>D</i>Cl<sub>3</sub>) Î´ 166.0, 159.8, 154.0, 143.1, 137.0, 135.3, 130.8, 128.9, 128.4, 127.9, 125.3, 124.7, 121.2, 120.9, 120.3, 111.4, 106.1, 55.6, 51.2, 7.8.</div></div><div id="sec4_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 5-(Ethylsulfonyl)-2-(7-methoxynaphthalen-2-yl)benzo[<i>d</i>]oxazole (<b>4</b>)</h4><div class="NLM_p"><sup>1</sup>H NMR (400 MHz, C<i>D</i>Cl<sub>3</sub>) Î´ 8.67 (d, <i>J</i> = 1.7 Hz, 1H), 8.34 (dd, <i>J</i> = 1.8, 0.6 Hz, 1H), 8.13 (dd, <i>J</i> = 8.5, 1.7 Hz, 1H), 7.93 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 7.90 (d, <i>J</i> = 8.5 Hz, 1H), 7.81â7.76 (m, 1H), 7.74 (dd, <i>J</i> = 8.4, 0.6 Hz, 1H), 7.29â7.20 (m, 2H), 3.94 (d, <i>J</i> = 8.3 Hz, 3H), 3.19 (q, <i>J</i> = 7.4 Hz, 2H), 1.31 (t, <i>J</i> = 7.4 Hz, 3H).</div><div class="NLM_p last">BBr<sub>3</sub> (1.0 M in CH<sub>2</sub>Cl<sub>2</sub>, 43.6 mL, 43.6 mmol) was added dropwise to <b>3</b> or <b>4</b> at 0 Â°C, and the reaction was warmed to 40 Â°C. After 24 h, the reaction was cooled at 0 Â°C, quenched with water, extracted with CHCl<sub>3</sub>/<i>i</i>PrOH (3:1, 3 Ã 50 mL), and dried over MgSO<sub>4</sub>, and the solvents were evaporated in vacuo. The residue was triturated with ether to obtain 4.43 g of <b>5</b> (84% yield over three steps) or 3.41 g of <b>6</b> (67% yield over three steps). Both procedures were scaled up to 25 g with minor changes in yield (61 and 70% for <b>5</b> and <b>6</b>, respectively).</div></div><div id="sec4_6_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 6-(5-(Ethylsulfonyl)benzo[<i>d</i>]oxazol-2-yl)naphthalen-2-ol (<b>5</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.26 (s, 1H), 8.76 (d, <i>J</i> = 1.8 Hz, 1H), 8.29 (d, <i>J</i> = 1.9 Hz, 1H), 8.16 (dd, <i>J</i> = 8.7, 1.8 Hz, 1H), 8.08 (d, <i>J</i> = 4.0 Hz, 1H), 8.06 (d, <i>J</i> = 4.2 Hz, 1H), 7.94 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 7.92 (d, <i>J</i> = 8.7 Hz, 1H), 7.24 (d, <i>J</i> = 2.4 Hz, 1H), 7.22 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 3.39 (q, <i>J</i> = 7.3 Hz, 2H), 1.13 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (125.5 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.2, 157.8, 153.2, 142.2, 136.7, 135.3, 131.1, 128.6, 127.3, 127.1, 125.1, 123.9, 120.0, 119.7, 111.8, 109.0, 49.5, 7.3. HRMS (ESI): [M â H]<sup>â</sup> 352.064â¯38 (error: â1.45 ppm).</div></div><div id="sec4_6_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 7-(5-(Ethylsulfonyl)benzo[<i>d</i>]oxazol-2-yl)naphthalen-2-ol (<b>6</b>)</h4><div class="NLM_p last">mp 273â275 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.07 (s, 1H), 8.65 (d, <i>J</i> = 1.6 Hz, 1H), 8.32 (d, <i>J</i> = 1.8 Hz, 1H), 8.08 (d, <i>J</i> = 8.5 Hz, 1H), 8.03 (dd, <i>J</i> = 8.5, 1.7 Hz, 1H), 8.00 (d, <i>J</i> = 8.6 Hz, 1H), 7.96 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 7.89 (d, <i>J</i> = 8.8 Hz, 1H), 7.39 (d, <i>J</i> = 2.4 Hz, 1H), 7.25 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 3.40 (q, <i>J</i> = 7.3 Hz, 2H), 1.14 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (125.5 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.5, 156.9, 153.7, 142.5, 135.9, 134.7, 130.0, 129.8, 129.4, 127.2, 125.8, 123.6, 121.7, 120.9, 120.4, 112.4, 110.4, 50.0, 7.7. HRMS (ESI): [M + H]<sup>+</sup> 354.079â¯16 (error: â0.83 ppm).</div></div><div id="sec4_6_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> General Method for the Synthesis of Diols</h4><div class="NLM_p last">To a stirred solution of <b>5</b> or <b>6</b> (1.0 g, 2.8 mmol) in DMF (10 mL) under a N<sub>2</sub> atmosphere, stabilized IBX (800 mg, 2.8 mmol) was added portionwise at 0 Â°C. The resulting mixture was stirred at rt for 48 h, and then Et<sub>2</sub>O (5 mL) was added. The mixture was filtered and rinsed with Et<sub>2</sub>O (10 mL). The collected orange solid was redissolved with <i>i</i>PrOH/CHCl<sub>3</sub> (1:3, 400 mL), washed with saturated aqueous NaHCO<sub>3</sub> (200 mL), dried over MgSO<sub>4</sub>, and concentrated in vacuo to give a bright orange solid (1.05 g, quant). Scale-up to 20 g gave the two products in very good to excellent yields (86 and 95% for <b>7</b> and <b>8</b>, respectively).</div></div><div id="sec4_6_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 6-(5-(Ethylsulfonyl)benzo[<i>d</i>]oxazol-2-yl)naphthalene-1,2-dione (<b>7</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, C<i>D</i>Cl<sub>3</sub>) Î´ 8.43â8.39 (m, 1H), 8.33 (d, <i>J</i> = 1.6 Hz, 1H), 8.31 (d, <i>J</i> = 8.1 Hz, 1H), 8.05â8.00 (m, 2H), 7.82 (dd, <i>J</i> = 8.6, 0.6 Hz, 1H), 7.60 (d, <i>J</i> = 10.1 Hz, 1H), 6.59 (d, <i>J</i> = 10.2 Hz, 1H), 3.20 (q, <i>J</i> = 7.4 Hz, 2H), 1.33 (t, <i>J</i> = 7.4 Hz, 3H).</div></div><div id="sec4_6_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 7-(5-(Ethylsulfonyl)benzo[<i>d</i>]oxazol-2-yl)naphthalene-1,2-dione (<b>8</b>)</h4><div class="NLM_p"><sup>1</sup>H NMR (400 MHz, C<i>D</i>Cl<sub>3</sub>) Î´ 8.98 (d, <i>J</i> = 1.8 Hz, 1H), 8.58 (dd, <i>J</i> = 7.9, 1.8 Hz, 1H), 8.39 (dd, <i>J</i> = 1.8, 0.6 Hz, 1H), 8.00 (dd, <i>J</i> = 8.6, 1.8 Hz, 1H), 7.81 (d, <i>J</i> = 8.8 Hz, 1H), 7.61 (d, <i>J</i> = 8.0 Hz, 1H), 7.56 (d, <i>J</i> = 10.1 Hz, 1H), 6.60 (d, <i>J</i> = 10.1 Hz, 1H), 3.20 (q, <i>J</i> = 7.4 Hz, 2H), 1.32 (t, <i>J</i> = 7.4 Hz, 3H).</div><div class="NLM_p">The residue of <b>7</b> or <b>8</b> (1.05 g, 2.8 mmol) was suspended in EtOH (50 mL) under an O<sub>2</sub> atmosphere, and LiBH<sub>4</sub> (0.25 g, 11.3 mmol) was added at 0 Â°C. The resultant mixture was stirred at rt for 24 h. The solvents were evaporated in vacuo, and the resulting residue was then partitioned between H<sub>2</sub>O (250 mL) and DCM/EtOAc (1:1, 250 mL Ã 2), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. Thus, 283 mg of <b>9</b> and 242 mg of <b>10</b> were obtained (27 and 23% yields for <b>9</b> and <b>10</b>, respectively) as crude material for further chromatographic purification (vide infra).</div><div class="NLM_p last">The last step was not scaled up significantly, and it was run up to a 2.5 g scale. For this reason, several batches were combined to derive the desired product in adequate quantities. For example, from 3.48 g of combined <b>7</b>, 1.69 g of <b>9</b> were obtained, and from 5.2 g of combined <b>8</b>, 2.4 g of <b>10</b> were obtained (48 and 46% yields for <b>9</b> and <b>10</b>, respectively) as crude material for further purification.</div></div><div id="sec4_6_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Purification of <b>9</b></h4><div class="NLM_p last">The crude material was then purified by HPLC with a Waters CSH C18 column and MeCN/H<sub>2</sub>O/NH<sub>3</sub> as the mobile phase, followed by chiral supercritical fluid chromatography (SFC) with a Lux iC5 column in 45:55 EtOH/CO<sub>2</sub> (0.2% NH<sub>3</sub>) (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Supporting Information</a>). For the small scale, 39.1 and 36.8 mg of the two enantiomers were obtained (3.75 and 3.53% yields, respectively). The combined scaled up material gave 263 and 238 mg (5.61 and 5.08% yields, respectively). The order in which the two enantiomers are reported is the order of elution. The first enantiomer had a similar retention time to that of <b>D1</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec4_6_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Purification of <b>10</b></h4><div class="NLM_p last">The crude material was then purified by achiral SFC with a Torus Diol column in 80:20 MeOH/CO<sub>2</sub> and then by chiral chromatography with a Lux C3 column in 50:50 MeOH/CO<sub>2</sub> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Supporting Information</a>). For the small scale, 23.5 and 24.2 mg of the two enantiomers were obtained (3.73 and 3.84% yields, respectively). The combined scaled up material gave 341 and 349 mg (6.49 and 6.64% yields, respectively). The first enantiomer had a similar retention time to that of <b>D2</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec4_6_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (1,2-<i>trans</i>)-6-(5-(Ethylsulfonyl)benzo[<i>d</i>]oxazol-2-yl)-1,2-dihydronaphthalene-1,2-diol (<b>9</b>)</h4><div class="NLM_p last">mp 193â194 Â°C. <sup>1</sup>H NMR (500 MHz, MeOH-<i>d</i><sub>4</sub>) Î´ 8.27 (d, <i>J</i> = 1.9 Hz, 1H), 8.15 (dd, <i>J</i> = 8.0, 1.8 Hz, 1H), 7.99 (d, <i>J</i> = 1.8 Hz, 1H), 7.98 (dd, <i>J</i> = 8.6, 1.8 Hz, 1H), 7.92 (d, <i>J</i> = 8.5 Hz, 1H), 7.78 (dd, <i>J</i> = 8.0, 1.2 Hz, 1H), 6.58 (dd, <i>J</i> = 9.9, 2.3 Hz, 1H), 6.07 (dd, <i>J</i> = 9.8, 2.5 Hz, 1H), 4.77 (dd, <i>J</i> = 10.5, 1.2 Hz, 1H), 4.43 (dt, <i>J</i> = 10.5, 2.4 Hz, 1H), 3.30 (q, <i>J</i> = 7.4 Hz, 2H), 1.26 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (125.5 MHz, MeOH-<i>d</i><sub>4</sub>) Î´ 166.8, 155.2, 143.7, 143.7, 136.9, 135.1, 134.2, 128.2, 127.40, 127.37, 126.8, 126.7, 126.3, 121.5, 112.9, 75.5, 73.7, 51.6, 7.7.</div></div><div id="sec4_6_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (1,2-<i>trans</i>)-7-(5-(Ethylsulfonyl)benzo[<i>d</i>]oxazol-2-yl)-1,2-dihydronaphthalene-1,2-diol (<b>10</b>)</h4><div class="NLM_p last">mp 200â202 Â°C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.37 (d, <i>J</i> = 1.5 Hz, 1H), 8.29 (d, <i>J</i> = 1.9 Hz, 1H), 8.09 (dd, <i>J</i> = 7.9, 1.9 Hz, 1H), 8.08 (d, <i>J</i> = 8.5 Hz, 1H), 7.95 (dd, <i>J</i> = 8.5, 1.9 Hz, 1H), 7.37 (d, <i>J</i> = 7.9 Hz, 1H), 6.52 (dd, <i>J</i> = 9.8, 2.3 Hz, 1H), 6.08 (dd, <i>J</i> = 9.8, 2.3 Hz, 1H), 5.85 (s, 1H), 5.39 (s, 1H), 4.65 (d, <i>J</i> = 10.8 Hz, 1H), 4.32 (d, <i>J</i> = 10.8 Hz, 1H), 3.39 (q, <i>J</i> = 7.4 Hz, 2H), 1.13 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (125.5 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.7, 153.2, 142.0, 139.6, 136.7, 136.4, 135.4, 126.9, 126.7, 125.6, 125.3, 124.6, 124.1, 119.9, 112.0, 73.3, 71.9, 49.5, 7.2. [Î±<sub class="stack">D</sub><sup class="stack">25</sup> ] â172.6 [<i>c</i> 0.1, MeOH].</div></div><div id="sec4_6_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Catechol Intermediate and Oxidation Product (1,2-<i>trans</i>)-6-(5-(Ethylsulfonyl)benzo[<i>d</i>]oxazol-2-yl)-1,2-dihydronaphthalene-1,2-diol</h4><div class="NLM_p">To a stirred solution of <b>5</b> (20.6 g, 58.3 mmol) in DMF (200 mL) under a N<sub>2</sub> atmosphere, stabilized IBX (16.3 g, 58.3 mmol) was added portionwise at 0 Â°C. The resulting mixture was stirred at rt for 48 h, and then water (1000 mL) was added. The mixture was filtered, basified with NaHCO<sub>3</sub>, and filtered again, and the precipitate was washed with water (3 Ã 100 mL), THF (2 Ã 100 mL), and Et<sub>2</sub>O (18.2 g of <b>7a</b> was collected).</div><div class="NLM_p"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.49 (s, 1H), 8.38 (d, <i>J</i> = 1.3 Hz, 1H), 8.37â8.33 (m, 1H), 8.20â8.15 (m, 1H), 8.14 (dd, <i>J</i> = 8.6, 0.6 Hz, 1H), 8.02 (dd, <i>J</i> = 8.6, 1.8 Hz, 1H), 7.88 (m, 1H), 6.52 (d, <i>J</i> = 10.1 Hz, 1H), 3.41 (q, <i>J</i> = 7.3 Hz, 2H), 1.14 (t, <i>J</i> = 7.3 Hz, 3H). LCMS (ESI+) 370.1 [M + H]<sup>+</sup>, (ESIâ) 368.1 [M + H]<sup>â</sup>.</div><div class="NLM_p last">To a solution of <b>7a</b> (5.00 g, approximately 13.5 mmol) in DMF (10 mL), tetrachloro-<i>o</i>-benzoquinone (8.65 g, 35.2 mmol) was added under a N<sub>2</sub> atmosphere, and the resulting mixture was stirred at room temperature for 24 h. The mixture was then poured into water (100 mL), and the precipitate was collected by filtration and washed with water (4.64 g, 79%). The spectroscopic data were identical to that of <b>7</b>.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01547" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71855" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71855" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b01547" class="ext-link">10.1021/acs.jmedchem.9b01547</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Additional tables, figures, schemes, graphs, experimental procedures, and copies of NMR spectra (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf">jm9b01547_si_001.pdf (19.73 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_002.csv">jm9b01547_si_002.csv (0.63 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01547" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32237" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32237" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela J. Russell</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Oxford, Chemistry
Research Laboratory, Mansfield Road, Oxford OX1 3TA, United Kingdom</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3PQ, United
Kingdom</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3610-9369" title="Orcid link">http://orcid.org/0000-0003-3610-9369</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e1808f86848d80cf93949292848d8da18289848ccf8e99cf8082cf948a"><span class="__cf_email__" data-cfemail="7d1c131a18111c530f080e0e1811113d1e151810531205531c1e530816">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Chatzopoulou</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Oxford, Chemistry
Research Laboratory, Mansfield Road, Oxford OX1 3TA, United Kingdom</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1886-7705" title="Orcid link">http://orcid.org/0000-0003-1886-7705</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tim D. W. Claridge</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Oxford, Chemistry
Research Laboratory, Mansfield Road, Oxford OX1 3TA, United Kingdom</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5583-6460" title="Orcid link">http://orcid.org/0000-0001-5583-6460</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kay E. Davies</span> - <span class="hlFld-Affiliation affiliation">Department
of Physiology, Anatomy and Genetics, MDUK Oxford Neuromuscular Centre, University of Oxford, Oxford OX1 3PT, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen G. Davies</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Oxford, Chemistry
Research Laboratory, Mansfield Road, Oxford OX1 3TA, United Kingdom</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3181-8748" title="Orcid link">http://orcid.org/0000-0003-3181-8748</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David J. Elsey</span> - <span class="hlFld-Affiliation affiliation">Summit
Therapeutics plc, 136a
Eastern Avenue, Milton Park, Abingdon OX14 4SB, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Enrico Emer</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Oxford, Chemistry
Research Laboratory, Mansfield Road, Oxford OX1 3TA, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ai M. Fletcher</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Oxford, Chemistry
Research Laboratory, Mansfield Road, Oxford OX1 3TA, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shawn Harriman</span> - <span class="hlFld-Affiliation affiliation">Summit
Therapeutics plc, One
Broadway, 14th Floor, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Neil Robinson</span> - <span class="hlFld-Affiliation affiliation">S.H.B.
Enterprises Ltd., 55
Station Road, Beaconsfield HP19 1QL, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jessica A. Rowley</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Oxford, Chemistry
Research Laboratory, Mansfield Road, Oxford OX1 3TA, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathon M. Tinsley</span> - <span class="hlFld-Affiliation affiliation">Summit
Therapeutics plc, 136a
Eastern Avenue, Milton Park, Abingdon OX14 4SB, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Weaver</span> - <span class="hlFld-Affiliation affiliation">XenoGesis
Ltd., BioCity Nottingham, Pennyfoot Street, Nottingham NG1 1GF, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isabel V. L. Wilkinson</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Oxford, Chemistry
Research Laboratory, Mansfield Road, Oxford OX1 3TA, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicky J. Willis</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Oxford, Chemistry
Research Laboratory, Mansfield Road, Oxford OX1 3TA, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francis X. Wilson</span> - <span class="hlFld-Affiliation affiliation">Summit
Therapeutics plc, 136a
Eastern Avenue, Milton Park, Abingdon OX14 4SB, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Graham M. Wynne</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Oxford, Chemistry
Research Laboratory, Mansfield Road, Oxford OX1 3TA, United Kingdom</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): D.J.E., S.H., N.R., J.M.T., and F.X.W. are or were Summit Therapeutics plc employees or consultants at the time that the work was conducted.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67622" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67622" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors wish to thank Summit Therapeutics plc (M.C., E.E., A.M.F., J.A.R., N.J.W.), the Medical Research Council (EP/L016044/1, I.V.L.W.; 1501AV003/CA2, K.E.D.), the Engineering and Physical Sciences Research Council (EP/L016044/1, I.V.L.W.), and Duchenne UK (N.J.W.) for financial support. The authors kindly acknowledge Synthesis Med Chem (U.K.) and Charnwood Molecular (U.K.) for the scale-ups for synthetic DHD1 and DHD3; Cerep (U.S.) for performing the experiments for intrinsic clearance of ezutromid in microsomes of different species, the in vitro metabolite identification study for ezutromid in HLM, and the secondary pharmacology evaluation for metabolites <b>D1</b> and <b>D2</b>; Cyprotex Discovery Ltd (U.K.) for the CYP 450 phenotyping, induction, and inhibition studies and the UGT phenotyping and inhibition studies; Covance Laboratories Ltd. (U.K.) for the in vivo radiochemical metabolite identification study for ezutromid in mice, the 28 day study in rats, and the 39 week study in minipigs; Reach Separations Ltd. (U.K.) for the chiral separations and determination of chemical and chiral purity; Albany Molecular Research Inc. (AMRI, U.S.) for the study of the in vitro production of dihydrodiol metabolites with MicroCyp enzymes, recombinant human cytochrome P450, and a microbial biocatalyst panel; Absorption Systems for the study of the biomimetic generation of dihydrodiols in human liver microsomes; XenoGesis Ltd. (U.K.) for the production of the dihydrodiols by induced rat S9; Q<sup>2</sup> Solutions for metabolite structure determination and verification studies; Evotec (France) for performing the HTRF measurements; Evotec (U.K.) for physicochemical and ADME evaluation; and SOLVO Biotechnology for the transporter interactions studies.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">administration, distribution, metabolism, excretion, and toxicity</p></td></tr><tr><td class="NLM_term">BCRP</td><td class="NLM_def"><p class="first last">breast cancer resistance protein</p></td></tr><tr><td class="NLM_term">BSEP</td><td class="NLM_def"><p class="first last">bile salt export pump</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">DHD</td><td class="NLM_def"><p class="first last">1,2-dihydrodiol</p></td></tr><tr><td class="NLM_term">DMD</td><td class="NLM_def"><p class="first last">Duchenne muscular dystrophy</p></td></tr><tr><td class="NLM_term">EH</td><td class="NLM_def"><p class="first last">epoxide hydrolase</p></td></tr><tr><td class="NLM_term">EMA</td><td class="NLM_def"><p class="first last">European Medicines Agency</p></td></tr><tr><td class="NLM_term">EROD</td><td class="NLM_def"><p class="first last">7-ethoxyresorufin-<i>O</i>-deethylase</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">HMBC</td><td class="NLM_def"><p class="first last"><sup>1</sup>Hâ<sup>13</sup>C heteronuclear multiple bond correlation</p></td></tr><tr><td class="NLM_term">HSQC</td><td class="NLM_def"><p class="first last"><sup>1</sup>Hâ<sup>13</sup>C heteronuclear single quantum correlation</p></td></tr><tr><td class="NLM_term">HTRF</td><td class="NLM_def"><p class="first last">homogeneous time-resolved fluorescence</p></td></tr><tr><td class="NLM_term">KinSol</td><td class="NLM_def"><p class="first last">kinetic solubility</p></td></tr><tr><td class="NLM_term">MAO</td><td class="NLM_def"><p class="first last">monoamino oxidase</p></td></tr><tr><td class="NLM_term">MATE</td><td class="NLM_def"><p class="first last">multidrug and toxic compound extrusion</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug resistant</p></td></tr><tr><td class="NLM_term">NOESY</td><td class="NLM_def"><p class="first last">nuclear Overhauser effect spectroscopy</p></td></tr><tr><td class="NLM_term">OCT</td><td class="NLM_def"><p class="first last">organic cation transporter</p></td></tr><tr><td class="NLM_term">OATP</td><td class="NLM_def"><p class="first last">organic anion transporter protein</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeability assay</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">PROD</td><td class="NLM_def"><p class="first last">7-pentoxyresorufin <i>O</i>-depentylase</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">TDO</td><td class="NLM_def"><p class="first last">toluene dioxygenase</p></td></tr><tr><td class="NLM_term">UGT</td><td class="NLM_def"><p class="first last">uridine glucuronyl transferase</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72537" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72537" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 39 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emery, A. E.</span></span> <span> </span><span class="NLM_article-title">Population frequencies of inherited neuromuscular diseases -a world survey</span>. <i>Neuromuscul. Disord.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">19</span>â <span class="NLM_lpage">29</span>, <span class="refDoi">Â DOI: 10.1016/0960-8966(91)90039-U</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1016%2F0960-8966%2891%2990039-U" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1822774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A280%3ADyaK38zltlKktw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1991&pages=19-29&author=A.+E.+Emery&title=Population+frequencies+of+inherited+neuromuscular+diseases+-a+world+survey&doi=10.1016%2F0960-8966%2891%2990039-U"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Population frequencies of inherited neuromuscular diseases--a world survey</span></div><div class="casAuthors">Emery A E</div><div class="citationInfo"><span class="NLM_cas:title">Neuromuscular disorders : NMD</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-29</span>
        ISSN:<span class="NLM_cas:issn">0960-8966</span>.
    </div><div class="casAbstract">A survey of the world literature, involving over 150 reported studies, of the population frequencies of various inherited neuromuscular diseases has been carried out.  Data are presented for the commoner forms of muscular dystrophy (Duchenne, Becker, facioscapulohumeral, limb girdle), myotonic dystrophy and congenital myotonias, proximal spinal muscular atrophies, and the hereditary motor and sensory neuropathies.  A conservative estimate of the overall prevalence among both sexes is around 286 x 10(-6), that is 1 in 3500 of the population may be expected to have a disabling inherited neuromuscular disease presenting in childhood or in later life.  If severe disorders manifest only in infancy and early childhood (e.g.  Werdnig-Hoffmann disease and severe congenital muscular dystrophy) and the rare forms of dystrophy and myopathy are also included, then the overall prevalence could well exceed 1 in 3000.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQWrkTRbMpV1rt7lRqEFUJVfW6udTcc2ebeA6TZehoCibntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38zltlKktw%253D%253D&md5=df244b36fc033ad5842c29cf47d2814b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2F0960-8966%2891%2990039-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-8966%252891%252990039-U%26sid%3Dliteratum%253Aachs%26aulast%3DEmery%26aufirst%3DA.%2BE.%26atitle%3DPopulation%2520frequencies%2520of%2520inherited%2520neuromuscular%2520diseases%2520-a%2520world%2520survey%26jtitle%3DNeuromuscul.%2520Disord.%26date%3D1991%26volume%3D1%26spage%3D19%26epage%3D29%26doi%3D10.1016%2F0960-8966%2891%2990039-U" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Deutekom, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Ommen, G. J.</span></span> <span> </span><span class="NLM_article-title">Advances in Duchenne muscular dystrophy gene therapy</span>. <i>Nat. Rev. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">774</span>â <span class="NLM_lpage">783</span>, <span class="refDoi">Â DOI: 10.1038/nrg1180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1038%2Fnrg1180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=14526374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot1aksb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=774-783&author=J.+C.+van%0ADeutekomauthor=G.+J.+van+Ommen&title=Advances+in+Duchenne+muscular+dystrophy+gene+therapy&doi=10.1038%2Fnrg1180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in Duchenne muscular dystrophy gene therapy</span></div><div class="casAuthors">van Deutekom, Judith C. T.; van Ommen, Gert-Jan B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">774-783</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the initial characterization of the genetic defect for Duchenne muscular dystrophy, much effort has been expended in attempts to develop a therapy for this devastating childhood disease.  Gene therapy was the obvious answer but, initially, the dystrophin gene and its product seemed too large and complex for this approach.  However, our increasing knowledge of the organization of the gene and the role of dystrophin in muscle function has indicated ways to manipulate them both.  Gene therapy for Duchenne muscular dystrophy now seems to be in reach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7gdYCTBMpRbVg90H21EOLACvtfcHk0lh6WDynSdDqlA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot1aksb4%253D&md5=3867ee5bbd09bca922512e53b8be7784</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrg1180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg1180%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BDeutekom%26aufirst%3DJ.%2BC.%26aulast%3Dvan%2BOmmen%26aufirst%3DG.%2BJ.%26atitle%3DAdvances%2520in%2520Duchenne%2520muscular%2520dystrophy%2520gene%2520therapy%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2003%26volume%3D4%26spage%3D774%26epage%3D783%26doi%3D10.1038%2Fnrg1180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blake, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newey, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span> <span> </span><span class="NLM_article-title">Function and genetics of dystrophin and dystrophin-related proteins in muscle</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">291</span>â <span class="NLM_lpage">329</span>, <span class="refDoi">Â DOI: 10.1152/physrev.00028.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1152%2Fphysrev.00028.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=11917091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtFOns7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=291-329&author=D.+J.+Blakeauthor=A.+Weirauthor=S.+E.+Neweyauthor=K.+E.+Davies&title=Function+and+genetics+of+dystrophin+and+dystrophin-related+proteins+in+muscle&doi=10.1152%2Fphysrev.00028.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Function and genetics of dystrophin and dystrophin-related proteins in muscle</span></div><div class="casAuthors">Blake, Derek J.; Weir, Andrew; Newey, Sarah E.; Davies, Kay E.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">291-329</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The X-linked muscle-wasting disease Duchenne muscular dystrophy is caused by mutations in the gene encoding dystrophin.  There is currently no effective treatment for the disease; however, the complex mol. pathol. of this disorder is now being unravelled.  Dystrophin is located at the muscle sarcolemma in a membrane-spanning protein complex that connects the cytoskeleton to the basal lamina.  Mutations in many components of the dystrophin protein complex cause other forms of autosomally inherited muscular dystrophy, indicating the importance of this complex in normal muscle function.  Although the precise function of dystrophin is unknown, the lack of protein causes membrane destabilization and the activation of multiple pathophysiol. processes, many of which converge on alterations in intracellular calcium handling.  Dystrophin is also the prototype of a family of dystrophin-related proteins, many of which are found in muscle.  This family includes utrophin and Î±-dystrobrevin, which are involved in the maintenance of the neuromuscular junction architecture and in muscle homeostasis.  New insights into the pathophysiol. of dystrophic muscle, the identification of compensating proteins, and the discovery of new binding partners are paving the way for novel therapeutic strategies to treat this fatal muscle disease.  This review discusses the role of the dystrophin complex and protein family in muscle and describes the physiol. processes that are affected in Duchenne muscular dystrophy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql5aeDBptVUrVg90H21EOLACvtfcHk0lhbqlJiJclXOg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtFOns7Y%253D&md5=f57019afadbf0448eba2c580f7a2a6a7</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00028.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00028.2001%26sid%3Dliteratum%253Aachs%26aulast%3DBlake%26aufirst%3DD.%2BJ.%26aulast%3DWeir%26aufirst%3DA.%26aulast%3DNewey%26aufirst%3DS.%2BE.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26atitle%3DFunction%2520and%2520genetics%2520of%2520dystrophin%2520and%2520dystrophin-related%2520proteins%2520in%2520muscle%26jtitle%3DPhysiol.%2520Rev.%26date%3D2002%26volume%3D82%26spage%3D291%26epage%3D329%26doi%3D10.1152%2Fphysrev.00028.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, R. H.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunkel, L. M.</span></span> <span> </span><span class="NLM_article-title">Dystrophin: the protein product of the Duchenne muscular dystrophy locus</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">919</span>â <span class="NLM_lpage">928</span>, <span class="refDoi">Â DOI: 10.1016/0092-8674(87)90579-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1016%2F0092-8674%2887%2990579-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=3319190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaL1cXntlWqug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1987&pages=919-928&author=E.+P.+Hoffmanauthor=R.+H.+Brownauthor=L.+M.+Kunkel&title=Dystrophin%3A+the+protein+product+of+the+Duchenne+muscular+dystrophy+locus&doi=10.1016%2F0092-8674%2887%2990579-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Dystrophin:  the protein product of the Duchenne muscular dystrophy locus</span></div><div class="casAuthors">Hoffman, Eric P.; Brown, Robert H., Jr.; Kunkel, Louis M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">919-28</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">The protein product of the human Duchenne muscular dystrophy locus (DMD) and its mouse homolog (mDMD) have been identified by using polyclonal antibodies directed against fusion proteins contg. two distinct regions of the mDMD cDNA.  The DMD protein is shown to be â¼400 kd and to represent â¼0.002% of total striated muscle protein.  This protein is also detected in smooth muscle (stomach).  Muscle tissue isolated from both DMD-affected boys and mdx mice contained no detectable DMD protein, suggesting that these genetic disorders are homologous.  Since mdx mice present no obvious clin. abnormalities, the identification of the mdx mouse as an animal model for DMD has important implications with regard to the etiol. of the lethal DMD phenotype.  The protein has been named dystrophin because of its identification via the isolation of the Duchenne muscular dystrophy locus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSCpwGgytCyrVg90H21EOLACvtfcHk0lhbqlJiJclXOg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXntlWqug%253D%253D&md5=8d0516411c935e1d6df7b9ac1aa575da</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2887%2990579-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252887%252990579-4%26sid%3Dliteratum%253Aachs%26aulast%3DHoffman%26aufirst%3DE.%2BP.%26aulast%3DBrown%26aufirst%3DR.%2BH.%26aulast%3DKunkel%26aufirst%3DL.%2BM.%26atitle%3DDystrophin%253A%2520the%2520protein%2520product%2520of%2520the%2520Duchenne%2520muscular%2520dystrophy%2520locus%26jtitle%3DCell%26date%3D1987%26volume%3D51%26spage%3D919%26epage%3D928%26doi%3D10.1016%2F0092-8674%2887%2990579-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guiraud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span> <span> </span><span class="NLM_article-title">Pharmacological advances for treatment in Duchenne muscular dystrophy</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">36</span>â <span class="NLM_lpage">48</span>, <span class="refDoi">Â DOI: 10.1016/j.coph.2017.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1016%2Fj.coph.2017.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=28486179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvVGqurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2017&pages=36-48&author=S.+Guiraudauthor=K.+E.+Davies&title=Pharmacological+advances+for+treatment+in+Duchenne+muscular+dystrophy&doi=10.1016%2Fj.coph.2017.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological advances for treatment in Duchenne muscular dystrophy</span></div><div class="casAuthors">Guiraud, Simon; Davies, Kay E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36-48</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Duchenne muscular dystrophy (DMD) is a lethal, X-linked muscle-wasting disease caused by lack of dystrophin, essential for muscle fiber integrity.  Despite extensive pre-clin. studies, development of an effective treatment has proved challenging.  More recently, significant progress has been made with the first drug approval using a genetic approach and the application of pharmacol. agents which slow the progression of the disease.  Drug development for DMD has mainly used two strategies: (1) the restoration of dystrophin expression or the expression of the compensatory utrophin protein as an efficient surrogate, and (2) the mitigation of secondary downstream pathol. mechanisms.  This review details current most promising pharmacol. approaches and clin. trials aiming to tackle the pathogenesis of this multifaceted disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4bL76CfzS1rVg90H21EOLACvtfcHk0lich_gzANBZwg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvVGqurw%253D&md5=ed36a5afd8e07f41f8c3ae14195f304e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2017.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2017.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DGuiraud%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26atitle%3DPharmacological%2520advances%2520for%2520treatment%2520in%2520Duchenne%2520muscular%2520dystrophy%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2017%26volume%3D34%26spage%3D36%26epage%3D48%26doi%3D10.1016%2Fj.coph.2017.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Love, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurr, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byth, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsden, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span> <span> </span><span class="NLM_article-title">An autosomal transcript in skeletal muscle with homology to dystrophin</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>339</i></span>,  <span class="NLM_fpage">55</span>â <span class="NLM_lpage">58</span>, <span class="refDoi">Â DOI: 10.1038/339055a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1038%2F339055a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=2541343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaL1MXktVWqtbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=1989&pages=55-58&author=D.+R.+Loveauthor=D.+F.+Hillauthor=G.+Dicksonauthor=N.+K.+Spurrauthor=B.+C.+Bythauthor=R.+F.+Marsdenauthor=F.+S.+Walshauthor=Y.+H.+Edwardsauthor=K.+E.+Davies&title=An+autosomal+transcript+in+skeletal+muscle+with+homology+to+dystrophin&doi=10.1038%2F339055a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">An autosomal transcript in skeletal muscle with homology to dystrophin</span></div><div class="casAuthors">Love, Donald R.; Hill, Diane F.; Dickson, George; Spurr, Nigel K.; Byth, Barbara C.; Marsden, Rosalind F.; Walsh, Frank S.; Edwards, Yvonne H.; Davies, Kay E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">6219</span>),
    <span class="NLM_cas:pages">55-8</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The Duchenne muscular dystrophy (DMD) gene has been localized to chromosome Xp21 and codes for a 14-kilobase (kb) transcript and a protein called dystrophin, of relative mol. mass 427,000.  Dystrophin is assocd. with the cytoplasmic face of muscle fiber membranes, and its C-terminal domain is thought to mediate membrane attachment.  Although N-terminal and central domain structures share common features with other cytoskeletal components, no significant sequence similarity between the C-terminal region of dystrophin and other previously characterized proteins has been described.  Fragments from the C-terminal domain of the DMD cDNA detect a closely related sequence which exhibits nucleic acid and predicted amino acid identities with dystrophin of approx. 65 and 80%, resp.  The dystrophin-related sequence identifies a 13-kb transcript in human fetal muscle and maps to chromosome 6.  Thus, dystrophin may be a member of a family of functionally related large structural proteins in muscle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruW-WbVv6WP7Vg90H21EOLACvtfcHk0lich_gzANBZwg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktVWqtbk%253D&md5=39b72b03aa694a6c5cecb70110bc244a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F339055a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F339055a0%26sid%3Dliteratum%253Aachs%26aulast%3DLove%26aufirst%3DD.%2BR.%26aulast%3DHill%26aufirst%3DD.%2BF.%26aulast%3DDickson%26aufirst%3DG.%26aulast%3DSpurr%26aufirst%3DN.%2BK.%26aulast%3DByth%26aufirst%3DB.%2BC.%26aulast%3DMarsden%26aufirst%3DR.%2BF.%26aulast%3DWalsh%26aufirst%3DF.%2BS.%26aulast%3DEdwards%26aufirst%3DY.%2BH.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26atitle%3DAn%2520autosomal%2520transcript%2520in%2520skeletal%2520muscle%2520with%2520homology%2520to%2520dystrophin%26jtitle%3DNature%26date%3D1989%26volume%3D339%26spage%3D55%26epage%3D58%26doi%3D10.1038%2F339055a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deconinck, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Backer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phelps, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, J. M.</span></span> <span> </span><span class="NLM_article-title">Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1216</span>â <span class="NLM_lpage">1221</span>, <span class="refDoi">Â DOI: 10.1038/nm1197-1216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1038%2Fnm1197-1216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=9359695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaK2sXntFansb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=1216-1221&author=N.+Deconinckauthor=J.+Tinsleyauthor=F.+De+Backerauthor=R.+Fisherauthor=D.+Kahnauthor=S.+Phelpsauthor=K.+Daviesauthor=J.+M.+Gillis&title=Expression+of+truncated+utrophin+leads+to+major+functional+improvements+in+dystrophin-deficient+muscles+of+mice&doi=10.1038%2Fnm1197-1216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice</span></div><div class="casAuthors">Deconinck, Nicolas; Tinsley, Jonathon; De Backer, Fabienne; Fisher, Rosie; Kahn, David; Phelps, Steve; Davies, Kay; Gillis, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1216-1221</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Dystrophin-deficient mice (mdx) expressing a truncated (trc) utrophin transgene show amelioration of the dystrophic phenotype.  Here, we report a multifunctional study demonstrating that trc-utrophin expression leads to major improvements of the mech. performance of muscle (i.e., force development, mech. resistance to forced lengthenings, and maximal spontaneous activity) and of the maintenance of the intracellular calcium homeostasis.  These are two essential functions of muscle fibers, known to be impaired in mdx mouse muscles and Duchenne muscular dystrophy (DMD) patients.  Our results bring strong support to the hypothesis that muscle wasting in dystrophin-deficient DMD patients could be prevented by upregulation of utrophin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4gcI8wE3cErVg90H21EOLACvtfcHk0lich_gzANBZwg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXntFansb8%253D&md5=e1680364e0b9b2d703caf8fc2e5a5113</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnm1197-1216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1197-1216%26sid%3Dliteratum%253Aachs%26aulast%3DDeconinck%26aufirst%3DN.%26aulast%3DTinsley%26aufirst%3DJ.%26aulast%3DDe%2BBacker%26aufirst%3DF.%26aulast%3DFisher%26aufirst%3DR.%26aulast%3DKahn%26aufirst%3DD.%26aulast%3DPhelps%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DK.%26aulast%3DGillis%26aufirst%3DJ.%2BM.%26atitle%3DExpression%2520of%2520truncated%2520utrophin%2520leads%2520to%2520major%2520functional%2520improvements%2520in%2520dystrophin-deficient%2520muscles%2520of%2520mice%26jtitle%3DNat.%2520Med.%26date%3D1997%26volume%3D3%26spage%3D1216%26epage%3D1221%26doi%3D10.1038%2Fnm1197-1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deconinck, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phelps, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K.</span></span> <span> </span><span class="NLM_article-title">Expression of full-length utrophin prevents muscular dystrophy in mdx mice</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1441</span>â <span class="NLM_lpage">1444</span>, <span class="refDoi">Â DOI: 10.1038/4033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1038%2F4033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=9846586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaK1cXnvVOhur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=1441-1444&author=J.+Tinsleyauthor=N.+Deconinckauthor=R.+Fisherauthor=D.+Kahnauthor=S.+Phelpsauthor=J.+M.+Gillisauthor=K.+Davies&title=Expression+of+full-length+utrophin+prevents+muscular+dystrophy+in+mdx+mice&doi=10.1038%2F4033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of full-length utrophin prevents muscular dystrophy in mdx mice</span></div><div class="casAuthors">Tinsley, Jonathon; Deconinck, Nicolas; Fisher, Rosie; Kahn, David; Phelps, Steve; Gillis, Jean-Marie; Davies, Kay</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1441-1444</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the muscle fiber leading to the gradual depletion of skeletal muscle.  The mol. structure of dystrophin is very similar to that of the related protein utrophin2.  Utrophin is found in all tissues and is confined to the neuromuscular and myotendinous junctions in mature muscle.  Sarcolemmal localization of a truncated utrophin transgene in the dystrophin-deficient mdx mouse significantly improves the dystrophic muscle phenotype.  Therefore, up-regulation of utrophin by drug therapy is a plausible therapeutic approach in the treatment of DMD.  Here, the authors demonstrate that expression of full-length utrophin in mdx mice prevents the development of muscular dystrophy.  The authors assessed muscle morphol., fiber regeneration and mech. properties (force development and resistance to stretch) of mdx and transgenic mdx skeletal and diaphragm muscle.  The utrophin levels required in muscle are significantly less than the normal endogenous in utrophin levels seen in lung and kidney, and the authors provide evidence that the pathol. depends on the amt. of utrophin expression.  These results also have important implications for DMD therapies in which utrophin replacement is achieved by delivery using exogenous vectors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkZwAIp6gKKrVg90H21EOLACvtfcHk0lg0Sk2iPWdL2Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvVOhur0%253D&md5=3bc3ecaf7e29380b3289796b9f444ab1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F4033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F4033%26sid%3Dliteratum%253Aachs%26aulast%3DTinsley%26aufirst%3DJ.%26aulast%3DDeconinck%26aufirst%3DN.%26aulast%3DFisher%26aufirst%3DR.%26aulast%3DKahn%26aufirst%3DD.%26aulast%3DPhelps%26aufirst%3DS.%26aulast%3DGillis%26aufirst%3DJ.%2BM.%26aulast%3DDavies%26aufirst%3DK.%26atitle%3DExpression%2520of%2520full-length%2520utrophin%2520prevents%2520muscular%2520dystrophy%2520in%2520mdx%2520mice%26jtitle%3DNat.%2520Med.%26date%3D1998%26volume%3D4%26spage%3D1441%26epage%3D1444%26doi%3D10.1038%2F4033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cerletti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negri, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colpo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreetta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozza, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karpati, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mora, M.</span></span> <span> </span><span class="NLM_article-title">Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer</span>. <i>Gene Ther.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">750</span>â <span class="NLM_lpage">757</span>, <span class="refDoi">Â DOI: 10.1038/sj.gt.3301941</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1038%2Fsj.gt.3301941" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=12704413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFGqtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=750-757&author=M.+Cerlettiauthor=T.+Negriauthor=F.+Cozziauthor=R.+Colpoauthor=F.+Andreettaauthor=D.+Crociauthor=K.+E.+Daviesauthor=F.+Cornelioauthor=O.+Pozzaauthor=G.+Karpatiauthor=R.+Gilbertauthor=M.+Mora&title=Dystrophic+phenotype+of+canine+X-linked+muscular+dystrophy+is+mitigated+by+adenovirus-mediated+utrophin+gene+transfer&doi=10.1038%2Fsj.gt.3301941"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer</span></div><div class="casAuthors">Cerletti, M.; Negri, T.; Cozzi, F.; Colpo, R.; Andreetta, F.; Croci, D.; Davies, K. E.; Cornelio, F.; Pozza, O.; Karpati, G.; Gilbert, R.; Mora, M.</div><div class="citationInfo"><span class="NLM_cas:title">Gene Therapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">750-757</span>CODEN:
                <span class="NLM_cas:coden">GETHEC</span>;
        ISSN:<span class="NLM_cas:issn">0969-7128</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Utrophin is highly homologous and structurally similar to dystrophin, and in gene delivery expts. in mdx mice was able to functionally replace dystrophin.  We performed mini-utrophin gene transfer in Golden Retriever dogs with canine muscular dystrophy (CXMD).  Unlike the mouse model, the clinicopathol. phenotype of CXMD is similar to that of Duchenne muscular dystrophy (DMD).  We injected an adenoviral vector expressing a synthetic utrophin into tibialis anterior muscles of newborn dogs affected with CXMD and examd. transgene expression by RNA and protein anal. at 10, 30 and 60 days postinjection in cyclosporin-treated and -untreated animals.  Immunosuppression by cyclosporin was required to mitigate the immune response to viral and transgene antigens.  RT-PCR anal. showed the presence of the exogenous transcript in the muscle of cyclosporin-treated and -untreated animals.  The transgenic utrophin was efficiently expressed at the extrajunctional membrane in immunosuppressed dogs and this expression was stable for at least 60 days.  We found reduced fibrosis and increased expression of dystrophin-assocd. proteins (DAPs) in assocn. with muscle areas expressing the utrophin minigene, indicating that mini-utrophin can functionally compensate for lack of dystrophin in injected muscles.  For this reason, utrophin transfer to dystrophin-deficient muscle appears as a promising therapeutic approach to DMD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogouwCfBh2grVg90H21EOLACvtfcHk0lg0Sk2iPWdL2Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFGqtrY%253D&md5=4c6d99d17a536daa4343868cd87f5f6a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fsj.gt.3301941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.gt.3301941%26sid%3Dliteratum%253Aachs%26aulast%3DCerletti%26aufirst%3DM.%26aulast%3DNegri%26aufirst%3DT.%26aulast%3DCozzi%26aufirst%3DF.%26aulast%3DColpo%26aufirst%3DR.%26aulast%3DAndreetta%26aufirst%3DF.%26aulast%3DCroci%26aufirst%3DD.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26aulast%3DCornelio%26aufirst%3DF.%26aulast%3DPozza%26aufirst%3DO.%26aulast%3DKarpati%26aufirst%3DG.%26aulast%3DGilbert%26aufirst%3DR.%26aulast%3DMora%26aufirst%3DM.%26atitle%3DDystrophic%2520phenotype%2520of%2520canine%2520X-linked%2520muscular%2520dystrophy%2520is%2520mitigated%2520by%2520adenovirus-mediated%2520utrophin%2520gene%2520transfer%26jtitle%3DGene%2520Ther.%26date%3D2003%26volume%3D10%26spage%3D750%26epage%3D757%26doi%3D10.1038%2Fsj.gt.3301941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wynne, G. M.</span>; <span class="NLM_string-name">Russell, A. J.</span></span> <span> </span><span class="NLM_article-title">Drug Discovery Approaches for Rare Neuromuscular Diseases</span>. In  <i>Orphan Drugs and Rare Diseases</i>; <span class="NLM_publisher-name">The Royal Society of Chemistry</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">2014</span>; pp  <span class="NLM_fpage">257</span>â <span class="NLM_lpage">343</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1039%2F9781782624202-00257" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=257-343&author=G.+M.+Wynne&author=A.+J.+Russell&title=Orphan+Drugs+and+Rare+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1039%2F9781782624202-00257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781782624202-00257%26sid%3Dliteratum%253Aachs%26aulast%3DWynne%26aufirst%3DG.%2BM.%26atitle%3DDrug%2520Discovery%2520Approaches%2520for%2520Rare%2520Neuromuscular%2520Diseases%26btitle%3DOrphan%2520Drugs%2520and%2520Rare%2520Diseases%26pub%3DThe%2520Royal%2520Society%2520of%2520Chemistry%26date%3D2014%26spage%3D257%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guiraud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roblin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kay, D. E.</span></span> <span> </span><span class="NLM_article-title">The potential of utrophin modulators for the treatment of Duchenne muscular dystrophy</span>. <i>Expert Opin. Orphan Drugs</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">179</span>â <span class="NLM_lpage">192</span>, <span class="refDoi">Â DOI: 10.1080/21678707.2018.1438261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1080%2F21678707.2018.1438261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFSmtL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=179-192&author=S.+Guiraudauthor=D.+Roblinauthor=D.+E.+Kay&title=The+potential+of+utrophin+modulators+for+the+treatment+of+Duchenne+muscular+dystrophy&doi=10.1080%2F21678707.2018.1438261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The potential of utrophin modulators for the treatment of Duchenne muscular dystrophy</span></div><div class="casAuthors">Guiraud, Simon; Roblin, David; Kay, Davies. E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Orphan Drugs</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">179-192</span>CODEN:
                <span class="NLM_cas:coden">EOODAJ</span>;
        ISSN:<span class="NLM_cas:issn">2167-8707</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Duchenne muscular dystrophy (DMD) is a lethal, X-linked muscle-wasting disease caused by the lack of dystrophin.  A few years after the identification of the dystrophin gene, a ubiquitously expressed transcript with high homol. to dystrophin was identified leading to the postulate that utrophin might be an effective surrogate to compensate for the lack of dystrophin in dystrophic muscles.: We review the utrophin gene, its regulation, the organization of the corresponding protein and its dynamic expression pattern in comparison with dystrophin.  In view of the evidence that utrophin acts as an efficient substitute to dystrophin to prevent the pathol., we describe the therapeutic approaches to modulate utrophin expression.  We review the current status in the development of ezutromid, the first small utrophin modulator drug currently tested in DMD patients.: A utrophin based strategy is a highly promising approach applicable to all DMD patients irresp. of their genetic defect.  Whereas accurate utrophin and regeneration quantification tools are urgently needed, the foundation of utrophin based therapies, defined 20 years ago, recently delivered first promising results in DMD patients with ezutromid.  The field is at an exciting stage on the road of a universal treatment for all DMD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcS_zSFMYHPrVg90H21EOLACvtfcHk0lg0-MtNsf_kKA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFSmtL0%253D&md5=7c785199bc688ebe4b0f143da09fa70d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1080%2F21678707.2018.1438261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21678707.2018.1438261%26sid%3Dliteratum%253Aachs%26aulast%3DGuiraud%26aufirst%3DS.%26aulast%3DRoblin%26aufirst%3DD.%26aulast%3DKay%26aufirst%3DD.%2BE.%26atitle%3DThe%2520potential%2520of%2520utrophin%2520modulators%2520for%2520the%2520treatment%2520of%2520Duchenne%2520muscular%2520dystrophy%26jtitle%3DExpert%2520Opin.%2520Orphan%2520Drugs%26date%3D2018%26volume%3D6%26spage%3D179%26epage%3D192%26doi%3D10.1080%2F21678707.2018.1438261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inacio, P.</span></span> <span> </span><span class="NLM_article-title">Summit Therapeutics Ends Development of Ezutromid Therapy for DMD After Trial Failure</span>.  <i>Muscular Dystrophy News Today</i>, June 29, <span class="NLM_year">2018</span>. <a href="https://musculardystrophynews.com/2018/06/29/summit-therapeutics-ends-ezutromid-development-trail-failure/" class="extLink">https://musculardystrophynews.com/2018/06/29/summit-therapeutics-ends-ezutromid-development-trail-failure/</a> (accessed Oct 8, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=P.+Inacio&title=Muscular+Dystrophy+News+Today"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DInacio%26aufirst%3DP.%26atitle%3DSummit%2520Therapeutics%2520Ends%2520Development%2520of%2520Ezutromid%2520Therapy%2520for%2520DMD%2520After%2520Trial%2520Failure%26btitle%3DMuscular%2520Dystrophy%2520News%2520Today%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to healthy male adult volunteers</span>. <i>J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">698</span>â <span class="NLM_lpage">707</span>, <span class="refDoi">Â DOI: 10.1002/jcph.468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1002%2Fjcph.468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=25651188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotVeltL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=698-707&author=J.+Tinsleyauthor=N.+Robinsonauthor=K.+E.+Davies&title=Safety%2C+tolerability%2C+and+pharmacokinetics+of+SMT+C1100%2C+a+2-arylbenzoxazole+utrophin+modulator%2C+following+single-+and+multiple-dose+administration+to+healthy+male+adult+volunteers&doi=10.1002%2Fjcph.468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to healthy male adult volunteers</span></div><div class="casAuthors">Tinsley, Jon; Robinson, Neil; Davies, Kay E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">698-707</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">SMT C1100 is a small mol. utrophin modulator in development to treat Duchenne muscular dystrophy.  This study evaluated the safety, tolerability, and pharmacokinetics of SMT C1100 in healthy volunteers.  This double-blind, placebo-controlled Phase 1 study comprised: Part 1, an escalating, single-dose with/without fasting involving 50 mg/kg, 100 mg/kg, 200 mg/kg, and 400 mg/kg doses; and Part 2, a multiple 10 day dose evaluation involving 100 mg/kg bid and 200 mg/kg bid doses.  Adverse events were recorded.  SMT C1100 was absorbed rapidly following single and multiple oral doses, with median tmax attained within 2-3.5 h across all doses.  Considerable variability of pharmacokinetic parameters was noted among subjects.  Following single doses, systemic exposure increased in a sub-proportional manner, with the 8.0-fold dose increment resulting in 2.7- and 2.4-fold increases in AUC0-â and Cmax, resp.  AUC0-â and Cmax were estd. as 4.2- and 4.8-fold greater, resp., following food.  Systemic exposure reduced upon repeat dosing with steady-state concns. achieved within 3-5 days of multiple bid dosing.  No serious or severe adverse events were reported.  SMT C1100 was safe and well tolerated with plasma concns. achieved sufficient to cause a 50% increase in concns. of utrophin in cells in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS-otCqjm06rVg90H21EOLACvtfcHk0lg0-MtNsf_kKA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotVeltL0%253D&md5=be9902e46e42d7921a17657a263ff552</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fjcph.468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcph.468%26sid%3Dliteratum%253Aachs%26aulast%3DTinsley%26aufirst%3DJ.%26aulast%3DRobinson%26aufirst%3DN.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26atitle%3DSafety%252C%2520tolerability%252C%2520and%2520pharmacokinetics%2520of%2520SMT%2520C1100%252C%2520a%25202-arylbenzoxazole%2520utrophin%2520modulator%252C%2520following%2520single-%2520and%2520multiple-dose%2520administration%2520to%2520healthy%2520male%2520adult%2520volunteers%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2015%26volume%3D55%26spage%3D698%26epage%3D707%26doi%3D10.1002%2Fjcph.468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ricotti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roper, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejura, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muntoni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J.</span></span> <span> </span><span class="NLM_article-title">Safety, Tolerability, and Pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole Utrophin Modulator, following Single- and Multiple-Dose Administration to Pediatric Patients with Duchenne Muscular Dystrophy</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e0152840</span> <span class="refDoi">Â DOI: 10.1371/journal.pone.0152840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1371%2Fjournal.pone.0152840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=27055247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1OqsLzM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&author=V.+Ricottiauthor=S.+Spintyauthor=H.+Roperauthor=I.+Hughesauthor=B.+Tejuraauthor=N.+Robinsonauthor=G.+Laytonauthor=K.+Daviesauthor=F.+Muntoniauthor=J.+Tinsley&title=Safety%2C+Tolerability%2C+and+Pharmacokinetics+of+SMT+C1100%2C+a+2-Arylbenzoxazole+Utrophin+Modulator%2C+following+Single-+and+Multiple-Dose+Administration+to+Pediatric+Patients+with+Duchenne+Muscular+Dystrophy&doi=10.1371%2Fjournal.pone.0152840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to pediatric patients with duchenne muscular dystrophy</span></div><div class="casAuthors">Ricotti, Valeria; Spinty, Stefan; Roper, Helen; Hughes, Imelda; Tejura, Bina; Robinson, Neil; Layton, Gary; Davies, Kay; Muntoni, Francesco; Tinsley, Jonathon</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e0152840/1-e0152840/16</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Purpose SMT C1100 is a utrophin modulator being evaluated as a treatment for Duchenne muscular dystrophy (DMD).  This study, the first in pediatric DMD patients, reports the safety, tolerability and PK parameters of single and multiple doses of SMT C1100, as well as analyze potential biomarkers of muscle damage.  Methods This multicenter, Phase 1 study enrolled 12 patients, divided equally into three groups (A- C).  Group A were given 50 mg/kg on Days 1 and 11, and 50 mg/kg bid on Days 2 to 10.  Group B and C received 100 mg/kg on Days 1 and 11; Group B and Group C were given 100 mg/kg bid and 100 mg/kg tid, resp., on Days 2 to 10.  A safety review was performed on all patients following the single dose and there was at least 2 wk between each dose escalation, for safety and PK review.  Adverse events (AEs) were monitored throughout the study.  Results Most patients experienced mild AEs and there were no serious AEs.  Two patients required analgesia for pain (headache, ear pain and toothache).  One patient experienced moderate psychiatric AEs (abnormal behavior and mood swings).  Plasma concns. of SMT C1100 at Days 1 and 11 indicated a high degree of patient variability regardless of dose.  Unexpectedly the SMT C1100 levels were significantly lower than similar doses administered to healthy volunteers in an earlier clin. study.  In general, individual baseline changes of creatine phosphokinase, alanine aminotransferase, aspartate aminotransferase levels fell with SMT C1100 dosing.  Conclusions SMT C1100 was well tolerated in pediatric DMD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt0w7VChgcJbVg90H21EOLACvtfcHk0lg32Ow4wFRb8g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1OqsLzM&md5=7e3080644fb23bed4b3b4bbfab8263de</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0152840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0152840%26sid%3Dliteratum%253Aachs%26aulast%3DRicotti%26aufirst%3DV.%26aulast%3DSpinty%26aufirst%3DS.%26aulast%3DRoper%26aufirst%3DH.%26aulast%3DHughes%26aufirst%3DI.%26aulast%3DTejura%26aufirst%3DB.%26aulast%3DRobinson%26aufirst%3DN.%26aulast%3DLayton%26aufirst%3DG.%26aulast%3DDavies%26aufirst%3DK.%26aulast%3DMuntoni%26aufirst%3DF.%26aulast%3DTinsley%26aufirst%3DJ.%26atitle%3DSafety%252C%2520Tolerability%252C%2520and%2520Pharmacokinetics%2520of%2520SMT%2520C1100%252C%2520a%25202-Arylbenzoxazole%2520Utrophin%2520Modulator%252C%2520following%2520Single-%2520and%2520Multiple-Dose%2520Administration%2520to%2520Pediatric%2520Patients%2520with%2520Duchenne%2520Muscular%2520Dystrophy%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26doi%3D10.1371%2Fjournal.pone.0152840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muntoni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejura, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roper, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harriman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J.</span></span> <span> </span><span class="NLM_article-title">A Phase 1b Trial to Assess the Pharmacokinetics of Ezutromid in Pediatric Duchenne Muscular Dystrophy Patients on a Balanced Diet</span>. <i>Clin. Pharmacol. Drug Dev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">922</span>â <span class="NLM_lpage">933</span>, <span class="refDoi">Â DOI: 10.1002/cpdd.642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1002%2Fcpdd.642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=30650257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFSgur%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=922-933&author=F.+Muntoniauthor=B.+Tejuraauthor=S.+Spintyauthor=H.+Roperauthor=I.+Hughesauthor=G.+Laytonauthor=K.+E.+Daviesauthor=S.+Harrimanauthor=J.+Tinsley&title=A+Phase+1b+Trial+to+Assess+the+Pharmacokinetics+of+Ezutromid+in+Pediatric+Duchenne+Muscular+Dystrophy+Patients+on+a+Balanced+Diet&doi=10.1002%2Fcpdd.642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase 1b Trial to Assess the Pharmacokinetics of Ezutromid in Pediatric Duchenne Muscular Dystrophy Patients on a Balanced Diet</span></div><div class="casAuthors">Muntoni, Francesco; Tejura, Bina; Spinty, Stefan; Roper, Helen; Hughes, Imelda; Layton, Gary; Davies, Kay E.; Harriman, Shawn; Tinsley, Jonathon</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology in Drug Development</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">922-933</span>CODEN:
                <span class="NLM_cas:coden">CPDDAH</span>;
        ISSN:<span class="NLM_cas:issn">2160-7648</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Ezutromid (SMT C1100) is a small-mol. utrophin modulator that was developed to treat Duchenne muscular dystrophy (DMD).  Previous clin. trials of this agent revealed lower exposure in DMD patients compared with healthy volunteers, which may reflect differences in diet.  This study evaluated the pharmacokinetics of ezutromid in patients with DMD who followed a balanced diet.  This was a multicenter, double-blind, placebo-controlled, ascending single and multiple oral dose study.  Twelve pediatric patients were randomly allocated to 1 of 3 treatment sequences within which were 3 treatment periods of 2 wk each.  Throughout the study, patients followed a balanced diet including recommended proportions of major food groups and administration of drug accompanied with 100 mL of full-fat milk.  This approach improved the absorption of ezutromid, resulting in higher systemic exposure, with considerable variability in exposure between patients at each dose level.  Single and multiple oral doses of 1250 mg and 2500 mg BID were considered safe and well tolerated.  No severe or serious adverse events and no study discontinuations due to adverse events were reported.  This study provides assurance that, with the formulation tested (F3) and instructions regarding food (balanced diet and whole-fat milk), 2500 mg BID of ezutromid achieves plasma concns. that, based on preclin. studies, should be able to modulate utrophin expression in future clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPQpDsHvNdwLVg90H21EOLACvtfcHk0lg32Ow4wFRb8g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFSgur%252FL&md5=fb4603906c131089d72bca2d5af9fc20</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fcpdd.642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpdd.642%26sid%3Dliteratum%253Aachs%26aulast%3DMuntoni%26aufirst%3DF.%26aulast%3DTejura%26aufirst%3DB.%26aulast%3DSpinty%26aufirst%3DS.%26aulast%3DRoper%26aufirst%3DH.%26aulast%3DHughes%26aufirst%3DI.%26aulast%3DLayton%26aufirst%3DG.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26aulast%3DHarriman%26aufirst%3DS.%26aulast%3DTinsley%26aufirst%3DJ.%26atitle%3DA%2520Phase%25201b%2520Trial%2520to%2520Assess%2520the%2520Pharmacokinetics%2520of%2520Ezutromid%2520in%2520Pediatric%2520Duchenne%2520Muscular%2520Dystrophy%2520Patients%2520on%2520a%2520Balanced%2520Diet%26jtitle%3DClin.%2520Pharmacol.%2520Drug%2520Dev.%26date%3D2019%26volume%3D8%26spage%3D922%26epage%3D933%26doi%3D10.1002%2Fcpdd.642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jerina, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witkop, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaltzman-Nirenberg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udenfriend, S.</span></span> <span> </span><span class="NLM_article-title">The role of arene oxide-oxepin systems in the metabolism of aromatic substrates. 3. Formation of 1,2-naphthalene oxide from naphthalene by liver microsomes</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1968</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">6525</span>â <span class="NLM_lpage">6527</span>, <span class="refDoi">Â DOI: 10.1021/ja01025a058</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01025a058" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaF1MXpslKg" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1968&pages=6525-6527&author=D.+M.+Jerinaauthor=J.+W.+Dalyauthor=B.+Witkopauthor=P.+Zaltzman-Nirenbergauthor=S.+Udenfriend&title=The+role+of+arene+oxide-oxepin+systems+in+the+metabolism+of+aromatic+substrates.+3.+Formation+of+1%2C2-naphthalene+oxide+from+naphthalene+by+liver+microsomes&doi=10.1021%2Fja01025a058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The role of arene oxide-oxepin systems in the metabolism of aromatic substrates.  III.  Formation of 1,2-naphthalene oxide from naphthalene  by liver microsomes</span></div><div class="casAuthors">Jerina, Donald M.; Daly, John W.; Witkop, Bernhard; Zaltzman-Nirenberg, Perola; Udenfriend, Sidney</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6525-7</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Naphthalene was readily metabolized by rat liver microsomes to 1-naphthol and (-)-trans-1,2-dihydro-1,2-dihydroxynaphthalene.  In the presence of liver supernatant and glutathione, the major product isolated was S-(1,2-dihydro-2-hydroxynaphthyl)glutathione.  Rat liver microsomes, incubated with 14C-labeled naphthalene and unlabeled 1,2-naphthalene oxide, formed a 14C-labeled oxidized metabolite which was trapped and identified as 1,2-naphthalene oxide.  Rabbit liver microsomes converted 1,2-naphthalene oxide to (-)-trans-1,2-dihydro-1,2-dihydroxynaphthalene which had the same abs. stereochemistry as the diol obtained on incubation of naphthalene.  Rat liver supernatant catalyzed the opening of 1,2-naphthalene oxide by glutathione, yielding S-(1,2-dihydro-2-hydroxynaphthyl)glutathione, indistinguishable from that obtained from naphthalene, microsomes, supernatant, and glutathione.  These data suggest that 1,2-naphthalene oxide is an obligatory intermediate in the enzymic hydroxylation of naphthalene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5Z0uP2DGlk7Vg90H21EOLACvtfcHk0liZobMtOSYAQA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXpslKg&md5=d332575744337cd4bf93cfb02c6314a4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fja01025a058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01025a058%26sid%3Dliteratum%253Aachs%26aulast%3DJerina%26aufirst%3DD.%2BM.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DWitkop%26aufirst%3DB.%26aulast%3DZaltzman-Nirenberg%26aufirst%3DP.%26aulast%3DUdenfriend%26aufirst%3DS.%26atitle%3DThe%2520role%2520of%2520arene%2520oxide-oxepin%2520systems%2520in%2520the%2520metabolism%2520of%2520aromatic%2520substrates.%25203.%2520Formation%2520of%25201%252C2-naphthalene%2520oxide%2520from%2520naphthalene%2520by%2520liver%2520microsomes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1968%26volume%3D90%26spage%3D6525%26epage%3D6527%26doi%3D10.1021%2Fja01025a058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jerina, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witkop, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaltzman-Nirenberg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udenfriend, S.</span></span> <span> </span><span class="NLM_article-title">1,2-naphthalene oxide as an intermediate in the microsomal hydroxylation of naphthalene</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">147</span>â <span class="NLM_lpage">156</span>, <span class="refDoi">Â DOI: 10.1021/bi00803a019</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00803a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaE3cXnsVKrtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1970&pages=147-156&author=D.+M.+Jerinaauthor=J.+W.+Dalyauthor=B.+Witkopauthor=P.+Zaltzman-Nirenbergauthor=S.+Udenfriend&title=1%2C2-naphthalene+oxide+as+an+intermediate+in+the+microsomal+hydroxylation+of+naphthalene&doi=10.1021%2Fbi00803a019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">1,2-Naphthalene oxide as an intermediate in the microsomal hydroxylation of naphthalene.  V</span></div><div class="casAuthors">Jerina, Donald M.; Daly, John W.; Witkop, Bernhard; Zaltzman-Nirenberg, P.; Udenfriend, S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">147-56</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">The microsomal metabolism of naphthalene was reinvestigated and the pathways leading to naphthol, trans-1,2-dihy-dro-1,2-dihydroxynaphthalene, and the conjugate, S-(1,2-dihydro-2-hydroxy-1-naphthyl) glutathione, were clarified.  In the microsomal system synthetic 1,2-naphthalene oxide was converted into all major naphthalene metabolites.  In the presence of microsomes 1,2-naphthalene oxide rearranges nonenzymically almost exclusively to 1-naphthol, the preponderant phenolic oxidn. product from naphthalene.  Racemic 1,2-naphthalene oxide is hydrated enzymically to an optically active diol identical with the diol from naphthalene with respect to abs. stereochemistry and the source of the O atom at the 2 position.  Sol. liver enzymes catalyze the addn. of glutathione to 1,2-naphthalene oxide to form a conjugate identical with that obtained on oxidn. of naphthalene.  The formation of 1,2-naphthalene oxide from naphthalene in the microsomal system was demonstrated both by radiotracer trapping technique and by isolation.  When increasing amts. of glutathione were added to the microsomal system, the conjugate increased commensurate with a decrease in naphtholand dihydrodiol.  When a competitive substrate for the epoxide hydrase is added, the yield of naphthol goes up at the expense of the diol.  These 2 observations strongly suggest that the oxide is an obligatory intermediate for all naphthalene metabolites.  The relevance of these findings to naphthalene metabolism in particular and phenol formation in general is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol2BdDDkN5n7Vg90H21EOLACvtfcHk0liZobMtOSYAQA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXnsVKrtw%253D%253D&md5=cc8f8d1c6ff8a863e07642e291deff76</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fbi00803a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00803a019%26sid%3Dliteratum%253Aachs%26aulast%3DJerina%26aufirst%3DD.%2BM.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DWitkop%26aufirst%3DB.%26aulast%3DZaltzman-Nirenberg%26aufirst%3DP.%26aulast%3DUdenfriend%26aufirst%3DS.%26atitle%3D1%252C2-naphthalene%2520oxide%2520as%2520an%2520intermediate%2520in%2520the%2520microsomal%2520hydroxylation%2520of%2520naphthalene%26jtitle%3DBiochemistry%26date%3D1970%26volume%3D9%26spage%3D147%26epage%3D156%26doi%3D10.1021%2Fbi00803a019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">d'Arcy
Doherty, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makowski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, G. M.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P-450 dependent metabolic activation of 1-naphthol to naphthoquinones and covalent binding species</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">2261</span>â <span class="NLM_lpage">2267</span>, <span class="refDoi">Â DOI: 10.1016/0006-2952(85)90779-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1016%2F0006-2952%2885%2990779-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=4015675" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1985&pages=2261-2267&author=M.+d%27Arcy%0ADohertyauthor=R.+Makowskiauthor=G.+G.+Gibsonauthor=G.+M.+Cohen&title=Cytochrome+P-450+dependent+metabolic+activation+of+1-naphthol+to+naphthoquinones+and+covalent+binding+species&doi=10.1016%2F0006-2952%2885%2990779-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2885%2990779-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252885%252990779-8%26sid%3Dliteratum%253Aachs%26aulast%3Dd%2527Arcy%2BDoherty%26aufirst%3DM.%26aulast%3DMakowski%26aufirst%3DR.%26aulast%3DGibson%26aufirst%3DG.%2BG.%26aulast%3DCohen%26aufirst%3DG.%2BM.%26atitle%3DCytochrome%2520P-450%2520dependent%2520metabolic%2520activation%2520of%25201-naphthol%2520to%2520naphthoquinones%2520and%2520covalent%2520binding%2520species%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1985%26volume%3D34%26spage%3D2261%26epage%3D2267%26doi%3D10.1016%2F0006-2952%2885%2990779-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckpitt, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirmohamed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">Characterisation of the toxic metabolite(s) of naphthalene</span>. <i>Toxicology</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">233</span>â <span class="NLM_lpage">242</span>, <span class="refDoi">Â DOI: 10.1016/S0300-483X(96)03515-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1016%2FS0300-483X%2896%2903515-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=8980712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaK28XntlOkur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1996&pages=233-242&author=A.+S.+Wilsonauthor=C.+D.+Davisauthor=D.+P.+Williamsauthor=A.+R.+Buckpittauthor=M.+Pirmohamedauthor=B.+K.+Park&title=Characterisation+of+the+toxic+metabolite%28s%29+of+naphthalene&doi=10.1016%2FS0300-483X%2896%2903515-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the toxic metabolite(s) of naphthalene</span></div><div class="casAuthors">Wilson, Andrew S.; Davis, Carl D.; Williams, Dominic P.; Buckpitt, Alan R.; Pirmohamed, Munir; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">233-242</span>CODEN:
                <span class="NLM_cas:coden">TXCYAC</span>;
        ISSN:<span class="NLM_cas:issn">0300-483X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The toxicity of naphthalene and its metabolites has been investigated in vitro.  Both naphthalene and its metabolite 1-naphthol were bioactivated by human hepatic microsomes to metabolite(s) which were toxic to mononuclear leukocytes (MNL).  However, 1-naphthol was more cytotoxic than naphthalene (49.8Â±13.9% vs. 19.0Â±10.0% cell death), indicating that the toxicity of naphthalene is dependent on the bioactivation of 1-naphthol.  CYP2E1-induced rat liver microsomes increased metab. of naphthalene by 13% compared to control microsomes with a concomitant increase in both 1-naphthol and dihydrodiol formation.  The cytotoxicity of naphthalene but not of 1-naphthol was increased by CYP2E1 induction, indicating that sep. enzymes are involved in the bioactivation of 1-naphthol.  The metabolites of 1-naphthol, 1,2-naphthoquinone (51.4Â±6.6% cell death) and 1,4-naphthoquinone (49.1Â±3.4% cell death) were directly toxic to MNL and depleted glutathione to 1.0% of the control levels.  Both quinones were also genotoxic to human lymphocytes.  In contrast, the primary metabolite of naphthalene, the 1,2-epoxide (0-100 Î¼M) was neither cytotoxic nor genotoxic, and did not deplete glutathione.  In conclusion, these data suggest that the cytotoxicity and genotoxicity of naphthalene is assocd. with the formation of quinones from 1-naphthol rather than naphthalene 1,2-epoxide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKgN6COtZW4rVg90H21EOLACvtfcHk0liLvs8FrEtmvA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntlOkur8%253D&md5=1fa8e989d248855cd9bc8834b5eeceea</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0300-483X%2896%2903515-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0300-483X%252896%252903515-9%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DA.%2BS.%26aulast%3DDavis%26aufirst%3DC.%2BD.%26aulast%3DWilliams%26aufirst%3DD.%2BP.%26aulast%3DBuckpitt%26aufirst%3DA.%2BR.%26aulast%3DPirmohamed%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DCharacterisation%2520of%2520the%2520toxic%2520metabolite%2528s%2529%2520of%2520naphthalene%26jtitle%3DToxicology%26date%3D1996%26volume%3D114%26spage%3D233%26epage%3D242%26doi%3D10.1016%2FS0300-483X%2896%2903515-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, E.</span></span> <span> </span><span class="NLM_article-title">In vitro metabolism of naphthalene by human liver microsomal cytochrome P450 enzymes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">176</span>â <span class="NLM_lpage">183</span>, <span class="refDoi">Â DOI: 10.1124/dmd.105.005785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1124%2Fdmd.105.005785" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=16243959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslyitw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=176-183&author=T.+M.+Choauthor=R.+L.+Roseauthor=E.+Hodgson&title=In+vitro+metabolism+of+naphthalene+by+human+liver+microsomal+cytochrome+P450+enzymes&doi=10.1124%2Fdmd.105.005785"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro metabolism of naphthalene by human liver microsomal cytochrome P450 enzymes</span></div><div class="casAuthors">Cho, Taehyeon M.; Rose, Randy L.; Hodgson, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">176-183</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The polycyclic arom. hydrocarbon naphthalene is an environmental pollutant, a component of jet fuel, and, since 2000, has been reclassified as a potential human carcinogen.  Few studies of the in vitro human metab. of naphthalene are available, and these focus primarily on lung metab.  The current studies were performed to characterize naphthalene metab. by human cytochromes P 450.  Naphthalene metabolites from pooled human liver microsomes (pHLMs) were trans-1,2-dihydro-1,2-naphthalenediol (dihydrodiol), 1-naphthol, and 2-naphthol.  Metabolite prodn. generated Km values of 23, 40, and 116 Î¼M and Vmax values of 2860, 268, and 22 pmol/mg protein/min, resp.  P 450 isoform screening of naphthalene metab. identified CYP1A2 as the most efficient isoform for producing dihydrodiol and 1-naphthol, and CYP3A4 as the most effective for 2-naphthol prodn.  Metab. of the primary metabolites of naphthalene was also studied to identify secondary metabolites.  Whereas 2-naphthol was readily metabolized by pHLMs to produce 2,6- and 1,7-dihydroxynaphthalene, dihydrodiol and 1-naphthol were inefficient substrates for pHLMs.  A series of human P 450 isoforms was used to further explore the metab. of dihydrodiol and 1-naphthol.  1,4-Naphthoquinone and four minor unknown metabolites from 1-naphthol were obsd., and CYP1A2 and 2D6*1 were identified as the most active isoforms for the prodn. of 1,4-naphthoquinone.  Dihydrodiol was metabolized by P 450 isoforms to three minor unidentified metabolites with CYP3A4 and CYP2A6 having the greatest activity toward this substrate.  The metab. of dihydrodiol by P 450 isoforms was lower than that of 1-naphthol.  These studies identify primary and secondary metabolites of naphthalene produced by pHLMs and P 450 isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplUEnriy1dFbVg90H21EOLACvtfcHk0liLvs8FrEtmvA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslyitw%253D%253D&md5=db5454f7e35cfbd14539860b5b435784</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fdmd.105.005785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.105.005785%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DT.%2BM.%26aulast%3DRose%26aufirst%3DR.%2BL.%26aulast%3DHodgson%26aufirst%3DE.%26atitle%3DIn%2520vitro%2520metabolism%2520of%2520naphthalene%2520by%2520human%2520liver%2520microsomal%2520cytochrome%2520P450%2520enzymes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26spage%3D176%26epage%3D183%26doi%3D10.1124%2Fdmd.105.005785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Genter, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marlowe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kevin Kerzee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nebert, D. W.</span></span> <span> </span><span class="NLM_article-title">Naphthalene toxicity in mice and aryl hydrocarbon receptor-mediated CYPs</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">120</span>â <span class="NLM_lpage">123</span>, <span class="refDoi">Â DOI: 10.1016/j.bbrc.2006.07.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1016%2Fj.bbrc.2006.07.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=16876762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1WqtLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2006&pages=120-123&author=M.+B.+Genterauthor=J.+Marloweauthor=J.+Kevin+Kerzeeauthor=N.+Draginauthor=A.+Pugaauthor=T.+P.+Daltonauthor=D.+W.+Nebert&title=Naphthalene+toxicity+in+mice+and+aryl+hydrocarbon+receptor-mediated+CYPs&doi=10.1016%2Fj.bbrc.2006.07.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Naphthalene toxicity in mice and aryl hydrocarbon receptor-mediated CYPs</span></div><div class="casAuthors">Genter, Mary Beth; Marlowe, Jennifer; Kerzee, J. Kevin; Dragin, Nadine; Puga, Alvaro; Dalton, Timothy P.; Nebert, Daniel W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">120-123</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Naphthalene (NP) has been designated a reasonably anticipated human carcinogen' because of pos. responses in carcinogenicity bioassays in rodents.  Whereas CYP2F enzymes are widely regarded as responsible for NP bioactivation, other metabolic enzymes-including CYP1A1 and CYP1A2-produce NP-1,2-oxide in vitro.  We investigated the role of these aryl hydrocarbon receptor (AHR)-mediated enzymes in NP toxicity in two ways.  First, NP was assessed for the ability to activate transcription via the AHR in an in vitro luciferase reporter assay and was found to have no activity.  Second, mice deficient in AHR, CYP1A1 or CYP1A2 were dosed with NP alone, or following pretreatment with the CYP2F inhibitor 5-phenyl-1-pentyne.  None of the knockout mice were protected from olfactory toxicity of NP.  In contrast, CYP1A1- and CYP1A2-null mice pretreated with 5-phenyl-1-pentyne exhibited no NP olfactory toxicity.  These results suggest that AHR-mediated enzymes do not contribute significantly to NP bioactivation in the intact animal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvw8sZkx1GcLVg90H21EOLACvtfcHk0lhDRGcFO14pvw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1WqtLo%253D&md5=e504d57e312e568f7d4e1cfe98cb9f66</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2006.07.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2006.07.025%26sid%3Dliteratum%253Aachs%26aulast%3DGenter%26aufirst%3DM.%2BB.%26aulast%3DMarlowe%26aufirst%3DJ.%26aulast%3DKevin%2BKerzee%26aufirst%3DJ.%26aulast%3DDragin%26aufirst%3DN.%26aulast%3DPuga%26aufirst%3DA.%26aulast%3DDalton%26aufirst%3DT.%2BP.%26aulast%3DNebert%26aufirst%3DD.%2BW.%26atitle%3DNaphthalene%2520toxicity%2520in%2520mice%2520and%2520aryl%2520hydrocarbon%2520receptor-mediated%2520CYPs%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D348%26spage%3D120%26epage%3D123%26doi%3D10.1016%2Fj.bbrc.2006.07.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tingle, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirmohamed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Templeton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madden, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitteringham, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">An investigation of the formation of cytotoxic, genotoxic, protein-reactive and stable metabolites from naphthalene by human liver microsomes</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1529</span>â <span class="NLM_lpage">1538</span>, <span class="refDoi">Â DOI: 10.1016/0006-2952(93)90319-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1016%2F0006-2952%2893%2990319-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=8240407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaK2cXntFamtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1993&pages=1529-1538&author=M.+D.+Tingleauthor=M.+Pirmohamedauthor=E.+Templetonauthor=A.+S.+Wilsonauthor=S.+Maddenauthor=N.+R.+Kitteringhamauthor=B.+K.+Park&title=An+investigation+of+the+formation+of+cytotoxic%2C+genotoxic%2C+protein-reactive+and+stable+metabolites+from+naphthalene+by+human+liver+microsomes&doi=10.1016%2F0006-2952%2893%2990319-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">An investigation of the formation of cytotoxic, genotoxic, protein-reactive and stable metabolites from naphthalene by human liver microsomes</span></div><div class="casAuthors">Tingle, Malcolm D.; Pirmohamed, Munir; Templeton, Elizabeth; Wilson, Andrew S.; Madden, Stephen; Kitteringham, Neil R.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1529-38</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">Naphthalene (I), which is metabolized to a 1,2-epoxide, has been used as a model compd. in this study in order to investigate the effects of perturbation of detoxication mechanisms on the in vitro toxicity of epoxides in the presence of human liver microsomes.  Naphthalene (100 Î¼M) was metabolized to cytotoxic, protein-reactive and stable, but not genotoxic, metabolites by human liver microsomes.  The metab.-dependent cytotoxicity and covalent binding to protein of naphthalene were significantly higher in the presence of phenobarbitone-induced mouse liver microsomes than with human liver microsomes.  The ratio of trans-1,2-dihydrodiol to 1-naphthol was 8.6 and 0.4 with the human and the induced mouse microsomes, resp.  The metab. dependent toxicity of naphthalene toward human peripheral mononuclear leukocytes was not affected by the glutathione transferase Î¼ status of the co-incubated cells.  Trichloropropene oxide (TCPO; 30 Î¼M), an epoxide hydrolase inhibitor, increased the human liver microsomal-dependent cytotoxicity (19.6 Â± 0.9% vs. 28.7 Â± 1.0%; P = 0.02) and covalent binding to protein (1.4 Â± 0.03% vs. 2.8 Â± 0.02%; P = 0.3) of naphthalene (100 Î¼M), and reversed the 1,2-dihydrodiol to 1-naphthol ratio from 6.6 (without TCPO) to 2.6, 0.6 and 0.1 at TCPO concns. of 30, 100 and 500 Î¼M, resp.  Increasing the human liver microsomal protein concn. reduced the cytotoxicity of naphthalene, while increasing its covalent binding to protein and the formation of the 1,2-dihydrodiol metabolite.  Co-incubation with glutathione (5 mM) reduced the cytotoxicity and covalent binding to protein of naphthalene by 68 and 64%, resp.  Covalent binding to protein was also inhibited by gestodene, while stable metabolite formation was reduced by gestodene (250 Î¼M) and enoxacin (250 Î¼M).  The study demonstrates that human liver cytochrome P 450 enzymes metabolize naphthalene to a cytotoxic and protein-reactive, but not genotoxic, metabolite which is probably an epoxide.  This is rapidly detoxified by microsomal epoxide hydrolase, the efficiency of which can be readily detd. by measurement of the ratio of the stable metabolites, naphthalene 1,2-dihydrodiol and 1-naphthol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM_oKzWw5OL7Vg90H21EOLACvtfcHk0lhDRGcFO14pvw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXntFamtA%253D%253D&md5=4015812377ffaa29b17c1f5f9db3379d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2893%2990319-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252893%252990319-R%26sid%3Dliteratum%253Aachs%26aulast%3DTingle%26aufirst%3DM.%2BD.%26aulast%3DPirmohamed%26aufirst%3DM.%26aulast%3DTempleton%26aufirst%3DE.%26aulast%3DWilson%26aufirst%3DA.%2BS.%26aulast%3DMadden%26aufirst%3DS.%26aulast%3DKitteringham%26aufirst%3DN.%2BR.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DAn%2520investigation%2520of%2520the%2520formation%2520of%2520cytotoxic%252C%2520genotoxic%252C%2520protein-reactive%2520and%2520stable%2520metabolites%2520from%2520naphthalene%2520by%2520human%2520liver%2520microsomes%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1993%26volume%3D46%26spage%3D1529%26epage%3D1538%26doi%3D10.1016%2F0006-2952%2893%2990319-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sproul, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poppe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gohdes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghoborah, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padhi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roskos, L.</span></span> <span> </span><span class="NLM_article-title">Metabolism and disposition of calcimimetic agent cinacalcet HCl in humans and animal models</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1491</span>â <span class="NLM_lpage">1500</span>, <span class="refDoi">Â DOI: 10.1124/dmd.104.000604</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1124%2Fdmd.104.000604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=15328250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFGit7%252FO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=1491-1500&author=G.+N.+Kumarauthor=C.+Sproulauthor=L.+Poppeauthor=S.+Turnerauthor=M.+Gohdesauthor=H.+Ghoborahauthor=D.+Padhiauthor=L.+Roskos&title=Metabolism+and+disposition+of+calcimimetic+agent+cinacalcet+HCl+in+humans+and+animal+models&doi=10.1124%2Fdmd.104.000604"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and disposition of calcimimetic agent cinacalcet HCL in humans and animal models</span></div><div class="casAuthors">Kumar, Gondi N.; Sproul, Christopher; Poppe, Leszek; Turner, Sharon; Gohdes, Mark; Ghoborah, Hesham; Padhi, Desmond; Roskos, Lorin</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1491-1500</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The metab. and disposition of calcimimetic agent cinacalcet HCl was examd. after a single oral administration to mice, rats, monkeys, and human volunteers.  In all species examd., cinacalcet was well absorbed, with greater than 74% oral bioavailability of cinacalcet-derived radioactivity in monkeys and humans.  In rats, cinacalcet-derived radioactivity was widely distributed into most tissues, with no marked gender-related differences.  In all animal models examd., radioactivity was excreted rapidly via both hepatobiliary and urinary routes.  In humans, radioactivity was cleared primarily via the urinary route (80%), with 17% excreted in the feces.  Cinacalcet was not detected in the urine in humans.  The primary routes of metab. of cinacalcet were N-dealkylation leading to carboxylic acid derivs. (excreted in urine as glycine conjugates) and oxidn. of naphthalene ring to form dihydrodiols (excreted in urine and bile as glucuronide conjugates).  The plasma radioactivity in both animals and humans was primarily composed of carboxylic acid metabolites and dihydrodiol glucuronides, with <1% circulating radioactivity accounting for the unchanged cinacalcet.  Overall, the circulating and excreted metabolite profile of cinacalcet in humans was qual. similar to that obsd. in preclin. animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS-MCS9mF1mLVg90H21EOLACvtfcHk0li5_Q3oK5aCtg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFGit7%252FO&md5=3c50c530a01059e70ac50f97f4699124</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fdmd.104.000604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.104.000604%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DG.%2BN.%26aulast%3DSproul%26aufirst%3DC.%26aulast%3DPoppe%26aufirst%3DL.%26aulast%3DTurner%26aufirst%3DS.%26aulast%3DGohdes%26aufirst%3DM.%26aulast%3DGhoborah%26aufirst%3DH.%26aulast%3DPadhi%26aufirst%3DD.%26aulast%3DRoskos%26aufirst%3DL.%26atitle%3DMetabolism%2520and%2520disposition%2520of%2520calcimimetic%2520agent%2520cinacalcet%2520HCl%2520in%2520humans%2520and%2520animal%2520models%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2004%26volume%3D32%26spage%3D1491%26epage%3D1500%26doi%3D10.1124%2Fdmd.104.000604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Risch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeifer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segrestaa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fretz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pothier, J.</span></span> <span> </span><span class="NLM_article-title">Verification of the major metabolic oxidation path for the naphthoyl group in chemoattractant receptor-homologous molecule expressed on Th2 Cells (CRTh2) antagonist 2-(2-(1-naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic acid (Setipiprant/ACT-129968)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8011</span>â <span class="NLM_lpage">8035</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b00824</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00824" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFGltLvM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8011-8035&author=P.+Rischauthor=T.+Pfeiferauthor=J.+Segrestaaauthor=H.+Fretzauthor=J.+Pothier&title=Verification+of+the+major+metabolic+oxidation+path+for+the+naphthoyl+group+in+chemoattractant+receptor-homologous+molecule+expressed+on+Th2+Cells+%28CRTh2%29+antagonist+2-%282-%281-naphthoyl%29-8-fluoro-3%2C4-dihydro-1H-pyrido%5B4%2C3-b%5Dindol-5%282H%29-yl%29acetic+acid+%28Setipiprant%2FACT-129968%29&doi=10.1021%2Facs.jmedchem.5b00824"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Verification of the Major Metabolic Oxidation Path for the Naphthoyl Group in Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTh2) Antagonist 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic Acid (Setipiprant/ACT-129968)</span></div><div class="casAuthors">Risch, Philippe; Pfeifer, Thomas; Segrestaa, Jerome; Fretz, Heinz; Pothier, Julien</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8011-8035</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Various racemic and enantioenriched (trans)-X,Y-dihydroxy-X,Y-dihydronaphthoyl analogs as well as X-hydroxy-naphthoyl analogs of CRTh2 antagonist I (Setipiprant/ACT-129968) were synthesized in order to gain insight into regio- and enantioselectivity of the metabolic oxidn. of 1 and to verify the structures of four metabolites that were proposed earlier in a clin. ADME study.  Anal. data of the synthetic stds. were compared with data from samples of biol. origin.  The two major metabolites M7 and M9 were unambiguously verified as 2-(2-(trans)-3,4-dihydroxy-3,4-dihydronaphthalene-1-carbonyl)- and 2-((2-(trans)-5,6-dihydroxy-5,6-dihydronaphthalene-1-carbonyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic acid, resp., each composed of two enantiomers with 68% and 44% ee in favor of (+)-(3S,4S)-M7 and (+)-(5S,6S)-M9, resp.  Likewise, minor metabolites M3 and M13 were identified as 2-(8-fluoro-2-(5-hydroxy-1-naphthoyl))- and 2-(8-fluoro-2-(4-hydroxy-1-naphthoyl)-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5-yl)acetic acid, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwwdSyS1pBzrVg90H21EOLACvtfcHk0li5_Q3oK5aCtg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFGltLvM&md5=0d17d96dfa3605d3157535c25c74485b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00824%26sid%3Dliteratum%253Aachs%26aulast%3DRisch%26aufirst%3DP.%26aulast%3DPfeifer%26aufirst%3DT.%26aulast%3DSegrestaa%26aufirst%3DJ.%26aulast%3DFretz%26aufirst%3DH.%26aulast%3DPothier%26aufirst%3DJ.%26atitle%3DVerification%2520of%2520the%2520major%2520metabolic%2520oxidation%2520path%2520for%2520the%2520naphthoyl%2520group%2520in%2520chemoattractant%2520receptor-homologous%2520molecule%2520expressed%2520on%2520Th2%2520Cells%2520%2528CRTh2%2529%2520antagonist%25202-%25282-%25281-naphthoyl%2529-8-fluoro-3%252C4-dihydro-1H-pyrido%255B4%252C3-b%255Dindol-5%25282H%2529-yl%2529acetic%2520acid%2520%2528Setipiprant%252FACT-129968%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8011%26epage%3D8035%26doi%3D10.1021%2Facs.jmedchem.5b00824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wank, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kluge, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner-Redeker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingemanse, J.</span></span> <span> </span><span class="NLM_article-title">Disposition and metabolism of setipiprant, a selective oral CRTH2 antagonist, in humans</span>. <i>Drugs R&D</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">253</span>â <span class="NLM_lpage">269</span>, <span class="refDoi">Â DOI: 10.1007/s40268-013-0031-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1007%2Fs40268-013-0031-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=24214422" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=253-269&author=M.+Hochauthor=J.+Wankauthor=I.+Klugeauthor=W.+Wagner-Redekerauthor=J.+Dingemanse&title=Disposition+and+metabolism+of+setipiprant%2C+a+selective+oral+CRTH2+antagonist%2C+in+humans&doi=10.1007%2Fs40268-013-0031-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs40268-013-0031-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40268-013-0031-7%26sid%3Dliteratum%253Aachs%26aulast%3DHoch%26aufirst%3DM.%26aulast%3DWank%26aufirst%3DJ.%26aulast%3DKluge%26aufirst%3DI.%26aulast%3DWagner-Redeker%26aufirst%3DW.%26aulast%3DDingemanse%26aufirst%3DJ.%26atitle%3DDisposition%2520and%2520metabolism%2520of%2520setipiprant%252C%2520a%2520selective%2520oral%2520CRTH2%2520antagonist%252C%2520in%2520humans%26jtitle%3DDrugs%2520R%2526D%26date%3D2013%26volume%3D13%26spage%3D253%26epage%3D269%26doi%3D10.1007%2Fs40268-013-0031-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vickers, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinclair, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zollinger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glanzel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johanson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, V.</span></span> <span> </span><span class="NLM_article-title">Multiple cytochrome P-450s involved in the metabolism of terbinafine suggest a limited potential for drug-drug interactions</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1029</span>â <span class="NLM_lpage">1038</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10460803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaK1MXlslCqsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1029-1038&author=A.+E.+Vickersauthor=J.+R.+Sinclairauthor=M.+Zollingerauthor=F.+Heitzauthor=U.+Glanzelauthor=L.+Johansonauthor=V.+Fischer&title=Multiple+cytochrome+P-450s+involved+in+the+metabolism+of+terbinafine+suggest+a+limited+potential+for+drug-drug+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple cytochrome P-450s involved in the metabolism of terbinafine suggest a limited potential for drug-drug interactions</span></div><div class="casAuthors">Vickers, Alison E. M.; Sinclair, John R.; Zollinger, Markus; Heitz, Francis; Glanzel, Ulrike; Johanson, Laurie; Fischer, Volker</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1029-1038</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Biotransformation pathways and the potential for drug-drug interactions of the orally active antifungal terbinafine were characterized using human liver microsomes and recombinant human cytochrome P-450s (CYPs).  The terbinafine metabolites represented four major pathways: 1. N-demethylation, 2. deamination, 3. alkyl side chain oxidn., and 4. dihydrodiol formation.  Michaelis-Menten kinetics for the pathways revealed mean Km values ranging from 4.4 to 27.8 Î¼M, and Vmax values of 9.8 to 82 nmol/h/mg protein.  At least seven CYP enzymes are involved in terbinafine metab.  Recombinant human CYPs predict that CYP2C9, CYP1A2, and CYP3A4 are the most important for total metab.  N-demethylation is primarily mediated by CYP2C9, CYP2C8, and CYP1A2; dihydrodiol formation by CYP2C9 and CYP1A2; deamination by CYP3A4; and side chain oxidn. equally by CYP1A2, CYP2C8, CYP2C9, and CYP2C19.  Addnl., characteristic CYP substrates inhibited pathways of terbinafine metabolite formation, confirming the involvement of multiple enzymes.  The deamination pathway was mainly inhibited by CYP3A inhibitors, including troleandomycin and azole antifungals.  Dihydrodiol formation was inhibited by the CYP1A2 inhibitor furafylline.  Terbinafine had little or no effect on the metab. of many characteristic CYP substrates.  Terbinafine, however, is a competitive inhibitor of the CYP2D6 reaction, dextromethorphan O-demethylation (Ki = 0.03 Î¼M).  In summary, terbinafine is metabolized by at least seven CYPs.  The potential for terbinafine interaction with other drugs is predicted to be insignificant with the exception that it may inhibit the metab. of CYP2D6 substrates.  Clin. trials are needed to assess the relevance of these findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlDKX8_KrMM7Vg90H21EOLACvtfcHk0lhjyaZwRTPjmA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlslCqsr0%253D&md5=c6a65bf93e3b416da1009bece3777e5a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVickers%26aufirst%3DA.%2BE.%26aulast%3DSinclair%26aufirst%3DJ.%2BR.%26aulast%3DZollinger%26aufirst%3DM.%26aulast%3DHeitz%26aufirst%3DF.%26aulast%3DGlanzel%26aufirst%3DU.%26aulast%3DJohanson%26aufirst%3DL.%26aulast%3DFischer%26aufirst%3DV.%26atitle%3DMultiple%2520cytochrome%2520P-450s%2520involved%2520in%2520the%2520metabolism%2520of%2520terbinafine%2520suggest%2520a%2520limited%2520potential%2520for%2520drug-drug%2520interactions%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1999%26volume%3D27%26spage%3D1029%26epage%3D1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gennaro, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelizzoni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bestetti, G.</span></span> <span> </span><span class="NLM_article-title">Production of substituted naphthalene dihydrodiols by engineered Escherichia coli containing the cloned naphthalene 1,2-dioxygenase gene from Pseudomonas fluorescens N3</span>. <i>Res. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">355</span>â <span class="NLM_lpage">364</span>, <span class="refDoi">Â DOI: 10.1016/s0923-2508(97)81591-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1016%2FS0923-2508%2897%2981591-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=9765814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A280%3ADyaK1cvjvV2msw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=1997&pages=355-364&author=P.+D.+Gennaroauthor=E.+Galliauthor=G.+Albiniauthor=F.+Pelizzoniauthor=G.+Selloauthor=G.+Bestetti&title=Production+of+substituted+naphthalene+dihydrodiols+by+engineered+Escherichia+coli+containing+the+cloned+naphthalene+1%2C2-dioxygenase+gene+from+Pseudomonas+fluorescens+N3&doi=10.1016%2Fs0923-2508%2897%2981591-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Production of substituted naphthalene dihydrodiols by engineered Escherichia coli containing the cloned naphthalene 1,2-dioxygenase gene from Pseudomonas fluorescens N3</span></div><div class="casAuthors">Gennaro P D; Galli E; Albini G; Pelizzoni F; Sello G; Bestetti G</div><div class="citationInfo"><span class="NLM_cas:title">Research in microbiology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-64</span>
        ISSN:<span class="NLM_cas:issn">0923-2508</span>.
    </div><div class="casAbstract">Naphthalene dioxygenase, a key enzyme in the dihydroxylation of naphthalene, is encoded by the plasmid pN3, responsible for naphthalene metabolism in Pseudomonas fluorescens N3.  The naphthalene dioxygenase, including all the sequences for its expression and the regulatory region, has been localized on the 4.3-kb HindIII-ClaI fragment and on the 3.5-kb HindIII fragment of the plasmid pN3, by Southern analysis using as probes nahA and nahR genes, the homologous genes of the plasmid NAH7 from Pseudomonas putida G7.  We cloned in Escherichia coli JM109 the dioxygenase gene and its regulatory region and developed an efficient bacterial system inducible by salicylic acid, able to produce dihydrodiols.  E. coli containing recombinant plasmids carrying the dioxygenase gene were analysed for their potential as a biocatalytic tool to produce dihydrodiols from different naphthalenes with the substituent on the aromatic ring at the alpha or beta position.  The dihydrodiols, identified by HPLC (high-performance liquid chromatography) and 1H-NMR (nuclear magnetic resonance) were produced with yields ranging from 50 to 94%.  The degree of bioconversion efficiency depends on the nature and the position of the substituent and indicates the broad substrate specificity of this dioxygenase and its potential for the production of a wide variety of fine chemicals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2kgk5L7LJi4xhnOQkIHOxfW6udTcc2eY05fg2YvNJnLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1cvjvV2msw%253D%253D&md5=d9d99694dc8fb323f511653540ec8c4b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0923-2508%2897%2981591-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0923-2508%252897%252981591-4%26sid%3Dliteratum%253Aachs%26aulast%3DGennaro%26aufirst%3DP.%2BD.%26aulast%3DGalli%26aufirst%3DE.%26aulast%3DAlbini%26aufirst%3DG.%26aulast%3DPelizzoni%26aufirst%3DF.%26aulast%3DSello%26aufirst%3DG.%26aulast%3DBestetti%26aufirst%3DG.%26atitle%3DProduction%2520of%2520substituted%2520naphthalene%2520dihydrodiols%2520by%2520engineered%2520Escherichia%2520coli%2520containing%2520the%2520cloned%2520naphthalene%25201%252C2-dioxygenase%2520gene%2520from%2520Pseudomonas%2520fluorescens%2520N3%26jtitle%3DRes.%2520Microbiol.%26date%3D1997%26volume%3D148%26spage%3D355%26epage%3D364%26doi%3D10.1016%2Fs0923-2508%2897%2981591-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shindo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iba, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saotome, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misawa, N.</span></span> <span> </span><span class="NLM_article-title">Hydroxylations of substituted naphthalenes by Escherichia coli expressing aromatic dihydroxylating dioxygenase genes from polycyclic aromatic hydrocarbon-utilizing marine bacteria</span>. <i>J. Mol. Catal. B: Enzym.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">77</span>â <span class="NLM_lpage">83</span>, <span class="refDoi">Â DOI: 10.1016/j.molcatb.2007.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1016%2Fj.molcatb.2007.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1Sit7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=77-83&author=K.+Shindoauthor=A.+Osawaauthor=Y.+Kasaiauthor=N.+Ibaauthor=A.+Saotomeauthor=N.+Misawa&title=Hydroxylations+of+substituted+naphthalenes+by+Escherichia+coli+expressing+aromatic+dihydroxylating+dioxygenase+genes+from+polycyclic+aromatic+hydrocarbon-utilizing+marine+bacteria&doi=10.1016%2Fj.molcatb.2007.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxylations of substituted naphthalenes by Escherichia coli expressing aromatic dihydroxylating dioxygenase genes from polycyclic aromatic hydrocarbon-utilizing marine bacteria</span></div><div class="casAuthors">Shindo, Kazutoshi; Osawa, Ayako; Kasai, Yuki; Iba, Nobuko; Saotome, Ayako; Misawa, Norihiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Catalysis B: Enzymatic</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">77-83</span>CODEN:
                <span class="NLM_cas:coden">JMCEF8</span>;
        ISSN:<span class="NLM_cas:issn">1381-1177</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bioconversion expts. of various mono- or di-substituted naphthalenes such as dimethylnaphthalenes were carried out using the cells of Escherichia coli that expressed arom. dihydroxylating dioxygenase genes (phnA1A2A3A4 and phdABCD) from polycyclic arom. hydrocarbon-utilizing marine bacteria, Nocardioides sp. KP7 and Cycloclasticus sp. A5, resp.  We found that the former dioxygenase PhnA1A2A3A4 had broad substrate preference for these compds. and often was able to hydroxylate their Me groups.  Specifically, 1,4-dimethylnaphthalene was predominantly bioconverted into 1,4-dihydroxymethylnaphthalene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5lXj_CYG0wrVg90H21EOLACvtfcHk0lgINZVDI5RUFg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1Sit7Y%253D&md5=a20882d7a9a13bb3b254b67ff9629a45</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.molcatb.2007.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcatb.2007.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DShindo%26aufirst%3DK.%26aulast%3DOsawa%26aufirst%3DA.%26aulast%3DKasai%26aufirst%3DY.%26aulast%3DIba%26aufirst%3DN.%26aulast%3DSaotome%26aufirst%3DA.%26aulast%3DMisawa%26aufirst%3DN.%26atitle%3DHydroxylations%2520of%2520substituted%2520naphthalenes%2520by%2520Escherichia%2520coli%2520expressing%2520aromatic%2520dihydroxylating%2520dioxygenase%2520genes%2520from%2520polycyclic%2520aromatic%2520hydrocarbon-utilizing%2520marine%2520bacteria%26jtitle%3DJ.%2520Mol.%2520Catal.%2520B%253A%2520Enzym.%26date%3D2007%26volume%3D48%26spage%3D77%26epage%3D83%26doi%3D10.1016%2Fj.molcatb.2007.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whited, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downie, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudlicky, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fearnley, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudding, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivo, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D.</span></span> <span> </span><span class="NLM_article-title">Oxidation of 2-methoxynaphthalene by toluene, naphthalene and biphenyl dioxygenases:structure and absolute stereochemistry of metabolites</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">727</span>â <span class="NLM_lpage">734</span>, <span class="refDoi">Â DOI: 10.1016/0968-0896(94)85024-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1016%2F0968-0896%2894%2985024-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=7858982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaK2MXitVOju78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1994&pages=727-734&author=G.+M.+Whitedauthor=J.+C.+Downieauthor=T.+Hudlickyauthor=S.+P.+Fearnleyauthor=T.+C.+Duddingauthor=H.+F.+Olivoauthor=D.+Parker&title=Oxidation+of+2-methoxynaphthalene+by+toluene%2C+naphthalene+and+biphenyl+dioxygenases%3Astructure+and+absolute+stereochemistry+of+metabolites&doi=10.1016%2F0968-0896%2894%2985024-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation of 2-methoxynaphthalene by toluene, naphthalene and biphenyl dioxygenases: structure and absolute stereochemistry of metabolites</span></div><div class="casAuthors">Whited, Gregory M.; Downie, J. Corey; Hudlicky, Tomas; Fearnley, Stephen P.; Dudding, Travis C.; Olivo, Horatio F.; Parker, Denise</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">727-34</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">2-Methoxynaphthalene was subjected to biooxidn. by whole cells of six organisms: Pseudomonas putida (contg. toluene dioxygenase), Escherichia coli (contg. recombinant toluene dioxygenase), Pseudomonas sp. (contg. naphthalene dioxygenase), E. coli (contg. recombinant naphthalene dioxygenase), E. coli (contg. recombinant naphthalene dioxygenase) and Beijerinckia sp. (biphenyl dioxygenase).  The major product of oxidn. by the naphthalene and biphenyl dioxygenases was isolated and identified as (1R,2S)-1,2-dihydroxy-7-methoxy-1,2-dihydronaphthalene.  A minor product, (1R,2S)-1,2-dihydroxy-6-methoxy-1,2-dihydronaphthalene, was detected.  Oxidn. by the toluene dioxygenase-contg. organisms led to the isolation of (1R,2S)-dihydroxy-6-methoxy-1,2-dihydronaphthalene as the major product.  Structural studies and dehydration of the diols to a mixt. of naphthols are described.  The abs. stereochem. of these new diols was detd. by correlation with known compds.  The organisms' potential in the prodn. of new metabolites as useful chiral synthons by biooxidn. of 2-substituted naphthalenes is indicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpg-seA617qLVg90H21EOLACvtfcHk0lgINZVDI5RUFg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXitVOju78%253D&md5=0cbe64f39d19ca724d01e0341c4b5a04</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2F0968-0896%2894%2985024-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0968-0896%252894%252985024-0%26sid%3Dliteratum%253Aachs%26aulast%3DWhited%26aufirst%3DG.%2BM.%26aulast%3DDownie%26aufirst%3DJ.%2BC.%26aulast%3DHudlicky%26aufirst%3DT.%26aulast%3DFearnley%26aufirst%3DS.%2BP.%26aulast%3DDudding%26aufirst%3DT.%2BC.%26aulast%3DOlivo%26aufirst%3DH.%2BF.%26aulast%3DParker%26aufirst%3DD.%26atitle%3DOxidation%2520of%25202-methoxynaphthalene%2520by%2520toluene%252C%2520naphthalene%2520and%2520biphenyl%2520dioxygenases%253Astructure%2520and%2520absolute%2520stereochemistry%2520of%2520metabolites%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1994%26volume%3D2%26spage%3D727%26epage%3D734%26doi%3D10.1016%2F0968-0896%2894%2985024-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bestetti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Gennaro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leoni, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelizzoni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sello, G.</span></span> <span> </span><span class="NLM_article-title">Bioconversion of substituted naphthalenes to the corresponding 1,2-dihydro-1,2-dihydroxy derivatives. Determination of the regio- and stereochemistry of the oxidation reactions</span>. <i>Appl. Microbiol. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">306</span>â <span class="NLM_lpage">313</span>, <span class="refDoi">Â DOI: 10.1007/BF00169921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1007%2FBF00169921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaK28XitVersL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1995&pages=306-313&author=G.+Bestettiauthor=D.+Bianchiauthor=A.+Bosettiauthor=P.+Di+Gennaroauthor=E.+Galliauthor=B.+Leoniauthor=F.+Pelizzoniauthor=G.+Sello&title=Bioconversion+of+substituted+naphthalenes+to+the+corresponding+1%2C2-dihydro-1%2C2-dihydroxy+derivatives.+Determination+of+the+regio-+and+stereochemistry+of+the+oxidation+reactions&doi=10.1007%2FBF00169921"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Bioconversion of substituted naphthalenes to the corresponding 1,2-dihydro-1,2-dihydroxy derivatives. Determination of the regio- and stereochemistry of the oxidation reactions</span></div><div class="casAuthors">Bestetti, G.; Bianchi, D.; Bosetti, A.; Di Gennaro, P.; Galli, E.; Leoni, B.; Pelizzoni, F.; Sello, G.</div><div class="citationInfo"><span class="NLM_cas:title">Applied Microbiology and Biotechnology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">306-13</span>CODEN:
                <span class="NLM_cas:coden">AMBIDG</span>;
        ISSN:<span class="NLM_cas:issn">0175-7598</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A mutant (TTC1) derived from Pseudomonas fluorescens N3 has been obtained for use in bioconversion of several naphthalene derivs. to the corresponding optically active cis-dihydrodiols on a milligrams-to-grams scale.  All main compds. have been characterized, their relative and abs. configuration assigned, and their enantiomeric purity detd.  The regio- and stereoselectivity of the transformation has been established.  The procedure therefore represents a valid method for the convenient prepn. of a pool of valuable chiral syntons and auxiliaries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZZTpUrVz0HrVg90H21EOLACvtfcHk0lhqzWi4Y68qjA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitVersL0%253D&md5=7609c6ad71611253272c7cca9c683d2d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2FBF00169921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00169921%26sid%3Dliteratum%253Aachs%26aulast%3DBestetti%26aufirst%3DG.%26aulast%3DBianchi%26aufirst%3DD.%26aulast%3DBosetti%26aufirst%3DA.%26aulast%3DDi%2BGennaro%26aufirst%3DP.%26aulast%3DGalli%26aufirst%3DE.%26aulast%3DLeoni%26aufirst%3DB.%26aulast%3DPelizzoni%26aufirst%3DF.%26aulast%3DSello%26aufirst%3DG.%26atitle%3DBioconversion%2520of%2520substituted%2520naphthalenes%2520to%2520the%2520corresponding%25201%252C2-dihydro-1%252C2-dihydroxy%2520derivatives.%2520Determination%2520of%2520the%2520regio-%2520and%2520stereochemistry%2520of%2520the%2520oxidation%2520reactions%26jtitle%3DAppl.%2520Microbiol.%2520Biotechnol.%26date%3D1995%26volume%3D44%26spage%3D306%26epage%3D313%26doi%3D10.1007%2FBF00169921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hudlicky, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endoma, M. A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butora, G.</span></span> <span> </span><span class="NLM_article-title">New chiral synthons from the microbial oxidation of bromonaphthalenes</span>. <i>Tetrahedron: Asymmetry</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">61</span>â <span class="NLM_lpage">68</span>, <span class="refDoi">Â DOI: 10.1016/0957-4166(95)00421-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1016%2F0957-4166%2895%2900421-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaK28XpsVWrsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1996&pages=61-68&author=T.+Hudlickyauthor=M.+A.+A.+Endomaauthor=G.+Butora&title=New+chiral+synthons+from+the+microbial+oxidation+of+bromonaphthalenes&doi=10.1016%2F0957-4166%2895%2900421-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">New chiral synthons from the microbial oxidation of bromonaphthalenes</span></div><div class="casAuthors">Hudlicky, Tomas; Endoma, Mary Ann A.; Butora, Gabor</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron: Asymmetry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-8</span>CODEN:
                <span class="NLM_cas:coden">TASYE3</span>;
        ISSN:<span class="NLM_cas:issn">0957-4166</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">1-Bromo- and 2-bromonaphthalene were subjected to biooxidn. with whole cells of Pseudomonas putida NCIB 9816-11.  The major metabolites were isolated and spectroscopically characterized as (+)-cis-(1R,2S)-dihydroxy-1,2-dihydro-8-bromonaphthalene and (+)-cis-(1R,2S)-dihydroxy-1,2-dihydro-5-bromonaphthalene from 1-bromonaphthalene and (+)-cis-(1R,2S)-dihydroxy-1,2-dihydro-7-bromonaphthalene from 2-bromonaphthalene.  The abs. stereochem. and enantiomeric excess were detd. by conversion of each metabolite to the known (-)-cis-(1R,2S)-dihydroxy-1,2,3,4-tetrahydronaphthalene diol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxZ4fVCDdjHrVg90H21EOLACvtfcHk0lhqzWi4Y68qjA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XpsVWrsA%253D%253D&md5=d09b845ab702ec9b06cbeaea6fc5fc37</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2F0957-4166%2895%2900421-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0957-4166%252895%252900421-1%26sid%3Dliteratum%253Aachs%26aulast%3DHudlicky%26aufirst%3DT.%26aulast%3DEndoma%26aufirst%3DM.%2BA.%2BA.%26aulast%3DButora%26aufirst%3DG.%26atitle%3DNew%2520chiral%2520synthons%2520from%2520the%2520microbial%2520oxidation%2520of%2520bromonaphthalenes%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1996%26volume%3D7%26spage%3D61%26epage%3D68%26doi%3D10.1016%2F0957-4166%2895%2900421-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gawronski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">More OâFerrall, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudavalli, J. S.</span></span> <span> </span><span class="NLM_article-title">Toluene dioxygenase-catalyzed synthesis of cis-dihydrodiol metabolites from 2-substituted naphthalene substrates: assignments of absolute configurations and conformations from circular dichroism and optical rotation measurements</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">11500</span>â <span class="NLM_lpage">11511</span>, <span class="refDoi">Â DOI: 10.1002/chem.200801686</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1002%2Fchem.200801686" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=19006170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktV2gtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=11500-11511&author=M.+Kwitauthor=J.+Gawronskiauthor=D.+R.+Boydauthor=N.+D.+Sharmaauthor=M.+Kaikauthor=R.+A.+More+O%E2%80%99Ferrallauthor=J.+S.+Kudavalli&title=Toluene+dioxygenase-catalyzed+synthesis+of+cis-dihydrodiol+metabolites+from+2-substituted+naphthalene+substrates%3A+assignments+of+absolute+configurations+and+conformations+from+circular+dichroism+and+optical+rotation+measurements&doi=10.1002%2Fchem.200801686"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Toluene dioxygenase-catalyzed synthesis of cis-dihydrodiol metabolites from 2-substituted naphthalene substrates: assignments of absolute configurations and conformations from circular dichroism and optical rotation measurements</span></div><div class="casAuthors">Kwit, Marcin; Gawronski, Jacek; Boyd, Derek R.; Sharma, Narain D.; Kaik, Magdalena; More O'Ferrall, Rory A.; Kudavalli, Jaya S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">11500-11511</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Cis-Dihydrodiol metabolites have been isolated from naphthalene and six 2-substituted naphthalene substrates.  Their structures and abs. configurations have been detd. by a combination of calcd. (TDDFT) and exptl. based CD (CD) and optical rotation (OR) methods.  The "inverse" styrene helicity rule is shown to be incorrect for the interpretation of the CD spectra of cis-dihydrodiols.  A striking conclusion is that CD spectra correlate directly with the helicity of the styrene chromophore: i.e., the sign of the long-wavelength Cotton effect is identical with the sign of styrene torsion angle, whereas the OR sign is dependent on the abs. configuration of the allylic carbon atom.  The results demonstrate that a predictive model previously used for the detn. of preferred regio- and stereoselectivity assocd. with TDO-catalyzed cis-dihydroxylation of substituted benzene substrates can now be successfully extended to substituted naphthalene substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZy_Ti9kWyU7Vg90H21EOLACvtfcHk0lhEcGDEnFsCwQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktV2gtg%253D%253D&md5=c4e0048e9a6b73494c33a46b25c6625e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fchem.200801686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200801686%26sid%3Dliteratum%253Aachs%26aulast%3DKwit%26aufirst%3DM.%26aulast%3DGawronski%26aufirst%3DJ.%26aulast%3DBoyd%26aufirst%3DD.%2BR.%26aulast%3DSharma%26aufirst%3DN.%2BD.%26aulast%3DKaik%26aufirst%3DM.%26aulast%3DMore%2BO%25E2%2580%2599Ferrall%26aufirst%3DR.%2BA.%26aulast%3DKudavalli%26aufirst%3DJ.%2BS.%26atitle%3DToluene%2520dioxygenase-catalyzed%2520synthesis%2520of%2520cis-dihydrodiol%2520metabolites%2520from%25202-substituted%2520naphthalene%2520substrates%253A%2520assignments%2520of%2520absolute%2520configurations%2520and%2520conformations%2520from%2520circular%2520dichroism%2520and%2520optical%2520rotation%2520measurements%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2008%26volume%3D14%26spage%3D11500%26epage%3D11511%26doi%3D10.1002%2Fchem.200801686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lautens, M.</span></span> <span> </span><span class="NLM_article-title">Rhodium(I)-catalyzed domino asymmetric ring opening/enantioselective isomerization of oxabicyclic alkenes with water</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5400</span>â <span class="NLM_lpage">5404</span>, <span class="refDoi">Â DOI: 10.1002/anie.201200390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1002%2Fanie.201200390" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BC38Xls1eltr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=5400-5404&author=G.+C.+Tsuiauthor=M.+Lautens&title=Rhodium%28I%29-catalyzed+domino+asymmetric+ring+opening%2Fenantioselective+isomerization+of+oxabicyclic+alkenes+with+water&doi=10.1002%2Fanie.201200390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Rhodium(I)-Catalyzed Domino Asymmetric Ring Opening/Enantioselective Isomerization of Oxabicyclic Alkenes with Water</span></div><div class="casAuthors">Tsui, Gavin C.; Lautens, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5400-5404, S5400/1-S5400/27</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Enantio-enriched 2-hydroxy-1-tetralones are formed from oxabicyclic alkenes through a novel RhI-catalyzed domino reaction.  The proposed mechanism involves water-induced asym. ring opening to generate chiral trans-1,2-diol intermediates and subsequent enantioselective isomerization (I â II â III).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmSvFWbDYA27Vg90H21EOLACvtfcHk0lhEcGDEnFsCwQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xls1eltr0%253D&md5=16b4b24fe5d28bcf14aa0685f0decfd4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fanie.201200390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201200390%26sid%3Dliteratum%253Aachs%26aulast%3DTsui%26aufirst%3DG.%2BC.%26aulast%3DLautens%26aufirst%3DM.%26atitle%3DRhodium%2528I%2529-catalyzed%2520domino%2520asymmetric%2520ring%2520opening%252Fenantioselective%2520isomerization%2520of%2520oxabicyclic%2520alkenes%2520with%2520water%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D5400%26epage%3D5404%26doi%3D10.1002%2Fanie.201200390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, T. K.</span></span> <span> </span><span class="NLM_article-title">A diversity-oriented synthesis of bicyclic cis-dihydroarenediols, cis-4-hydroxyscytalones, and bicyclic conduritol analogues</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2472</span>â <span class="NLM_lpage">2475</span>, <span class="refDoi">Â DOI: 10.1021/ol100557f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol100557f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BC3cXls12js78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=2472-2475&author=P.+Mukherjeeauthor=S.+J.+Royauthor=T.+K.+Sarkar&title=A+diversity-oriented+synthesis+of+bicyclic+cis-dihydroarenediols%2C+cis-4-hydroxyscytalones%2C+and+bicyclic+conduritol+analogues&doi=10.1021%2Fol100557f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A Diversity-Oriented Synthesis of Bicyclic cis-Dihydroarenediols, cis-4-Hydroxyscytalones, and Bicyclic Conduritol Analogues</span></div><div class="casAuthors">Mukherjee, Parag; Roy, Soumya J. Singha; Sarkar, Tarun K.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2472-2475</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A common-intermediate-based enantioselective strategy has been developed aiming at bicyclic arene cis-dihydrodiols, cis-4-hydroxyscytalones, and bicyclic mimics of conduritol.  Key features of this protocol include Barrett's asym. hydroxyallylation, ring-closing metathesis (RCM), and completely regioselective Wacker oxidn. of internal cyclic olefins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWBs8kqnKFRLVg90H21EOLACvtfcHk0liGiY6-1LG7sQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXls12js78%253D&md5=c1eddd68011c639a33f4f2ad35db4b57</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fol100557f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol100557f%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DP.%26aulast%3DRoy%26aufirst%3DS.%2BJ.%26aulast%3DSarkar%26aufirst%3DT.%2BK.%26atitle%3DA%2520diversity-oriented%2520synthesis%2520of%2520bicyclic%2520cis-dihydroarenediols%252C%2520cis-4-hydroxyscytalones%252C%2520and%2520bicyclic%2520conduritol%2520analogues%26jtitle%3DOrg.%2520Lett.%26date%3D2010%26volume%3D12%26spage%3D2472%26epage%3D2475%26doi%3D10.1021%2Fol100557f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olesen, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linnet, K.</span></span> <span> </span><span class="NLM_article-title">Identification of the human cytochrome P450 isoforms mediating in vitro N-dealkylation of perphenazine</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">563</span>â <span class="NLM_lpage">571</span>, <span class="refDoi">Â DOI: 10.1046/j.1365-2125.2000.00298.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1046%2Fj.1365-2125.2000.00298.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=11136295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkvVyqtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2000&pages=563-571&author=O.+V.+Olesenauthor=K.+Linnet&title=Identification+of+the+human+cytochrome+P450+isoforms+mediating+in+vitro+N-dealkylation+of+perphenazine&doi=10.1046%2Fj.1365-2125.2000.00298.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the human cytochrome P450 isoforms mediating in vitro N-dealkylation of perphenazine</span></div><div class="casAuthors">Olesen, Ole V.; Linnet, Kristian</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">563-571</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">To identify the human cytochrome P 450 (CYP) isoforms mediating the N-dealkylation of the antipsychotic drug perphenazine in vitro and est. the relative contributions of the CYP isoforms involved.  The cDNA-expressed CYP isoforms were used to identify the isoforms that are able to mediate the N-dealkylation of perphenazine, which is considered a major metabolic pathway for the drug.  Using human liver microsomal prepns. (HLM), inhibition studies were carried out to establish the relative contributions of the CYP isoforms involved in the N-dealkylation reaction.  CYP isoforms 1A2, 3A4, 2C8, 2C9, 2C18, 2C19 and 2D6 were able to mediate the N-dealkylation of perphenazine.  Reaction velocities and their relative abundance in HLM suggested that CYP1A2, 3A4, 2C19 and 2D6 were the most important contributors to N-dealkylation.  Apparent Km values of CYP1A2 and CYP2D6 were in the range 1-2 Î¼M, and Km values of CYP2C19 and CYP3A4 were 14 Î¼M and 7.9 Î¼M, resp.  Ketoconazole inhibition of N-dealkylation mediated by a mixed HLM indicated that CYP3A4 accounted for about 40% of perphenazine N-dealkylation at therapeutically relevant concns.  The contribution of the CYP isoforms 1A2, 2C19 and 2D6 amounted to 20-25% each as measured by the percentage inhibition obtained by addn. of furafylline, fluvoxamine or quinidine, resp.  HLM-mediated N-dealkylation of perphenazine accounted for 57% of the total amt. of substrate consumed during incubation.  The present in vitro study suggests that CYP isoforms 1A2, 3A4, 2C19 and 2CD6 are primarily involved in the N-dealkylation of perphenazine.  The relatively modest role of CYP2D6 is at variance with in vivo studies, which indicate a greater contribution of this isoform.  Alternative metabolic pathways, corresponding to 43% of the HLM-mediated metab. of the drug, may depend more strongly on CYP2D6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2m5O_BqlM5bVg90H21EOLACvtfcHk0liGiY6-1LG7sQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkvVyqtA%253D%253D&md5=4dc579d66f4b4539d827d48bfa688047</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2125.2000.00298.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2125.2000.00298.x%26sid%3Dliteratum%253Aachs%26aulast%3DOlesen%26aufirst%3DO.%2BV.%26aulast%3DLinnet%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520the%2520human%2520cytochrome%2520P450%2520isoforms%2520mediating%2520in%2520vitro%2520N-dealkylation%2520of%2520perphenazine%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2000%26volume%3D50%26spage%3D563%26epage%3D571%26doi%3D10.1046%2Fj.1365-2125.2000.00298.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dierks, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelius, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ball, S. E.</span></span> <span> </span><span class="NLM_article-title">A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">23</span>â <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=11124225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BD3MXpvFGq" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=23-29&author=E.+A.+Dierksauthor=K.+R.+Stamsauthor=H.+K.+Limauthor=G.+Corneliusauthor=H.+Zhangauthor=S.+E.+Ball&title=A+method+for+the+simultaneous+evaluation+of+the+activities+of+seven+major+human+drug-metabolizing+cytochrome+P450s+using+an+in+vitro+cocktail+of+probe+substrates+and+fast+gradient+liquid+chromatography+tandem+mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry</span></div><div class="casAuthors">Dierks, Elizabeth A.; Stams, Karen R.; Lim, Heng-Keang; Cornelius, Georgia; Zhang, Honglu; Ball, Simon E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-29</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P 450s (CYP3A4, CYP2D6, CYP2C9, CYP1A2, CYP2C19, CYP2A6, and CYP2C8) was developed.  This method uses an in vitro cocktail of specific substrates (midazolam, bufuralol, diclofenac, ethoxyresorufin, S-mephenytoin, coumarin, and paclitaxel) and fast gradient liq. chromatog. tandem mass spectrometry.  The assay incubation time is 20 min, which is in the linear range for all of the substrates, and the anal. time is 4 min/sample.  Substrate specificity was confirmed by incubating Escherichia coli-expressed enzymes with the cocktail.  Potent specific inhibitors of the seven enzymes (ketoconazole, quinidine, sulfaphenazole, tranylcypromine, quercetin, furafylline, and 8-methoxypsoralen) were evaluated in cocktail and individual substrate incubations.  Five of these inhibitors were further studied to det. more precise IC50 values for inhibition of the seven enzymes.  The IC50 values obtained in both cocktail and individual incubations were in good agreement with published values.  This cocktail method offers an efficient, robust way to det. the cytochrome P 450 inhibition profile of large nos. of compds.  The enhanced throughput of this method greatly facilitates its use to assess CYP inhibition as a drug candidate selection criterion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgC8bpIeyGTLVg90H21EOLACvtfcHk0liGiY6-1LG7sQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXpvFGq&md5=923c36cb4476b965eabcfee26f974372</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDierks%26aufirst%3DE.%2BA.%26aulast%3DStams%26aufirst%3DK.%2BR.%26aulast%3DLim%26aufirst%3DH.%2BK.%26aulast%3DCornelius%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBall%26aufirst%3DS.%2BE.%26atitle%3DA%2520method%2520for%2520the%2520simultaneous%2520evaluation%2520of%2520the%2520activities%2520of%2520seven%2520major%2520human%2520drug-metabolizing%2520cytochrome%2520P450s%2520using%2520an%2520in%2520vitro%2520cocktail%2520of%2520probe%2520substrates%2520and%2520fast%2520gradient%2520liquid%2520chromatography%2520tandem%2520mass%2520spectrometry%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2001%26volume%3D29%26spage%3D23%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Donato, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Lechon, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castell, J. V.</span></span> <span> </span><span class="NLM_article-title">A microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatocytes cultured on 96-well plates</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>213</i></span>,  <span class="NLM_fpage">29</span>â <span class="NLM_lpage">33</span>, <span class="refDoi">Â DOI: 10.1006/abio.1993.1381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1006%2Fabio.1993.1381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=8238878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaK3sXlsFCmsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=1993&pages=29-33&author=M.+T.+Donatoauthor=M.+J.+Gomez-Lechonauthor=J.+V.+Castell&title=A+microassay+for+measuring+cytochrome+P450IA1+and+P450IIB1+activities+in+intact+human+and+rat+hepatocytes+cultured+on+96-well+plates&doi=10.1006%2Fabio.1993.1381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatocytes cultured in 96-well plates</span></div><div class="casAuthors">Donato, M. Teresa; Gomez-Lechon, M. Jose; Castell, Jose V.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-33</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    </div><div class="casAbstract">A sensitive and simple microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatocytes was developed.  The method is based on the metab. by cells cultured in microwells of appropriate substrates at noncytotoxic concns. (8 Î¼M 7-ethoxyresorufin and 15 Î¼M 7-pentoxyresorufin).  After incubation of the probes with the cells, the dealkylated resorufin formed and released into culture medium was quantified.  To ensure the hydrolysis of the resorufin conjugates eventually formed, culture supernatants were incubated in the microwells with Î²-glucuronidase and arylsulfatase.  The fluorescence was then read using a microplate fluoroescence reader.  A high correlation between the monooxygenase activity measured by this procedure and that measured by conventional procedures in the microsomal fraction of the same cells was found.  The major advantages of this method are: (1) the small no. of cells required; (2) a drastic redn. in assay time; (3) that the assay is performed in intact cells; and (4) the possibility of performing repeated assays with the same cell monolayer over a period of several days since no injury to cells is detectable during the assay.  This method proved to be very convenient for studying cytochrome P 450 induction by xenobiotics in primary cultures of human hepatocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvkbBymI3qW7Vg90H21EOLACvtfcHk0lhmG04XZWn_Bg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlsFCmsLo%253D&md5=b0ad75f43217f05e9da8f78174310c51</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1006%2Fabio.1993.1381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.1993.1381%26sid%3Dliteratum%253Aachs%26aulast%3DDonato%26aufirst%3DM.%2BT.%26aulast%3DGomez-Lechon%26aufirst%3DM.%2BJ.%26aulast%3DCastell%26aufirst%3DJ.%2BV.%26atitle%3DA%2520microassay%2520for%2520measuring%2520cytochrome%2520P450IA1%2520and%2520P450IIB1%2520activities%2520in%2520intact%2520human%2520and%2520rat%2520hepatocytes%2520cultured%2520on%252096-well%2520plates%26jtitle%3DAnal.%2520Biochem.%26date%3D1993%26volume%3D213%26spage%3D29%26epage%3D33%26doi%3D10.1006%2Fabio.1993.1381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skaanild, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friis, C.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P450 sex differences in minipigs and conventional pigs</span>. <i>Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">174</span>â <span class="NLM_lpage">180</span>, <span class="refDoi">Â DOI: 10.1111/j.1600-0773.1999.tb00088.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1111%2Fj.1600-0773.1999.tb00088.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10563516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaK1MXmslarsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1999&pages=174-180&author=M.+T.+Skaanildauthor=C.+Friis&title=Cytochrome+P450+sex+differences+in+minipigs+and+conventional+pigs&doi=10.1111%2Fj.1600-0773.1999.tb00088.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 sex differences in minipigs and conventional pigs</span></div><div class="casAuthors">Skaanild, Mette T.; Friis, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Toxicology (Copenhagen)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">174-180</span>CODEN:
                <span class="NLM_cas:coden">PHTOEH</span>;
        ISSN:<span class="NLM_cas:issn">0901-9928</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">Minipigs have become a popular alternative to the traditional non-rodent species although little information is available on their P 450 system.  The total P 450, the enzyme activity and immunochem. levels of some of the most important drug metabolizing isoenzymes CYP1A2, CYP2A6, CYP2C19, CYP2D6, CYP2E1 and CYP3A4 were measured in liver microsomes from 8 minipigs and 12 conventional pigs of both sexes and castrate conventional pigs.  The mRNA expression was analyzed for 3 isoenzymes: CYP1A2, CYP2A6 and CYP2E1.  The total P 450 activity was slightly higher in minipigs compared to conventional pigs but no sex differences were detected.  CYP1A2 activity was 4 times higher in female than in male minipigs.  The activity of the male minipigs possessed the same activity as were identical to the conventional females, males and castrates.  The activity of CYP2E1 was 4 times higher in female than in male minipigs and 2 times higher in female than in male pigs.  No activity of CYP2D6 or CYP2C19 could be detected.  The CYP3A4 activity detected in minipigs was higher than the activity in conventional pigs.  A slight sex difference was seen in both strains.  Correlations between enzyme activity and immunochem. levels were found for CYP1A2, CYP2A6 and CYP3A4 but not for CYP2E1.  The mRNA concn. of CYP1A2, CYP2A6 and CYP2E1 was detd. because the activity of these enzymes showed marked sex differences.  A Spearman ranking correlation anal. between mRNA expression and enzyme activity showed a weak correlation for CYP2A6, but not for CYP1A2 and CYP2E1.  These results seem to indicate that CYP2A6 could be transcriptionally regulated, whereas CYP1A2 might be post-transcriptionally regulated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrodFDTcba_9rVg90H21EOLACvtfcHk0lhmG04XZWn_Bg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmslarsbc%253D&md5=a49969afd2d11ded6418281a6084bebb</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0773.1999.tb00088.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0773.1999.tb00088.x%26sid%3Dliteratum%253Aachs%26aulast%3DSkaanild%26aufirst%3DM.%2BT.%26aulast%3DFriis%26aufirst%3DC.%26atitle%3DCytochrome%2520P450%2520sex%2520differences%2520in%2520minipigs%2520and%2520conventional%2520pigs%26jtitle%3DPharmacol.%2520Toxicol.%26date%3D1999%26volume%3D85%26spage%3D174%26epage%3D180%26doi%3D10.1111%2Fj.1600-0773.1999.tb00088.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairclough, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkes, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squire, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozzoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capogrosso, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wren, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Luca, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span> <span> </span><span class="NLM_article-title">Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e19189</span> <span class="refDoi">Â DOI: 10.1371/journal.pone.0019189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1371%2Fjournal.pone.0019189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=21573153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFKjurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=J.+M.+Tinsleyauthor=R.+J.+Faircloughauthor=R.+Storerauthor=F.+J.+Wilkesauthor=A.+C.+Potterauthor=S.+E.+Squireauthor=D.+S.+Powellauthor=A.+Cozzoliauthor=R.+F.+Capogrossoauthor=A.+Lambertauthor=F.+X.+Wilsonauthor=S.+P.+Wrenauthor=A.+De+Lucaauthor=K.+E.+Davies&title=Daily+treatment+with+SMTC1100%2C+a+novel+small+molecule+utrophin+upregulator%2C+dramatically+reduces+the+dystrophic+symptoms+in+the+mdx+mouse&doi=10.1371%2Fjournal.pone.0019189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse</span></div><div class="casAuthors">Tinsley, Jonathon M.; Fairclough, Rebecca J.; Storer, Richard; Wilkes, Fraser J.; Potter, Allyson C.; Squire, Sarah E.; Powell, Dave S.; Cozzoli, Anna; Capogrosso, Roberta F.; Lambert, Adam; Wilson, Francis X.; Wren, Stephen P.; De Luca, Annamaria; Davies, Kay E.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e19189</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the muscle fibers leading to the gradual depletion of skeletal muscle.  There is significant evidence demonstrating that increasing levels of the dystrophin-related protein, utrophin, in mouse models results in sarcolemmal bound utrophin and prevents the muscular dystrophy pathol.  The aim of this work was to develop a small mol. which increases the levels of utrophin in muscle and thus has therapeutic potential.  Methodol. and Principal Findings: We describe the in vivo activity of SMT C1100; the first orally bioavailable small mol. utrophin upregulator.  Once-a-day daily-dosing with SMT C1100 reduces a no. of the pathol. effects of dystrophin deficiency.  Treatment results in reduced pathol., better muscle physiol. leading to an increase in overall strength, and an ability to resist fatigue after forced exercise; a surrogate for the six minute walk test currently recommended as the pivotal outcome measure in human trials for DMD.  Conclusions and Significance: This study demonstrates proof-of-principle for the use of in vitro screening methods in allowing identification of pharmacol. agents for utrophin transcriptional upregulation.  The best compd. identified, SMT C1100, demonstrated significant disease modifying effects in DMD models.  Our data warrant the full evaluation of this compd. in clin. trials in DMD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfaIHZ6ne-KrVg90H21EOLACvtfcHk0lgyCAY0Wh6ZEg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFKjurs%253D&md5=634efc4fcd4c7c591b82ab8142eb6085</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0019189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0019189%26sid%3Dliteratum%253Aachs%26aulast%3DTinsley%26aufirst%3DJ.%2BM.%26aulast%3DFairclough%26aufirst%3DR.%2BJ.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DWilkes%26aufirst%3DF.%2BJ.%26aulast%3DPotter%26aufirst%3DA.%2BC.%26aulast%3DSquire%26aufirst%3DS.%2BE.%26aulast%3DPowell%26aufirst%3DD.%2BS.%26aulast%3DCozzoli%26aufirst%3DA.%26aulast%3DCapogrosso%26aufirst%3DR.%2BF.%26aulast%3DLambert%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DF.%2BX.%26aulast%3DWren%26aufirst%3DS.%2BP.%26aulast%3DDe%2BLuca%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26atitle%3DDaily%2520treatment%2520with%2520SMTC1100%252C%2520a%2520novel%2520small%2520molecule%2520utrophin%2520upregulator%252C%2520dramatically%2520reduces%2520the%2520dystrophic%2520symptoms%2520in%2520the%2520mdx%2520mouse%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0019189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 7 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Maria Chatzopoulou, Enrico Emer, Cristina Lecci, Jessica A. Rowley, Anne-Sophie Casagrande, Lee Moir, Sarah E. Squire, Stephen G. Davies, Shawn Harriman, Graham M. Wynne, Francis X. Wilson, Kay E. Davies, <span class="NLM_string-name hlFld-ContribAuthor">Angela J. Russell</span>. </span><span class="cited-content_cbyCitation_article-title">Decreasing HepG2 Cytotoxicity by Lowering the Lipophilicity of Benzo[d]oxazolephosphinate Ester Utrophin Modulators. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (12)
                                     , 2421-2427. <a href="https://doi.org/10.1021/acsmedchemlett.0c00405" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00405</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00405%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDecreasing%252BHepG2%252BCytotoxicity%252Bby%252BLowering%252Bthe%252BLipophilicity%252Bof%252BBenzo%25255Bd%25255Doxazolephosphinate%252BEster%252BUtrophin%252BModulators%26aulast%3DChatzopoulou%26aufirst%3DMaria%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D20072020%26date%3D26102020%26date%3D04112020%26volume%3D11%26issue%3D12%26spage%3D2421%26epage%3D2427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Arran Babbs, Adam Berg, Maria Chatzopoulou, Kay E. Davies, Stephen G. Davies, Benjamin Edwards, David J. Elsey, Enrico Emer, Simon Guiraud, Shawn Harriman, Cristina Lecci, Lee Moir, David Peters, Neil Robinson, Jessica A. Rowley, Angela J. Russell, Sarah E. Squire, Jonathon M. Tinsley, Francis X. Wilson, <span class="NLM_string-name hlFld-ContribAuthor">Graham M. Wynne</span>. </span><span class="cited-content_cbyCitation_article-title">2-Arylbenzo[d]oxazole Phosphinate Esters as Second-Generation Modulators of Utrophin for the Treatment of Duchenne Muscular Dystrophy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (14)
                                     , 7880-7891. <a href="https://doi.org/10.1021/acs.jmedchem.0c00807" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00807%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2-Arylbenzo%25255Bd%25255Doxazole%252BPhosphinate%252BEsters%252Bas%252BSecond-Generation%252BModulators%252Bof%252BUtrophin%252Bfor%252Bthe%252BTreatment%252Bof%252BDuchenne%252BMuscular%252BDystrophy%26aulast%3DBabbs%26aufirst%3DArran%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D12052020%26date%3D10072020%26date%3D18062020%26volume%3D63%26issue%3D14%26spage%3D7880%26epage%3D7891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting Xiang  Lim</span>, <span class="hlFld-ContribAuthor ">Gregory K.  Pierens</span>, <span class="hlFld-ContribAuthor ">Paul V.  Bernhardt</span>, <span class="hlFld-ContribAuthor ">Muneer  Ahamed</span>, <span class="hlFld-ContribAuthor ">David C.  Reutens</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, isolation and characterisation of fluorinatedâbenzimidazoisoquinoline regioisomers. </span><span class="cited-content_cbyCitation_journal-name">Magnetic Resonance in Chemistry</span><span> <strong>2021,</strong> <em>5 </em><a href="https://doi.org/10.1002/mrc.5193" title="DOI URL">https://doi.org/10.1002/mrc.5193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/mrc.5193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmrc.5193%26sid%3Dliteratum%253Aachs%26jtitle%3DMagnetic%2520Resonance%2520in%2520Chemistry%26atitle%3DSynthesis%25252C%252Bisolation%252Band%252Bcharacterisation%252Bof%252Bfluorinated%2525E2%252580%252590benzimidazoisoquinoline%252Bregioisomers%26aulast%3DLim%26aufirst%3DTing%2BXiang%26date%3D2021%26date%3D2021%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patricia  SoblecheroâMartÃ­n</span>, <span class="hlFld-ContribAuthor ">Andrea  LÃ³pezâMartÃ­nez</span>, <span class="hlFld-ContribAuthor ">Laura  PuenteâOvejero</span>, <span class="hlFld-ContribAuthor ">Ainara  VallejoâIllarramendi</span>, <span class="hlFld-ContribAuthor ">Virginia  ArechavalaâGomeza</span>. </span><span class="cited-content_cbyCitation_article-title">Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies. </span><span class="cited-content_cbyCitation_journal-name">Neuropathology and Applied Neurobiology</span><span> <strong>2021,</strong> <em>51 </em><a href="https://doi.org/10.1111/nan.12735" title="DOI URL">https://doi.org/10.1111/nan.12735</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/nan.12735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fnan.12735%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropathology%2520and%2520Applied%2520Neurobiology%26atitle%3DUtrophin%252Bmodulator%252Bdrugs%252Bas%252Bpotential%252Btherapies%252Bfor%252BDuchenne%252Band%252BBecker%252Bmuscular%252Bdystrophies%26aulast%3DSoblechero%25E2%2580%2590Mart%25C3%25ADn%26aufirst%3DPatricia%26date%3D2021%26date%3D2021%26volume%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aini  Vuorinen</span>, <span class="hlFld-ContribAuthor ">Isabel V.L.  Wilkinson</span>, <span class="hlFld-ContribAuthor ">Maria  Chatzopoulou</span>, <span class="hlFld-ContribAuthor ">Ben  Edwards</span>, <span class="hlFld-ContribAuthor ">Sarah E.  Squire</span>, <span class="hlFld-ContribAuthor ">Rebecca J.  Fairclough</span>, <span class="hlFld-ContribAuthor ">Noelia Araujo  Bazan</span>, <span class="hlFld-ContribAuthor ">Josh A.  Milner</span>, <span class="hlFld-ContribAuthor ">Daniel  Conole</span>, <span class="hlFld-ContribAuthor ">James R.  Donald</span>, <span class="hlFld-ContribAuthor ">Nandini  Shah</span>, <span class="hlFld-ContribAuthor ">Nicky J.  Willis</span>, <span class="hlFld-ContribAuthor ">Fernando Martinez  Vazquez</span>, <span class="hlFld-ContribAuthor ">Francis X.  Wilson</span>, <span class="hlFld-ContribAuthor ">Graham M.  Wynne</span>, <span class="hlFld-ContribAuthor ">Stephen G.  Davies</span>, <span class="hlFld-ContribAuthor ">Kay E.  Davies</span>, <span class="hlFld-ContribAuthor ">Angela J.  Russell</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Mechanism of Action studies of 4,6-diphenylpyrimidine-2-carbohydrazides as utrophin modulators for the treatment of Duchenne muscular dystrophy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>34 </em>, 113431. <a href="https://doi.org/10.1016/j.ejmech.2021.113431" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113431</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113431%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BMechanism%252Bof%252BAction%252Bstudies%252Bof%252B4%25252C6-diphenylpyrimidine-2-carbohydrazides%252Bas%252Butrophin%252Bmodulators%252Bfor%252Bthe%252Btreatment%252Bof%252BDuchenne%252Bmuscular%252Bdystrophy%26aulast%3DVuorinen%26aufirst%3DAini%26date%3D2021%26volume%3D34%26spage%3D113431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cynthia  Shu</span>, <span class="hlFld-ContribAuthor ">Liubov  Parfenova</span>, <span class="hlFld-ContribAuthor ">Ekaterina  Mokhonova</span>, <span class="hlFld-ContribAuthor ">Judd R.  Collado</span>, <span class="hlFld-ContribAuthor ">Robert  Damoiseaux</span>, <span class="hlFld-ContribAuthor ">Jesus  Campagna</span>, <span class="hlFld-ContribAuthor ">Varghese  John</span>, <span class="hlFld-ContribAuthor ">Rachelle H.  Crosbie</span>. </span><span class="cited-content_cbyCitation_article-title">High-throughput screening identifies modulators of sarcospan that stabilize muscle cells and exhibit activity in the mouse model of Duchenne muscular dystrophy. </span><span class="cited-content_cbyCitation_journal-name">Skeletal Muscle</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13395-020-00244-3" title="DOI URL">https://doi.org/10.1186/s13395-020-00244-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13395-020-00244-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13395-020-00244-3%26sid%3Dliteratum%253Aachs%26jtitle%3DSkeletal%2520Muscle%26atitle%3DHigh-throughput%252Bscreening%252Bidentifies%252Bmodulators%252Bof%252Bsarcospan%252Bthat%252Bstabilize%252Bmuscle%252Bcells%252Band%252Bexhibit%252Bactivity%252Bin%252Bthe%252Bmouse%252Bmodel%252Bof%252BDuchenne%252Bmuscular%252Bdystrophy%26aulast%3DShu%26aufirst%3DCynthia%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arran  Babbs</span>, <span class="hlFld-ContribAuthor ">Maria  Chatzopoulou</span>, <span class="hlFld-ContribAuthor ">Ben  Edwards</span>, <span class="hlFld-ContribAuthor ">Sarah E.  Squire</span>, <span class="hlFld-ContribAuthor ">Isabel V.L.  Wilkinson</span>, <span class="hlFld-ContribAuthor ">Graham M.  Wynne</span>, <span class="hlFld-ContribAuthor ">Angela J.  Russell</span>, <span class="hlFld-ContribAuthor ">Kay E.  Davies</span>. </span><span class="cited-content_cbyCitation_article-title">From diagnosis to therapy in Duchenne muscular dystrophy. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Society Transactions</span><span> <strong>2020,</strong> <em>48 </em>
                                    (3)
                                     , 813-821. <a href="https://doi.org/10.1042/BST20190282" title="DOI URL">https://doi.org/10.1042/BST20190282</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BST20190282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBST20190282%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Society%2520Transactions%26atitle%3DFrom%252Bdiagnosis%252Bto%252Btherapy%252Bin%252BDuchenne%252Bmuscular%252Bdystrophy%26aulast%3DBabbs%26aufirst%3DArran%26date%3D2020%26date%3D2020%26volume%3D48%26issue%3D3%26spage%3D813%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/medium/jm9b01547_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01547&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/medium/jm9b01547_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structure of ezutromid and isolated major metabolites DHD1 and DHD3 (in each case, one of two possible enantiomers is drawn, as absolute configuration was not determined).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01547&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/medium/jm9b01547_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Proposed fragmentation pathway of (A) ezutromid and (B) its main metabolite in human liver microsomes (HLM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01547&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/medium/jm9b01547_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cumulative accurate mass summed ion chromatograms for (A) equimolar mixture of ezutromid, <b>D1</b>, and <b>D2</b> reference standards and (B) plasma following multiple oral doses of ezutromid (1.0 g, BID) in pediatric DMD subjects 8 h after the a.m. dose on day 7.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01547&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/medium/jm9b01547_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route to <i>trans</i>-1,2-Dihydrodiols <b>9</b> and <b>10</b><sup>a</sup><sup>,</sup><sup>b</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01547&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label"><sup>a</sup></span>For each, one of two possible enantiomers is depicted, as absolute configuration was not unambiguously determined.</p><p class="last"><span class="fn-label"><sup>b</sup></span>Reagents and conditions: (a) (1) SOCl<sub>2</sub>, DMF, 1,4-dioxane, 80 Â°C, 1 h; (2) 2-amino-4-(ethylsulfonyl)phenol, MsOH, <i>p</i>-xylene, 140 Â°C, 48 h. (b) BBr<sub>3</sub>, DCM, 0â40 Â°C, 24 h. (c) IBX, DMF, rt, 90 min. (d) LiBH<sub>4</sub>, O<sub>2</sub>, rt, 24 h. (e) <i>o</i>-Chloranil, DMF, rt, 24 h.</p></p></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/medium/jm9b01547_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. NOESY spectra and NOE correlations for structure elucidation of (a) <b>D1</b> and (b) <b>D2</b>. In each, one of two possible enantiomers is shown, as absolute configuration was not determined.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01547/20200306/images/large/jm9b01547_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01547&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i46">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33447" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33447" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 39 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emery, A. E.</span></span> <span> </span><span class="NLM_article-title">Population frequencies of inherited neuromuscular diseases -a world survey</span>. <i>Neuromuscul. Disord.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">19</span>â <span class="NLM_lpage">29</span>, <span class="refDoi">Â DOI: 10.1016/0960-8966(91)90039-U</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1016%2F0960-8966%2891%2990039-U" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1822774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A280%3ADyaK38zltlKktw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1991&pages=19-29&author=A.+E.+Emery&title=Population+frequencies+of+inherited+neuromuscular+diseases+-a+world+survey&doi=10.1016%2F0960-8966%2891%2990039-U"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Population frequencies of inherited neuromuscular diseases--a world survey</span></div><div class="casAuthors">Emery A E</div><div class="citationInfo"><span class="NLM_cas:title">Neuromuscular disorders : NMD</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-29</span>
        ISSN:<span class="NLM_cas:issn">0960-8966</span>.
    </div><div class="casAbstract">A survey of the world literature, involving over 150 reported studies, of the population frequencies of various inherited neuromuscular diseases has been carried out.  Data are presented for the commoner forms of muscular dystrophy (Duchenne, Becker, facioscapulohumeral, limb girdle), myotonic dystrophy and congenital myotonias, proximal spinal muscular atrophies, and the hereditary motor and sensory neuropathies.  A conservative estimate of the overall prevalence among both sexes is around 286 x 10(-6), that is 1 in 3500 of the population may be expected to have a disabling inherited neuromuscular disease presenting in childhood or in later life.  If severe disorders manifest only in infancy and early childhood (e.g.  Werdnig-Hoffmann disease and severe congenital muscular dystrophy) and the rare forms of dystrophy and myopathy are also included, then the overall prevalence could well exceed 1 in 3000.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQWrkTRbMpV1rt7lRqEFUJVfW6udTcc2eZuhcrTiLyphrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38zltlKktw%253D%253D&md5=df244b36fc033ad5842c29cf47d2814b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2F0960-8966%2891%2990039-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-8966%252891%252990039-U%26sid%3Dliteratum%253Aachs%26aulast%3DEmery%26aufirst%3DA.%2BE.%26atitle%3DPopulation%2520frequencies%2520of%2520inherited%2520neuromuscular%2520diseases%2520-a%2520world%2520survey%26jtitle%3DNeuromuscul.%2520Disord.%26date%3D1991%26volume%3D1%26spage%3D19%26epage%3D29%26doi%3D10.1016%2F0960-8966%2891%2990039-U" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Deutekom, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Ommen, G. J.</span></span> <span> </span><span class="NLM_article-title">Advances in Duchenne muscular dystrophy gene therapy</span>. <i>Nat. Rev. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">774</span>â <span class="NLM_lpage">783</span>, <span class="refDoi">Â DOI: 10.1038/nrg1180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1038%2Fnrg1180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=14526374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot1aksb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=774-783&author=J.+C.+van%0ADeutekomauthor=G.+J.+van+Ommen&title=Advances+in+Duchenne+muscular+dystrophy+gene+therapy&doi=10.1038%2Fnrg1180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in Duchenne muscular dystrophy gene therapy</span></div><div class="casAuthors">van Deutekom, Judith C. T.; van Ommen, Gert-Jan B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">774-783</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the initial characterization of the genetic defect for Duchenne muscular dystrophy, much effort has been expended in attempts to develop a therapy for this devastating childhood disease.  Gene therapy was the obvious answer but, initially, the dystrophin gene and its product seemed too large and complex for this approach.  However, our increasing knowledge of the organization of the gene and the role of dystrophin in muscle function has indicated ways to manipulate them both.  Gene therapy for Duchenne muscular dystrophy now seems to be in reach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7gdYCTBMpRbVg90H21EOLACvtfcHk0lhYxg1e0yDU4Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot1aksb4%253D&md5=3867ee5bbd09bca922512e53b8be7784</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrg1180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg1180%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BDeutekom%26aufirst%3DJ.%2BC.%26aulast%3Dvan%2BOmmen%26aufirst%3DG.%2BJ.%26atitle%3DAdvances%2520in%2520Duchenne%2520muscular%2520dystrophy%2520gene%2520therapy%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2003%26volume%3D4%26spage%3D774%26epage%3D783%26doi%3D10.1038%2Fnrg1180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blake, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newey, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span> <span> </span><span class="NLM_article-title">Function and genetics of dystrophin and dystrophin-related proteins in muscle</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">291</span>â <span class="NLM_lpage">329</span>, <span class="refDoi">Â DOI: 10.1152/physrev.00028.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1152%2Fphysrev.00028.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=11917091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtFOns7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=291-329&author=D.+J.+Blakeauthor=A.+Weirauthor=S.+E.+Neweyauthor=K.+E.+Davies&title=Function+and+genetics+of+dystrophin+and+dystrophin-related+proteins+in+muscle&doi=10.1152%2Fphysrev.00028.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Function and genetics of dystrophin and dystrophin-related proteins in muscle</span></div><div class="casAuthors">Blake, Derek J.; Weir, Andrew; Newey, Sarah E.; Davies, Kay E.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">291-329</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The X-linked muscle-wasting disease Duchenne muscular dystrophy is caused by mutations in the gene encoding dystrophin.  There is currently no effective treatment for the disease; however, the complex mol. pathol. of this disorder is now being unravelled.  Dystrophin is located at the muscle sarcolemma in a membrane-spanning protein complex that connects the cytoskeleton to the basal lamina.  Mutations in many components of the dystrophin protein complex cause other forms of autosomally inherited muscular dystrophy, indicating the importance of this complex in normal muscle function.  Although the precise function of dystrophin is unknown, the lack of protein causes membrane destabilization and the activation of multiple pathophysiol. processes, many of which converge on alterations in intracellular calcium handling.  Dystrophin is also the prototype of a family of dystrophin-related proteins, many of which are found in muscle.  This family includes utrophin and Î±-dystrobrevin, which are involved in the maintenance of the neuromuscular junction architecture and in muscle homeostasis.  New insights into the pathophysiol. of dystrophic muscle, the identification of compensating proteins, and the discovery of new binding partners are paving the way for novel therapeutic strategies to treat this fatal muscle disease.  This review discusses the role of the dystrophin complex and protein family in muscle and describes the physiol. processes that are affected in Duchenne muscular dystrophy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql5aeDBptVUrVg90H21EOLACvtfcHk0lhYxg1e0yDU4Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtFOns7Y%253D&md5=f57019afadbf0448eba2c580f7a2a6a7</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00028.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00028.2001%26sid%3Dliteratum%253Aachs%26aulast%3DBlake%26aufirst%3DD.%2BJ.%26aulast%3DWeir%26aufirst%3DA.%26aulast%3DNewey%26aufirst%3DS.%2BE.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26atitle%3DFunction%2520and%2520genetics%2520of%2520dystrophin%2520and%2520dystrophin-related%2520proteins%2520in%2520muscle%26jtitle%3DPhysiol.%2520Rev.%26date%3D2002%26volume%3D82%26spage%3D291%26epage%3D329%26doi%3D10.1152%2Fphysrev.00028.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, R. H.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunkel, L. M.</span></span> <span> </span><span class="NLM_article-title">Dystrophin: the protein product of the Duchenne muscular dystrophy locus</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">919</span>â <span class="NLM_lpage">928</span>, <span class="refDoi">Â DOI: 10.1016/0092-8674(87)90579-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1016%2F0092-8674%2887%2990579-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=3319190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaL1cXntlWqug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1987&pages=919-928&author=E.+P.+Hoffmanauthor=R.+H.+Brownauthor=L.+M.+Kunkel&title=Dystrophin%3A+the+protein+product+of+the+Duchenne+muscular+dystrophy+locus&doi=10.1016%2F0092-8674%2887%2990579-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Dystrophin:  the protein product of the Duchenne muscular dystrophy locus</span></div><div class="casAuthors">Hoffman, Eric P.; Brown, Robert H., Jr.; Kunkel, Louis M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">919-28</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">The protein product of the human Duchenne muscular dystrophy locus (DMD) and its mouse homolog (mDMD) have been identified by using polyclonal antibodies directed against fusion proteins contg. two distinct regions of the mDMD cDNA.  The DMD protein is shown to be â¼400 kd and to represent â¼0.002% of total striated muscle protein.  This protein is also detected in smooth muscle (stomach).  Muscle tissue isolated from both DMD-affected boys and mdx mice contained no detectable DMD protein, suggesting that these genetic disorders are homologous.  Since mdx mice present no obvious clin. abnormalities, the identification of the mdx mouse as an animal model for DMD has important implications with regard to the etiol. of the lethal DMD phenotype.  The protein has been named dystrophin because of its identification via the isolation of the Duchenne muscular dystrophy locus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSCpwGgytCyrVg90H21EOLACvtfcHk0ljz7rbmalTRQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXntlWqug%253D%253D&md5=8d0516411c935e1d6df7b9ac1aa575da</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2887%2990579-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252887%252990579-4%26sid%3Dliteratum%253Aachs%26aulast%3DHoffman%26aufirst%3DE.%2BP.%26aulast%3DBrown%26aufirst%3DR.%2BH.%26aulast%3DKunkel%26aufirst%3DL.%2BM.%26atitle%3DDystrophin%253A%2520the%2520protein%2520product%2520of%2520the%2520Duchenne%2520muscular%2520dystrophy%2520locus%26jtitle%3DCell%26date%3D1987%26volume%3D51%26spage%3D919%26epage%3D928%26doi%3D10.1016%2F0092-8674%2887%2990579-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guiraud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span> <span> </span><span class="NLM_article-title">Pharmacological advances for treatment in Duchenne muscular dystrophy</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">36</span>â <span class="NLM_lpage">48</span>, <span class="refDoi">Â DOI: 10.1016/j.coph.2017.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1016%2Fj.coph.2017.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=28486179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvVGqurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2017&pages=36-48&author=S.+Guiraudauthor=K.+E.+Davies&title=Pharmacological+advances+for+treatment+in+Duchenne+muscular+dystrophy&doi=10.1016%2Fj.coph.2017.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological advances for treatment in Duchenne muscular dystrophy</span></div><div class="casAuthors">Guiraud, Simon; Davies, Kay E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36-48</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Duchenne muscular dystrophy (DMD) is a lethal, X-linked muscle-wasting disease caused by lack of dystrophin, essential for muscle fiber integrity.  Despite extensive pre-clin. studies, development of an effective treatment has proved challenging.  More recently, significant progress has been made with the first drug approval using a genetic approach and the application of pharmacol. agents which slow the progression of the disease.  Drug development for DMD has mainly used two strategies: (1) the restoration of dystrophin expression or the expression of the compensatory utrophin protein as an efficient surrogate, and (2) the mitigation of secondary downstream pathol. mechanisms.  This review details current most promising pharmacol. approaches and clin. trials aiming to tackle the pathogenesis of this multifaceted disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4bL76CfzS1rVg90H21EOLACvtfcHk0ljz7rbmalTRQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvVGqurw%253D&md5=ed36a5afd8e07f41f8c3ae14195f304e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2017.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2017.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DGuiraud%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26atitle%3DPharmacological%2520advances%2520for%2520treatment%2520in%2520Duchenne%2520muscular%2520dystrophy%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2017%26volume%3D34%26spage%3D36%26epage%3D48%26doi%3D10.1016%2Fj.coph.2017.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Love, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurr, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byth, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsden, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span> <span> </span><span class="NLM_article-title">An autosomal transcript in skeletal muscle with homology to dystrophin</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>339</i></span>,  <span class="NLM_fpage">55</span>â <span class="NLM_lpage">58</span>, <span class="refDoi">Â DOI: 10.1038/339055a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1038%2F339055a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=2541343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaL1MXktVWqtbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=1989&pages=55-58&author=D.+R.+Loveauthor=D.+F.+Hillauthor=G.+Dicksonauthor=N.+K.+Spurrauthor=B.+C.+Bythauthor=R.+F.+Marsdenauthor=F.+S.+Walshauthor=Y.+H.+Edwardsauthor=K.+E.+Davies&title=An+autosomal+transcript+in+skeletal+muscle+with+homology+to+dystrophin&doi=10.1038%2F339055a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">An autosomal transcript in skeletal muscle with homology to dystrophin</span></div><div class="casAuthors">Love, Donald R.; Hill, Diane F.; Dickson, George; Spurr, Nigel K.; Byth, Barbara C.; Marsden, Rosalind F.; Walsh, Frank S.; Edwards, Yvonne H.; Davies, Kay E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">6219</span>),
    <span class="NLM_cas:pages">55-8</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The Duchenne muscular dystrophy (DMD) gene has been localized to chromosome Xp21 and codes for a 14-kilobase (kb) transcript and a protein called dystrophin, of relative mol. mass 427,000.  Dystrophin is assocd. with the cytoplasmic face of muscle fiber membranes, and its C-terminal domain is thought to mediate membrane attachment.  Although N-terminal and central domain structures share common features with other cytoskeletal components, no significant sequence similarity between the C-terminal region of dystrophin and other previously characterized proteins has been described.  Fragments from the C-terminal domain of the DMD cDNA detect a closely related sequence which exhibits nucleic acid and predicted amino acid identities with dystrophin of approx. 65 and 80%, resp.  The dystrophin-related sequence identifies a 13-kb transcript in human fetal muscle and maps to chromosome 6.  Thus, dystrophin may be a member of a family of functionally related large structural proteins in muscle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruW-WbVv6WP7Vg90H21EOLACvtfcHk0ljz7rbmalTRQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktVWqtbk%253D&md5=39b72b03aa694a6c5cecb70110bc244a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F339055a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F339055a0%26sid%3Dliteratum%253Aachs%26aulast%3DLove%26aufirst%3DD.%2BR.%26aulast%3DHill%26aufirst%3DD.%2BF.%26aulast%3DDickson%26aufirst%3DG.%26aulast%3DSpurr%26aufirst%3DN.%2BK.%26aulast%3DByth%26aufirst%3DB.%2BC.%26aulast%3DMarsden%26aufirst%3DR.%2BF.%26aulast%3DWalsh%26aufirst%3DF.%2BS.%26aulast%3DEdwards%26aufirst%3DY.%2BH.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26atitle%3DAn%2520autosomal%2520transcript%2520in%2520skeletal%2520muscle%2520with%2520homology%2520to%2520dystrophin%26jtitle%3DNature%26date%3D1989%26volume%3D339%26spage%3D55%26epage%3D58%26doi%3D10.1038%2F339055a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deconinck, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Backer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phelps, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, J. M.</span></span> <span> </span><span class="NLM_article-title">Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1216</span>â <span class="NLM_lpage">1221</span>, <span class="refDoi">Â DOI: 10.1038/nm1197-1216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1038%2Fnm1197-1216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=9359695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaK2sXntFansb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=1216-1221&author=N.+Deconinckauthor=J.+Tinsleyauthor=F.+De+Backerauthor=R.+Fisherauthor=D.+Kahnauthor=S.+Phelpsauthor=K.+Daviesauthor=J.+M.+Gillis&title=Expression+of+truncated+utrophin+leads+to+major+functional+improvements+in+dystrophin-deficient+muscles+of+mice&doi=10.1038%2Fnm1197-1216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice</span></div><div class="casAuthors">Deconinck, Nicolas; Tinsley, Jonathon; De Backer, Fabienne; Fisher, Rosie; Kahn, David; Phelps, Steve; Davies, Kay; Gillis, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1216-1221</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Dystrophin-deficient mice (mdx) expressing a truncated (trc) utrophin transgene show amelioration of the dystrophic phenotype.  Here, we report a multifunctional study demonstrating that trc-utrophin expression leads to major improvements of the mech. performance of muscle (i.e., force development, mech. resistance to forced lengthenings, and maximal spontaneous activity) and of the maintenance of the intracellular calcium homeostasis.  These are two essential functions of muscle fibers, known to be impaired in mdx mouse muscles and Duchenne muscular dystrophy (DMD) patients.  Our results bring strong support to the hypothesis that muscle wasting in dystrophin-deficient DMD patients could be prevented by upregulation of utrophin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4gcI8wE3cErVg90H21EOLACvtfcHk0ljAXXxZ_KUwMw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXntFansb8%253D&md5=e1680364e0b9b2d703caf8fc2e5a5113</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnm1197-1216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1197-1216%26sid%3Dliteratum%253Aachs%26aulast%3DDeconinck%26aufirst%3DN.%26aulast%3DTinsley%26aufirst%3DJ.%26aulast%3DDe%2BBacker%26aufirst%3DF.%26aulast%3DFisher%26aufirst%3DR.%26aulast%3DKahn%26aufirst%3DD.%26aulast%3DPhelps%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DK.%26aulast%3DGillis%26aufirst%3DJ.%2BM.%26atitle%3DExpression%2520of%2520truncated%2520utrophin%2520leads%2520to%2520major%2520functional%2520improvements%2520in%2520dystrophin-deficient%2520muscles%2520of%2520mice%26jtitle%3DNat.%2520Med.%26date%3D1997%26volume%3D3%26spage%3D1216%26epage%3D1221%26doi%3D10.1038%2Fnm1197-1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deconinck, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phelps, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K.</span></span> <span> </span><span class="NLM_article-title">Expression of full-length utrophin prevents muscular dystrophy in mdx mice</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1441</span>â <span class="NLM_lpage">1444</span>, <span class="refDoi">Â DOI: 10.1038/4033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1038%2F4033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=9846586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaK1cXnvVOhur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=1441-1444&author=J.+Tinsleyauthor=N.+Deconinckauthor=R.+Fisherauthor=D.+Kahnauthor=S.+Phelpsauthor=J.+M.+Gillisauthor=K.+Davies&title=Expression+of+full-length+utrophin+prevents+muscular+dystrophy+in+mdx+mice&doi=10.1038%2F4033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of full-length utrophin prevents muscular dystrophy in mdx mice</span></div><div class="casAuthors">Tinsley, Jonathon; Deconinck, Nicolas; Fisher, Rosie; Kahn, David; Phelps, Steve; Gillis, Jean-Marie; Davies, Kay</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1441-1444</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the muscle fiber leading to the gradual depletion of skeletal muscle.  The mol. structure of dystrophin is very similar to that of the related protein utrophin2.  Utrophin is found in all tissues and is confined to the neuromuscular and myotendinous junctions in mature muscle.  Sarcolemmal localization of a truncated utrophin transgene in the dystrophin-deficient mdx mouse significantly improves the dystrophic muscle phenotype.  Therefore, up-regulation of utrophin by drug therapy is a plausible therapeutic approach in the treatment of DMD.  Here, the authors demonstrate that expression of full-length utrophin in mdx mice prevents the development of muscular dystrophy.  The authors assessed muscle morphol., fiber regeneration and mech. properties (force development and resistance to stretch) of mdx and transgenic mdx skeletal and diaphragm muscle.  The utrophin levels required in muscle are significantly less than the normal endogenous in utrophin levels seen in lung and kidney, and the authors provide evidence that the pathol. depends on the amt. of utrophin expression.  These results also have important implications for DMD therapies in which utrophin replacement is achieved by delivery using exogenous vectors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkZwAIp6gKKrVg90H21EOLACvtfcHk0ljAXXxZ_KUwMw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvVOhur0%253D&md5=3bc3ecaf7e29380b3289796b9f444ab1</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F4033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F4033%26sid%3Dliteratum%253Aachs%26aulast%3DTinsley%26aufirst%3DJ.%26aulast%3DDeconinck%26aufirst%3DN.%26aulast%3DFisher%26aufirst%3DR.%26aulast%3DKahn%26aufirst%3DD.%26aulast%3DPhelps%26aufirst%3DS.%26aulast%3DGillis%26aufirst%3DJ.%2BM.%26aulast%3DDavies%26aufirst%3DK.%26atitle%3DExpression%2520of%2520full-length%2520utrophin%2520prevents%2520muscular%2520dystrophy%2520in%2520mdx%2520mice%26jtitle%3DNat.%2520Med.%26date%3D1998%26volume%3D4%26spage%3D1441%26epage%3D1444%26doi%3D10.1038%2F4033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cerletti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negri, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colpo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreetta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozza, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karpati, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mora, M.</span></span> <span> </span><span class="NLM_article-title">Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer</span>. <i>Gene Ther.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">750</span>â <span class="NLM_lpage">757</span>, <span class="refDoi">Â DOI: 10.1038/sj.gt.3301941</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1038%2Fsj.gt.3301941" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=12704413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFGqtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=750-757&author=M.+Cerlettiauthor=T.+Negriauthor=F.+Cozziauthor=R.+Colpoauthor=F.+Andreettaauthor=D.+Crociauthor=K.+E.+Daviesauthor=F.+Cornelioauthor=O.+Pozzaauthor=G.+Karpatiauthor=R.+Gilbertauthor=M.+Mora&title=Dystrophic+phenotype+of+canine+X-linked+muscular+dystrophy+is+mitigated+by+adenovirus-mediated+utrophin+gene+transfer&doi=10.1038%2Fsj.gt.3301941"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer</span></div><div class="casAuthors">Cerletti, M.; Negri, T.; Cozzi, F.; Colpo, R.; Andreetta, F.; Croci, D.; Davies, K. E.; Cornelio, F.; Pozza, O.; Karpati, G.; Gilbert, R.; Mora, M.</div><div class="citationInfo"><span class="NLM_cas:title">Gene Therapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">750-757</span>CODEN:
                <span class="NLM_cas:coden">GETHEC</span>;
        ISSN:<span class="NLM_cas:issn">0969-7128</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Utrophin is highly homologous and structurally similar to dystrophin, and in gene delivery expts. in mdx mice was able to functionally replace dystrophin.  We performed mini-utrophin gene transfer in Golden Retriever dogs with canine muscular dystrophy (CXMD).  Unlike the mouse model, the clinicopathol. phenotype of CXMD is similar to that of Duchenne muscular dystrophy (DMD).  We injected an adenoviral vector expressing a synthetic utrophin into tibialis anterior muscles of newborn dogs affected with CXMD and examd. transgene expression by RNA and protein anal. at 10, 30 and 60 days postinjection in cyclosporin-treated and -untreated animals.  Immunosuppression by cyclosporin was required to mitigate the immune response to viral and transgene antigens.  RT-PCR anal. showed the presence of the exogenous transcript in the muscle of cyclosporin-treated and -untreated animals.  The transgenic utrophin was efficiently expressed at the extrajunctional membrane in immunosuppressed dogs and this expression was stable for at least 60 days.  We found reduced fibrosis and increased expression of dystrophin-assocd. proteins (DAPs) in assocn. with muscle areas expressing the utrophin minigene, indicating that mini-utrophin can functionally compensate for lack of dystrophin in injected muscles.  For this reason, utrophin transfer to dystrophin-deficient muscle appears as a promising therapeutic approach to DMD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogouwCfBh2grVg90H21EOLACvtfcHk0ljiq13mgDhpdQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFGqtrY%253D&md5=4c6d99d17a536daa4343868cd87f5f6a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fsj.gt.3301941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.gt.3301941%26sid%3Dliteratum%253Aachs%26aulast%3DCerletti%26aufirst%3DM.%26aulast%3DNegri%26aufirst%3DT.%26aulast%3DCozzi%26aufirst%3DF.%26aulast%3DColpo%26aufirst%3DR.%26aulast%3DAndreetta%26aufirst%3DF.%26aulast%3DCroci%26aufirst%3DD.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26aulast%3DCornelio%26aufirst%3DF.%26aulast%3DPozza%26aufirst%3DO.%26aulast%3DKarpati%26aufirst%3DG.%26aulast%3DGilbert%26aufirst%3DR.%26aulast%3DMora%26aufirst%3DM.%26atitle%3DDystrophic%2520phenotype%2520of%2520canine%2520X-linked%2520muscular%2520dystrophy%2520is%2520mitigated%2520by%2520adenovirus-mediated%2520utrophin%2520gene%2520transfer%26jtitle%3DGene%2520Ther.%26date%3D2003%26volume%3D10%26spage%3D750%26epage%3D757%26doi%3D10.1038%2Fsj.gt.3301941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wynne, G. M.</span>; <span class="NLM_string-name">Russell, A. J.</span></span> <span> </span><span class="NLM_article-title">Drug Discovery Approaches for Rare Neuromuscular Diseases</span>. In  <i>Orphan Drugs and Rare Diseases</i>; <span class="NLM_publisher-name">The Royal Society of Chemistry</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">2014</span>; pp  <span class="NLM_fpage">257</span>â <span class="NLM_lpage">343</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1039%2F9781782624202-00257" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=257-343&author=G.+M.+Wynne&author=A.+J.+Russell&title=Orphan+Drugs+and+Rare+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1039%2F9781782624202-00257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781782624202-00257%26sid%3Dliteratum%253Aachs%26aulast%3DWynne%26aufirst%3DG.%2BM.%26atitle%3DDrug%2520Discovery%2520Approaches%2520for%2520Rare%2520Neuromuscular%2520Diseases%26btitle%3DOrphan%2520Drugs%2520and%2520Rare%2520Diseases%26pub%3DThe%2520Royal%2520Society%2520of%2520Chemistry%26date%3D2014%26spage%3D257%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guiraud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roblin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kay, D. E.</span></span> <span> </span><span class="NLM_article-title">The potential of utrophin modulators for the treatment of Duchenne muscular dystrophy</span>. <i>Expert Opin. Orphan Drugs</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">179</span>â <span class="NLM_lpage">192</span>, <span class="refDoi">Â DOI: 10.1080/21678707.2018.1438261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1080%2F21678707.2018.1438261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFSmtL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=179-192&author=S.+Guiraudauthor=D.+Roblinauthor=D.+E.+Kay&title=The+potential+of+utrophin+modulators+for+the+treatment+of+Duchenne+muscular+dystrophy&doi=10.1080%2F21678707.2018.1438261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The potential of utrophin modulators for the treatment of Duchenne muscular dystrophy</span></div><div class="casAuthors">Guiraud, Simon; Roblin, David; Kay, Davies. E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Orphan Drugs</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">179-192</span>CODEN:
                <span class="NLM_cas:coden">EOODAJ</span>;
        ISSN:<span class="NLM_cas:issn">2167-8707</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Duchenne muscular dystrophy (DMD) is a lethal, X-linked muscle-wasting disease caused by the lack of dystrophin.  A few years after the identification of the dystrophin gene, a ubiquitously expressed transcript with high homol. to dystrophin was identified leading to the postulate that utrophin might be an effective surrogate to compensate for the lack of dystrophin in dystrophic muscles.: We review the utrophin gene, its regulation, the organization of the corresponding protein and its dynamic expression pattern in comparison with dystrophin.  In view of the evidence that utrophin acts as an efficient substitute to dystrophin to prevent the pathol., we describe the therapeutic approaches to modulate utrophin expression.  We review the current status in the development of ezutromid, the first small utrophin modulator drug currently tested in DMD patients.: A utrophin based strategy is a highly promising approach applicable to all DMD patients irresp. of their genetic defect.  Whereas accurate utrophin and regeneration quantification tools are urgently needed, the foundation of utrophin based therapies, defined 20 years ago, recently delivered first promising results in DMD patients with ezutromid.  The field is at an exciting stage on the road of a universal treatment for all DMD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcS_zSFMYHPrVg90H21EOLACvtfcHk0ljiq13mgDhpdQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFSmtL0%253D&md5=7c785199bc688ebe4b0f143da09fa70d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1080%2F21678707.2018.1438261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21678707.2018.1438261%26sid%3Dliteratum%253Aachs%26aulast%3DGuiraud%26aufirst%3DS.%26aulast%3DRoblin%26aufirst%3DD.%26aulast%3DKay%26aufirst%3DD.%2BE.%26atitle%3DThe%2520potential%2520of%2520utrophin%2520modulators%2520for%2520the%2520treatment%2520of%2520Duchenne%2520muscular%2520dystrophy%26jtitle%3DExpert%2520Opin.%2520Orphan%2520Drugs%26date%3D2018%26volume%3D6%26spage%3D179%26epage%3D192%26doi%3D10.1080%2F21678707.2018.1438261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inacio, P.</span></span> <span> </span><span class="NLM_article-title">Summit Therapeutics Ends Development of Ezutromid Therapy for DMD After Trial Failure</span>.  <i>Muscular Dystrophy News Today</i>, June 29, <span class="NLM_year">2018</span>. <a href="https://musculardystrophynews.com/2018/06/29/summit-therapeutics-ends-ezutromid-development-trail-failure/" class="extLink">https://musculardystrophynews.com/2018/06/29/summit-therapeutics-ends-ezutromid-development-trail-failure/</a> (accessed Oct 8, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=P.+Inacio&title=Muscular+Dystrophy+News+Today"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DInacio%26aufirst%3DP.%26atitle%3DSummit%2520Therapeutics%2520Ends%2520Development%2520of%2520Ezutromid%2520Therapy%2520for%2520DMD%2520After%2520Trial%2520Failure%26btitle%3DMuscular%2520Dystrophy%2520News%2520Today%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to healthy male adult volunteers</span>. <i>J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">698</span>â <span class="NLM_lpage">707</span>, <span class="refDoi">Â DOI: 10.1002/jcph.468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1002%2Fjcph.468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=25651188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotVeltL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=698-707&author=J.+Tinsleyauthor=N.+Robinsonauthor=K.+E.+Davies&title=Safety%2C+tolerability%2C+and+pharmacokinetics+of+SMT+C1100%2C+a+2-arylbenzoxazole+utrophin+modulator%2C+following+single-+and+multiple-dose+administration+to+healthy+male+adult+volunteers&doi=10.1002%2Fjcph.468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to healthy male adult volunteers</span></div><div class="casAuthors">Tinsley, Jon; Robinson, Neil; Davies, Kay E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">698-707</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">SMT C1100 is a small mol. utrophin modulator in development to treat Duchenne muscular dystrophy.  This study evaluated the safety, tolerability, and pharmacokinetics of SMT C1100 in healthy volunteers.  This double-blind, placebo-controlled Phase 1 study comprised: Part 1, an escalating, single-dose with/without fasting involving 50 mg/kg, 100 mg/kg, 200 mg/kg, and 400 mg/kg doses; and Part 2, a multiple 10 day dose evaluation involving 100 mg/kg bid and 200 mg/kg bid doses.  Adverse events were recorded.  SMT C1100 was absorbed rapidly following single and multiple oral doses, with median tmax attained within 2-3.5 h across all doses.  Considerable variability of pharmacokinetic parameters was noted among subjects.  Following single doses, systemic exposure increased in a sub-proportional manner, with the 8.0-fold dose increment resulting in 2.7- and 2.4-fold increases in AUC0-â and Cmax, resp.  AUC0-â and Cmax were estd. as 4.2- and 4.8-fold greater, resp., following food.  Systemic exposure reduced upon repeat dosing with steady-state concns. achieved within 3-5 days of multiple bid dosing.  No serious or severe adverse events were reported.  SMT C1100 was safe and well tolerated with plasma concns. achieved sufficient to cause a 50% increase in concns. of utrophin in cells in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS-otCqjm06rVg90H21EOLACvtfcHk0lj4J5CM_vo7JQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotVeltL0%253D&md5=be9902e46e42d7921a17657a263ff552</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fjcph.468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcph.468%26sid%3Dliteratum%253Aachs%26aulast%3DTinsley%26aufirst%3DJ.%26aulast%3DRobinson%26aufirst%3DN.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26atitle%3DSafety%252C%2520tolerability%252C%2520and%2520pharmacokinetics%2520of%2520SMT%2520C1100%252C%2520a%25202-arylbenzoxazole%2520utrophin%2520modulator%252C%2520following%2520single-%2520and%2520multiple-dose%2520administration%2520to%2520healthy%2520male%2520adult%2520volunteers%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2015%26volume%3D55%26spage%3D698%26epage%3D707%26doi%3D10.1002%2Fjcph.468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ricotti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roper, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejura, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muntoni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J.</span></span> <span> </span><span class="NLM_article-title">Safety, Tolerability, and Pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole Utrophin Modulator, following Single- and Multiple-Dose Administration to Pediatric Patients with Duchenne Muscular Dystrophy</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e0152840</span> <span class="refDoi">Â DOI: 10.1371/journal.pone.0152840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1371%2Fjournal.pone.0152840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=27055247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1OqsLzM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&author=V.+Ricottiauthor=S.+Spintyauthor=H.+Roperauthor=I.+Hughesauthor=B.+Tejuraauthor=N.+Robinsonauthor=G.+Laytonauthor=K.+Daviesauthor=F.+Muntoniauthor=J.+Tinsley&title=Safety%2C+Tolerability%2C+and+Pharmacokinetics+of+SMT+C1100%2C+a+2-Arylbenzoxazole+Utrophin+Modulator%2C+following+Single-+and+Multiple-Dose+Administration+to+Pediatric+Patients+with+Duchenne+Muscular+Dystrophy&doi=10.1371%2Fjournal.pone.0152840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to pediatric patients with duchenne muscular dystrophy</span></div><div class="casAuthors">Ricotti, Valeria; Spinty, Stefan; Roper, Helen; Hughes, Imelda; Tejura, Bina; Robinson, Neil; Layton, Gary; Davies, Kay; Muntoni, Francesco; Tinsley, Jonathon</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e0152840/1-e0152840/16</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Purpose SMT C1100 is a utrophin modulator being evaluated as a treatment for Duchenne muscular dystrophy (DMD).  This study, the first in pediatric DMD patients, reports the safety, tolerability and PK parameters of single and multiple doses of SMT C1100, as well as analyze potential biomarkers of muscle damage.  Methods This multicenter, Phase 1 study enrolled 12 patients, divided equally into three groups (A- C).  Group A were given 50 mg/kg on Days 1 and 11, and 50 mg/kg bid on Days 2 to 10.  Group B and C received 100 mg/kg on Days 1 and 11; Group B and Group C were given 100 mg/kg bid and 100 mg/kg tid, resp., on Days 2 to 10.  A safety review was performed on all patients following the single dose and there was at least 2 wk between each dose escalation, for safety and PK review.  Adverse events (AEs) were monitored throughout the study.  Results Most patients experienced mild AEs and there were no serious AEs.  Two patients required analgesia for pain (headache, ear pain and toothache).  One patient experienced moderate psychiatric AEs (abnormal behavior and mood swings).  Plasma concns. of SMT C1100 at Days 1 and 11 indicated a high degree of patient variability regardless of dose.  Unexpectedly the SMT C1100 levels were significantly lower than similar doses administered to healthy volunteers in an earlier clin. study.  In general, individual baseline changes of creatine phosphokinase, alanine aminotransferase, aspartate aminotransferase levels fell with SMT C1100 dosing.  Conclusions SMT C1100 was well tolerated in pediatric DMD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt0w7VChgcJbVg90H21EOLACvtfcHk0lj4J5CM_vo7JQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1OqsLzM&md5=7e3080644fb23bed4b3b4bbfab8263de</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0152840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0152840%26sid%3Dliteratum%253Aachs%26aulast%3DRicotti%26aufirst%3DV.%26aulast%3DSpinty%26aufirst%3DS.%26aulast%3DRoper%26aufirst%3DH.%26aulast%3DHughes%26aufirst%3DI.%26aulast%3DTejura%26aufirst%3DB.%26aulast%3DRobinson%26aufirst%3DN.%26aulast%3DLayton%26aufirst%3DG.%26aulast%3DDavies%26aufirst%3DK.%26aulast%3DMuntoni%26aufirst%3DF.%26aulast%3DTinsley%26aufirst%3DJ.%26atitle%3DSafety%252C%2520Tolerability%252C%2520and%2520Pharmacokinetics%2520of%2520SMT%2520C1100%252C%2520a%25202-Arylbenzoxazole%2520Utrophin%2520Modulator%252C%2520following%2520Single-%2520and%2520Multiple-Dose%2520Administration%2520to%2520Pediatric%2520Patients%2520with%2520Duchenne%2520Muscular%2520Dystrophy%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26doi%3D10.1371%2Fjournal.pone.0152840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muntoni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejura, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roper, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harriman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J.</span></span> <span> </span><span class="NLM_article-title">A Phase 1b Trial to Assess the Pharmacokinetics of Ezutromid in Pediatric Duchenne Muscular Dystrophy Patients on a Balanced Diet</span>. <i>Clin. Pharmacol. Drug Dev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">922</span>â <span class="NLM_lpage">933</span>, <span class="refDoi">Â DOI: 10.1002/cpdd.642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1002%2Fcpdd.642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=30650257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFSgur%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=922-933&author=F.+Muntoniauthor=B.+Tejuraauthor=S.+Spintyauthor=H.+Roperauthor=I.+Hughesauthor=G.+Laytonauthor=K.+E.+Daviesauthor=S.+Harrimanauthor=J.+Tinsley&title=A+Phase+1b+Trial+to+Assess+the+Pharmacokinetics+of+Ezutromid+in+Pediatric+Duchenne+Muscular+Dystrophy+Patients+on+a+Balanced+Diet&doi=10.1002%2Fcpdd.642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase 1b Trial to Assess the Pharmacokinetics of Ezutromid in Pediatric Duchenne Muscular Dystrophy Patients on a Balanced Diet</span></div><div class="casAuthors">Muntoni, Francesco; Tejura, Bina; Spinty, Stefan; Roper, Helen; Hughes, Imelda; Layton, Gary; Davies, Kay E.; Harriman, Shawn; Tinsley, Jonathon</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology in Drug Development</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">922-933</span>CODEN:
                <span class="NLM_cas:coden">CPDDAH</span>;
        ISSN:<span class="NLM_cas:issn">2160-7648</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Ezutromid (SMT C1100) is a small-mol. utrophin modulator that was developed to treat Duchenne muscular dystrophy (DMD).  Previous clin. trials of this agent revealed lower exposure in DMD patients compared with healthy volunteers, which may reflect differences in diet.  This study evaluated the pharmacokinetics of ezutromid in patients with DMD who followed a balanced diet.  This was a multicenter, double-blind, placebo-controlled, ascending single and multiple oral dose study.  Twelve pediatric patients were randomly allocated to 1 of 3 treatment sequences within which were 3 treatment periods of 2 wk each.  Throughout the study, patients followed a balanced diet including recommended proportions of major food groups and administration of drug accompanied with 100 mL of full-fat milk.  This approach improved the absorption of ezutromid, resulting in higher systemic exposure, with considerable variability in exposure between patients at each dose level.  Single and multiple oral doses of 1250 mg and 2500 mg BID were considered safe and well tolerated.  No severe or serious adverse events and no study discontinuations due to adverse events were reported.  This study provides assurance that, with the formulation tested (F3) and instructions regarding food (balanced diet and whole-fat milk), 2500 mg BID of ezutromid achieves plasma concns. that, based on preclin. studies, should be able to modulate utrophin expression in future clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPQpDsHvNdwLVg90H21EOLACvtfcHk0ljqCbCmf8_i4g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFSgur%252FL&md5=fb4603906c131089d72bca2d5af9fc20</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fcpdd.642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpdd.642%26sid%3Dliteratum%253Aachs%26aulast%3DMuntoni%26aufirst%3DF.%26aulast%3DTejura%26aufirst%3DB.%26aulast%3DSpinty%26aufirst%3DS.%26aulast%3DRoper%26aufirst%3DH.%26aulast%3DHughes%26aufirst%3DI.%26aulast%3DLayton%26aufirst%3DG.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26aulast%3DHarriman%26aufirst%3DS.%26aulast%3DTinsley%26aufirst%3DJ.%26atitle%3DA%2520Phase%25201b%2520Trial%2520to%2520Assess%2520the%2520Pharmacokinetics%2520of%2520Ezutromid%2520in%2520Pediatric%2520Duchenne%2520Muscular%2520Dystrophy%2520Patients%2520on%2520a%2520Balanced%2520Diet%26jtitle%3DClin.%2520Pharmacol.%2520Drug%2520Dev.%26date%3D2019%26volume%3D8%26spage%3D922%26epage%3D933%26doi%3D10.1002%2Fcpdd.642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jerina, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witkop, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaltzman-Nirenberg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udenfriend, S.</span></span> <span> </span><span class="NLM_article-title">The role of arene oxide-oxepin systems in the metabolism of aromatic substrates. 3. Formation of 1,2-naphthalene oxide from naphthalene by liver microsomes</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1968</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">6525</span>â <span class="NLM_lpage">6527</span>, <span class="refDoi">Â DOI: 10.1021/ja01025a058</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01025a058" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaF1MXpslKg" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1968&pages=6525-6527&author=D.+M.+Jerinaauthor=J.+W.+Dalyauthor=B.+Witkopauthor=P.+Zaltzman-Nirenbergauthor=S.+Udenfriend&title=The+role+of+arene+oxide-oxepin+systems+in+the+metabolism+of+aromatic+substrates.+3.+Formation+of+1%2C2-naphthalene+oxide+from+naphthalene+by+liver+microsomes&doi=10.1021%2Fja01025a058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The role of arene oxide-oxepin systems in the metabolism of aromatic substrates.  III.  Formation of 1,2-naphthalene oxide from naphthalene  by liver microsomes</span></div><div class="casAuthors">Jerina, Donald M.; Daly, John W.; Witkop, Bernhard; Zaltzman-Nirenberg, Perola; Udenfriend, Sidney</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6525-7</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Naphthalene was readily metabolized by rat liver microsomes to 1-naphthol and (-)-trans-1,2-dihydro-1,2-dihydroxynaphthalene.  In the presence of liver supernatant and glutathione, the major product isolated was S-(1,2-dihydro-2-hydroxynaphthyl)glutathione.  Rat liver microsomes, incubated with 14C-labeled naphthalene and unlabeled 1,2-naphthalene oxide, formed a 14C-labeled oxidized metabolite which was trapped and identified as 1,2-naphthalene oxide.  Rabbit liver microsomes converted 1,2-naphthalene oxide to (-)-trans-1,2-dihydro-1,2-dihydroxynaphthalene which had the same abs. stereochemistry as the diol obtained on incubation of naphthalene.  Rat liver supernatant catalyzed the opening of 1,2-naphthalene oxide by glutathione, yielding S-(1,2-dihydro-2-hydroxynaphthyl)glutathione, indistinguishable from that obtained from naphthalene, microsomes, supernatant, and glutathione.  These data suggest that 1,2-naphthalene oxide is an obligatory intermediate in the enzymic hydroxylation of naphthalene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5Z0uP2DGlk7Vg90H21EOLACvtfcHk0ljqCbCmf8_i4g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXpslKg&md5=d332575744337cd4bf93cfb02c6314a4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fja01025a058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01025a058%26sid%3Dliteratum%253Aachs%26aulast%3DJerina%26aufirst%3DD.%2BM.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DWitkop%26aufirst%3DB.%26aulast%3DZaltzman-Nirenberg%26aufirst%3DP.%26aulast%3DUdenfriend%26aufirst%3DS.%26atitle%3DThe%2520role%2520of%2520arene%2520oxide-oxepin%2520systems%2520in%2520the%2520metabolism%2520of%2520aromatic%2520substrates.%25203.%2520Formation%2520of%25201%252C2-naphthalene%2520oxide%2520from%2520naphthalene%2520by%2520liver%2520microsomes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1968%26volume%3D90%26spage%3D6525%26epage%3D6527%26doi%3D10.1021%2Fja01025a058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jerina, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witkop, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaltzman-Nirenberg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udenfriend, S.</span></span> <span> </span><span class="NLM_article-title">1,2-naphthalene oxide as an intermediate in the microsomal hydroxylation of naphthalene</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">147</span>â <span class="NLM_lpage">156</span>, <span class="refDoi">Â DOI: 10.1021/bi00803a019</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00803a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaE3cXnsVKrtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1970&pages=147-156&author=D.+M.+Jerinaauthor=J.+W.+Dalyauthor=B.+Witkopauthor=P.+Zaltzman-Nirenbergauthor=S.+Udenfriend&title=1%2C2-naphthalene+oxide+as+an+intermediate+in+the+microsomal+hydroxylation+of+naphthalene&doi=10.1021%2Fbi00803a019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">1,2-Naphthalene oxide as an intermediate in the microsomal hydroxylation of naphthalene.  V</span></div><div class="casAuthors">Jerina, Donald M.; Daly, John W.; Witkop, Bernhard; Zaltzman-Nirenberg, P.; Udenfriend, S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">147-56</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">The microsomal metabolism of naphthalene was reinvestigated and the pathways leading to naphthol, trans-1,2-dihy-dro-1,2-dihydroxynaphthalene, and the conjugate, S-(1,2-dihydro-2-hydroxy-1-naphthyl) glutathione, were clarified.  In the microsomal system synthetic 1,2-naphthalene oxide was converted into all major naphthalene metabolites.  In the presence of microsomes 1,2-naphthalene oxide rearranges nonenzymically almost exclusively to 1-naphthol, the preponderant phenolic oxidn. product from naphthalene.  Racemic 1,2-naphthalene oxide is hydrated enzymically to an optically active diol identical with the diol from naphthalene with respect to abs. stereochemistry and the source of the O atom at the 2 position.  Sol. liver enzymes catalyze the addn. of glutathione to 1,2-naphthalene oxide to form a conjugate identical with that obtained on oxidn. of naphthalene.  The formation of 1,2-naphthalene oxide from naphthalene in the microsomal system was demonstrated both by radiotracer trapping technique and by isolation.  When increasing amts. of glutathione were added to the microsomal system, the conjugate increased commensurate with a decrease in naphtholand dihydrodiol.  When a competitive substrate for the epoxide hydrase is added, the yield of naphthol goes up at the expense of the diol.  These 2 observations strongly suggest that the oxide is an obligatory intermediate for all naphthalene metabolites.  The relevance of these findings to naphthalene metabolism in particular and phenol formation in general is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol2BdDDkN5n7Vg90H21EOLACvtfcHk0ljE82I5wxhzSA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXnsVKrtw%253D%253D&md5=cc8f8d1c6ff8a863e07642e291deff76</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fbi00803a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00803a019%26sid%3Dliteratum%253Aachs%26aulast%3DJerina%26aufirst%3DD.%2BM.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DWitkop%26aufirst%3DB.%26aulast%3DZaltzman-Nirenberg%26aufirst%3DP.%26aulast%3DUdenfriend%26aufirst%3DS.%26atitle%3D1%252C2-naphthalene%2520oxide%2520as%2520an%2520intermediate%2520in%2520the%2520microsomal%2520hydroxylation%2520of%2520naphthalene%26jtitle%3DBiochemistry%26date%3D1970%26volume%3D9%26spage%3D147%26epage%3D156%26doi%3D10.1021%2Fbi00803a019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">d'Arcy
Doherty, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makowski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, G. M.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P-450 dependent metabolic activation of 1-naphthol to naphthoquinones and covalent binding species</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">2261</span>â <span class="NLM_lpage">2267</span>, <span class="refDoi">Â DOI: 10.1016/0006-2952(85)90779-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1016%2F0006-2952%2885%2990779-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=4015675" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1985&pages=2261-2267&author=M.+d%27Arcy%0ADohertyauthor=R.+Makowskiauthor=G.+G.+Gibsonauthor=G.+M.+Cohen&title=Cytochrome+P-450+dependent+metabolic+activation+of+1-naphthol+to+naphthoquinones+and+covalent+binding+species&doi=10.1016%2F0006-2952%2885%2990779-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2885%2990779-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252885%252990779-8%26sid%3Dliteratum%253Aachs%26aulast%3Dd%2527Arcy%2BDoherty%26aufirst%3DM.%26aulast%3DMakowski%26aufirst%3DR.%26aulast%3DGibson%26aufirst%3DG.%2BG.%26aulast%3DCohen%26aufirst%3DG.%2BM.%26atitle%3DCytochrome%2520P-450%2520dependent%2520metabolic%2520activation%2520of%25201-naphthol%2520to%2520naphthoquinones%2520and%2520covalent%2520binding%2520species%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1985%26volume%3D34%26spage%3D2261%26epage%3D2267%26doi%3D10.1016%2F0006-2952%2885%2990779-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckpitt, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirmohamed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">Characterisation of the toxic metabolite(s) of naphthalene</span>. <i>Toxicology</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">233</span>â <span class="NLM_lpage">242</span>, <span class="refDoi">Â DOI: 10.1016/S0300-483X(96)03515-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1016%2FS0300-483X%2896%2903515-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=8980712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaK28XntlOkur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1996&pages=233-242&author=A.+S.+Wilsonauthor=C.+D.+Davisauthor=D.+P.+Williamsauthor=A.+R.+Buckpittauthor=M.+Pirmohamedauthor=B.+K.+Park&title=Characterisation+of+the+toxic+metabolite%28s%29+of+naphthalene&doi=10.1016%2FS0300-483X%2896%2903515-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the toxic metabolite(s) of naphthalene</span></div><div class="casAuthors">Wilson, Andrew S.; Davis, Carl D.; Williams, Dominic P.; Buckpitt, Alan R.; Pirmohamed, Munir; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">233-242</span>CODEN:
                <span class="NLM_cas:coden">TXCYAC</span>;
        ISSN:<span class="NLM_cas:issn">0300-483X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The toxicity of naphthalene and its metabolites has been investigated in vitro.  Both naphthalene and its metabolite 1-naphthol were bioactivated by human hepatic microsomes to metabolite(s) which were toxic to mononuclear leukocytes (MNL).  However, 1-naphthol was more cytotoxic than naphthalene (49.8Â±13.9% vs. 19.0Â±10.0% cell death), indicating that the toxicity of naphthalene is dependent on the bioactivation of 1-naphthol.  CYP2E1-induced rat liver microsomes increased metab. of naphthalene by 13% compared to control microsomes with a concomitant increase in both 1-naphthol and dihydrodiol formation.  The cytotoxicity of naphthalene but not of 1-naphthol was increased by CYP2E1 induction, indicating that sep. enzymes are involved in the bioactivation of 1-naphthol.  The metabolites of 1-naphthol, 1,2-naphthoquinone (51.4Â±6.6% cell death) and 1,4-naphthoquinone (49.1Â±3.4% cell death) were directly toxic to MNL and depleted glutathione to 1.0% of the control levels.  Both quinones were also genotoxic to human lymphocytes.  In contrast, the primary metabolite of naphthalene, the 1,2-epoxide (0-100 Î¼M) was neither cytotoxic nor genotoxic, and did not deplete glutathione.  In conclusion, these data suggest that the cytotoxicity and genotoxicity of naphthalene is assocd. with the formation of quinones from 1-naphthol rather than naphthalene 1,2-epoxide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKgN6COtZW4rVg90H21EOLACvtfcHk0ljE82I5wxhzSA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntlOkur8%253D&md5=1fa8e989d248855cd9bc8834b5eeceea</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0300-483X%2896%2903515-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0300-483X%252896%252903515-9%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DA.%2BS.%26aulast%3DDavis%26aufirst%3DC.%2BD.%26aulast%3DWilliams%26aufirst%3DD.%2BP.%26aulast%3DBuckpitt%26aufirst%3DA.%2BR.%26aulast%3DPirmohamed%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DCharacterisation%2520of%2520the%2520toxic%2520metabolite%2528s%2529%2520of%2520naphthalene%26jtitle%3DToxicology%26date%3D1996%26volume%3D114%26spage%3D233%26epage%3D242%26doi%3D10.1016%2FS0300-483X%2896%2903515-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, E.</span></span> <span> </span><span class="NLM_article-title">In vitro metabolism of naphthalene by human liver microsomal cytochrome P450 enzymes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">176</span>â <span class="NLM_lpage">183</span>, <span class="refDoi">Â DOI: 10.1124/dmd.105.005785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1124%2Fdmd.105.005785" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=16243959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslyitw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=176-183&author=T.+M.+Choauthor=R.+L.+Roseauthor=E.+Hodgson&title=In+vitro+metabolism+of+naphthalene+by+human+liver+microsomal+cytochrome+P450+enzymes&doi=10.1124%2Fdmd.105.005785"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro metabolism of naphthalene by human liver microsomal cytochrome P450 enzymes</span></div><div class="casAuthors">Cho, Taehyeon M.; Rose, Randy L.; Hodgson, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">176-183</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The polycyclic arom. hydrocarbon naphthalene is an environmental pollutant, a component of jet fuel, and, since 2000, has been reclassified as a potential human carcinogen.  Few studies of the in vitro human metab. of naphthalene are available, and these focus primarily on lung metab.  The current studies were performed to characterize naphthalene metab. by human cytochromes P 450.  Naphthalene metabolites from pooled human liver microsomes (pHLMs) were trans-1,2-dihydro-1,2-naphthalenediol (dihydrodiol), 1-naphthol, and 2-naphthol.  Metabolite prodn. generated Km values of 23, 40, and 116 Î¼M and Vmax values of 2860, 268, and 22 pmol/mg protein/min, resp.  P 450 isoform screening of naphthalene metab. identified CYP1A2 as the most efficient isoform for producing dihydrodiol and 1-naphthol, and CYP3A4 as the most effective for 2-naphthol prodn.  Metab. of the primary metabolites of naphthalene was also studied to identify secondary metabolites.  Whereas 2-naphthol was readily metabolized by pHLMs to produce 2,6- and 1,7-dihydroxynaphthalene, dihydrodiol and 1-naphthol were inefficient substrates for pHLMs.  A series of human P 450 isoforms was used to further explore the metab. of dihydrodiol and 1-naphthol.  1,4-Naphthoquinone and four minor unknown metabolites from 1-naphthol were obsd., and CYP1A2 and 2D6*1 were identified as the most active isoforms for the prodn. of 1,4-naphthoquinone.  Dihydrodiol was metabolized by P 450 isoforms to three minor unidentified metabolites with CYP3A4 and CYP2A6 having the greatest activity toward this substrate.  The metab. of dihydrodiol by P 450 isoforms was lower than that of 1-naphthol.  These studies identify primary and secondary metabolites of naphthalene produced by pHLMs and P 450 isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplUEnriy1dFbVg90H21EOLACvtfcHk0ligochvx96HSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslyitw%253D%253D&md5=db5454f7e35cfbd14539860b5b435784</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fdmd.105.005785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.105.005785%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DT.%2BM.%26aulast%3DRose%26aufirst%3DR.%2BL.%26aulast%3DHodgson%26aufirst%3DE.%26atitle%3DIn%2520vitro%2520metabolism%2520of%2520naphthalene%2520by%2520human%2520liver%2520microsomal%2520cytochrome%2520P450%2520enzymes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26spage%3D176%26epage%3D183%26doi%3D10.1124%2Fdmd.105.005785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Genter, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marlowe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kevin Kerzee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nebert, D. W.</span></span> <span> </span><span class="NLM_article-title">Naphthalene toxicity in mice and aryl hydrocarbon receptor-mediated CYPs</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">120</span>â <span class="NLM_lpage">123</span>, <span class="refDoi">Â DOI: 10.1016/j.bbrc.2006.07.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1016%2Fj.bbrc.2006.07.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=16876762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1WqtLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2006&pages=120-123&author=M.+B.+Genterauthor=J.+Marloweauthor=J.+Kevin+Kerzeeauthor=N.+Draginauthor=A.+Pugaauthor=T.+P.+Daltonauthor=D.+W.+Nebert&title=Naphthalene+toxicity+in+mice+and+aryl+hydrocarbon+receptor-mediated+CYPs&doi=10.1016%2Fj.bbrc.2006.07.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Naphthalene toxicity in mice and aryl hydrocarbon receptor-mediated CYPs</span></div><div class="casAuthors">Genter, Mary Beth; Marlowe, Jennifer; Kerzee, J. Kevin; Dragin, Nadine; Puga, Alvaro; Dalton, Timothy P.; Nebert, Daniel W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">120-123</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Naphthalene (NP) has been designated a reasonably anticipated human carcinogen' because of pos. responses in carcinogenicity bioassays in rodents.  Whereas CYP2F enzymes are widely regarded as responsible for NP bioactivation, other metabolic enzymes-including CYP1A1 and CYP1A2-produce NP-1,2-oxide in vitro.  We investigated the role of these aryl hydrocarbon receptor (AHR)-mediated enzymes in NP toxicity in two ways.  First, NP was assessed for the ability to activate transcription via the AHR in an in vitro luciferase reporter assay and was found to have no activity.  Second, mice deficient in AHR, CYP1A1 or CYP1A2 were dosed with NP alone, or following pretreatment with the CYP2F inhibitor 5-phenyl-1-pentyne.  None of the knockout mice were protected from olfactory toxicity of NP.  In contrast, CYP1A1- and CYP1A2-null mice pretreated with 5-phenyl-1-pentyne exhibited no NP olfactory toxicity.  These results suggest that AHR-mediated enzymes do not contribute significantly to NP bioactivation in the intact animal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvw8sZkx1GcLVg90H21EOLACvtfcHk0ligochvx96HSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1WqtLo%253D&md5=e504d57e312e568f7d4e1cfe98cb9f66</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2006.07.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2006.07.025%26sid%3Dliteratum%253Aachs%26aulast%3DGenter%26aufirst%3DM.%2BB.%26aulast%3DMarlowe%26aufirst%3DJ.%26aulast%3DKevin%2BKerzee%26aufirst%3DJ.%26aulast%3DDragin%26aufirst%3DN.%26aulast%3DPuga%26aufirst%3DA.%26aulast%3DDalton%26aufirst%3DT.%2BP.%26aulast%3DNebert%26aufirst%3DD.%2BW.%26atitle%3DNaphthalene%2520toxicity%2520in%2520mice%2520and%2520aryl%2520hydrocarbon%2520receptor-mediated%2520CYPs%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D348%26spage%3D120%26epage%3D123%26doi%3D10.1016%2Fj.bbrc.2006.07.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tingle, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirmohamed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Templeton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madden, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitteringham, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">An investigation of the formation of cytotoxic, genotoxic, protein-reactive and stable metabolites from naphthalene by human liver microsomes</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1529</span>â <span class="NLM_lpage">1538</span>, <span class="refDoi">Â DOI: 10.1016/0006-2952(93)90319-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1016%2F0006-2952%2893%2990319-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=8240407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaK2cXntFamtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1993&pages=1529-1538&author=M.+D.+Tingleauthor=M.+Pirmohamedauthor=E.+Templetonauthor=A.+S.+Wilsonauthor=S.+Maddenauthor=N.+R.+Kitteringhamauthor=B.+K.+Park&title=An+investigation+of+the+formation+of+cytotoxic%2C+genotoxic%2C+protein-reactive+and+stable+metabolites+from+naphthalene+by+human+liver+microsomes&doi=10.1016%2F0006-2952%2893%2990319-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">An investigation of the formation of cytotoxic, genotoxic, protein-reactive and stable metabolites from naphthalene by human liver microsomes</span></div><div class="casAuthors">Tingle, Malcolm D.; Pirmohamed, Munir; Templeton, Elizabeth; Wilson, Andrew S.; Madden, Stephen; Kitteringham, Neil R.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1529-38</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">Naphthalene (I), which is metabolized to a 1,2-epoxide, has been used as a model compd. in this study in order to investigate the effects of perturbation of detoxication mechanisms on the in vitro toxicity of epoxides in the presence of human liver microsomes.  Naphthalene (100 Î¼M) was metabolized to cytotoxic, protein-reactive and stable, but not genotoxic, metabolites by human liver microsomes.  The metab.-dependent cytotoxicity and covalent binding to protein of naphthalene were significantly higher in the presence of phenobarbitone-induced mouse liver microsomes than with human liver microsomes.  The ratio of trans-1,2-dihydrodiol to 1-naphthol was 8.6 and 0.4 with the human and the induced mouse microsomes, resp.  The metab. dependent toxicity of naphthalene toward human peripheral mononuclear leukocytes was not affected by the glutathione transferase Î¼ status of the co-incubated cells.  Trichloropropene oxide (TCPO; 30 Î¼M), an epoxide hydrolase inhibitor, increased the human liver microsomal-dependent cytotoxicity (19.6 Â± 0.9% vs. 28.7 Â± 1.0%; P = 0.02) and covalent binding to protein (1.4 Â± 0.03% vs. 2.8 Â± 0.02%; P = 0.3) of naphthalene (100 Î¼M), and reversed the 1,2-dihydrodiol to 1-naphthol ratio from 6.6 (without TCPO) to 2.6, 0.6 and 0.1 at TCPO concns. of 30, 100 and 500 Î¼M, resp.  Increasing the human liver microsomal protein concn. reduced the cytotoxicity of naphthalene, while increasing its covalent binding to protein and the formation of the 1,2-dihydrodiol metabolite.  Co-incubation with glutathione (5 mM) reduced the cytotoxicity and covalent binding to protein of naphthalene by 68 and 64%, resp.  Covalent binding to protein was also inhibited by gestodene, while stable metabolite formation was reduced by gestodene (250 Î¼M) and enoxacin (250 Î¼M).  The study demonstrates that human liver cytochrome P 450 enzymes metabolize naphthalene to a cytotoxic and protein-reactive, but not genotoxic, metabolite which is probably an epoxide.  This is rapidly detoxified by microsomal epoxide hydrolase, the efficiency of which can be readily detd. by measurement of the ratio of the stable metabolites, naphthalene 1,2-dihydrodiol and 1-naphthol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM_oKzWw5OL7Vg90H21EOLACvtfcHk0ligochvx96HSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXntFamtA%253D%253D&md5=4015812377ffaa29b17c1f5f9db3379d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2893%2990319-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252893%252990319-R%26sid%3Dliteratum%253Aachs%26aulast%3DTingle%26aufirst%3DM.%2BD.%26aulast%3DPirmohamed%26aufirst%3DM.%26aulast%3DTempleton%26aufirst%3DE.%26aulast%3DWilson%26aufirst%3DA.%2BS.%26aulast%3DMadden%26aufirst%3DS.%26aulast%3DKitteringham%26aufirst%3DN.%2BR.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DAn%2520investigation%2520of%2520the%2520formation%2520of%2520cytotoxic%252C%2520genotoxic%252C%2520protein-reactive%2520and%2520stable%2520metabolites%2520from%2520naphthalene%2520by%2520human%2520liver%2520microsomes%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1993%26volume%3D46%26spage%3D1529%26epage%3D1538%26doi%3D10.1016%2F0006-2952%2893%2990319-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sproul, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poppe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gohdes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghoborah, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padhi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roskos, L.</span></span> <span> </span><span class="NLM_article-title">Metabolism and disposition of calcimimetic agent cinacalcet HCl in humans and animal models</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1491</span>â <span class="NLM_lpage">1500</span>, <span class="refDoi">Â DOI: 10.1124/dmd.104.000604</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1124%2Fdmd.104.000604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=15328250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFGit7%252FO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=1491-1500&author=G.+N.+Kumarauthor=C.+Sproulauthor=L.+Poppeauthor=S.+Turnerauthor=M.+Gohdesauthor=H.+Ghoborahauthor=D.+Padhiauthor=L.+Roskos&title=Metabolism+and+disposition+of+calcimimetic+agent+cinacalcet+HCl+in+humans+and+animal+models&doi=10.1124%2Fdmd.104.000604"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and disposition of calcimimetic agent cinacalcet HCL in humans and animal models</span></div><div class="casAuthors">Kumar, Gondi N.; Sproul, Christopher; Poppe, Leszek; Turner, Sharon; Gohdes, Mark; Ghoborah, Hesham; Padhi, Desmond; Roskos, Lorin</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1491-1500</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The metab. and disposition of calcimimetic agent cinacalcet HCl was examd. after a single oral administration to mice, rats, monkeys, and human volunteers.  In all species examd., cinacalcet was well absorbed, with greater than 74% oral bioavailability of cinacalcet-derived radioactivity in monkeys and humans.  In rats, cinacalcet-derived radioactivity was widely distributed into most tissues, with no marked gender-related differences.  In all animal models examd., radioactivity was excreted rapidly via both hepatobiliary and urinary routes.  In humans, radioactivity was cleared primarily via the urinary route (80%), with 17% excreted in the feces.  Cinacalcet was not detected in the urine in humans.  The primary routes of metab. of cinacalcet were N-dealkylation leading to carboxylic acid derivs. (excreted in urine as glycine conjugates) and oxidn. of naphthalene ring to form dihydrodiols (excreted in urine and bile as glucuronide conjugates).  The plasma radioactivity in both animals and humans was primarily composed of carboxylic acid metabolites and dihydrodiol glucuronides, with <1% circulating radioactivity accounting for the unchanged cinacalcet.  Overall, the circulating and excreted metabolite profile of cinacalcet in humans was qual. similar to that obsd. in preclin. animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS-MCS9mF1mLVg90H21EOLACvtfcHk0lh6KP2x3wKZfA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFGit7%252FO&md5=3c50c530a01059e70ac50f97f4699124</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fdmd.104.000604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.104.000604%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DG.%2BN.%26aulast%3DSproul%26aufirst%3DC.%26aulast%3DPoppe%26aufirst%3DL.%26aulast%3DTurner%26aufirst%3DS.%26aulast%3DGohdes%26aufirst%3DM.%26aulast%3DGhoborah%26aufirst%3DH.%26aulast%3DPadhi%26aufirst%3DD.%26aulast%3DRoskos%26aufirst%3DL.%26atitle%3DMetabolism%2520and%2520disposition%2520of%2520calcimimetic%2520agent%2520cinacalcet%2520HCl%2520in%2520humans%2520and%2520animal%2520models%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2004%26volume%3D32%26spage%3D1491%26epage%3D1500%26doi%3D10.1124%2Fdmd.104.000604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Risch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeifer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segrestaa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fretz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pothier, J.</span></span> <span> </span><span class="NLM_article-title">Verification of the major metabolic oxidation path for the naphthoyl group in chemoattractant receptor-homologous molecule expressed on Th2 Cells (CRTh2) antagonist 2-(2-(1-naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic acid (Setipiprant/ACT-129968)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8011</span>â <span class="NLM_lpage">8035</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b00824</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00824" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFGltLvM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8011-8035&author=P.+Rischauthor=T.+Pfeiferauthor=J.+Segrestaaauthor=H.+Fretzauthor=J.+Pothier&title=Verification+of+the+major+metabolic+oxidation+path+for+the+naphthoyl+group+in+chemoattractant+receptor-homologous+molecule+expressed+on+Th2+Cells+%28CRTh2%29+antagonist+2-%282-%281-naphthoyl%29-8-fluoro-3%2C4-dihydro-1H-pyrido%5B4%2C3-b%5Dindol-5%282H%29-yl%29acetic+acid+%28Setipiprant%2FACT-129968%29&doi=10.1021%2Facs.jmedchem.5b00824"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Verification of the Major Metabolic Oxidation Path for the Naphthoyl Group in Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTh2) Antagonist 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic Acid (Setipiprant/ACT-129968)</span></div><div class="casAuthors">Risch, Philippe; Pfeifer, Thomas; Segrestaa, Jerome; Fretz, Heinz; Pothier, Julien</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8011-8035</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Various racemic and enantioenriched (trans)-X,Y-dihydroxy-X,Y-dihydronaphthoyl analogs as well as X-hydroxy-naphthoyl analogs of CRTh2 antagonist I (Setipiprant/ACT-129968) were synthesized in order to gain insight into regio- and enantioselectivity of the metabolic oxidn. of 1 and to verify the structures of four metabolites that were proposed earlier in a clin. ADME study.  Anal. data of the synthetic stds. were compared with data from samples of biol. origin.  The two major metabolites M7 and M9 were unambiguously verified as 2-(2-(trans)-3,4-dihydroxy-3,4-dihydronaphthalene-1-carbonyl)- and 2-((2-(trans)-5,6-dihydroxy-5,6-dihydronaphthalene-1-carbonyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic acid, resp., each composed of two enantiomers with 68% and 44% ee in favor of (+)-(3S,4S)-M7 and (+)-(5S,6S)-M9, resp.  Likewise, minor metabolites M3 and M13 were identified as 2-(8-fluoro-2-(5-hydroxy-1-naphthoyl))- and 2-(8-fluoro-2-(4-hydroxy-1-naphthoyl)-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5-yl)acetic acid, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwwdSyS1pBzrVg90H21EOLACvtfcHk0lh6KP2x3wKZfA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFGltLvM&md5=0d17d96dfa3605d3157535c25c74485b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00824%26sid%3Dliteratum%253Aachs%26aulast%3DRisch%26aufirst%3DP.%26aulast%3DPfeifer%26aufirst%3DT.%26aulast%3DSegrestaa%26aufirst%3DJ.%26aulast%3DFretz%26aufirst%3DH.%26aulast%3DPothier%26aufirst%3DJ.%26atitle%3DVerification%2520of%2520the%2520major%2520metabolic%2520oxidation%2520path%2520for%2520the%2520naphthoyl%2520group%2520in%2520chemoattractant%2520receptor-homologous%2520molecule%2520expressed%2520on%2520Th2%2520Cells%2520%2528CRTh2%2529%2520antagonist%25202-%25282-%25281-naphthoyl%2529-8-fluoro-3%252C4-dihydro-1H-pyrido%255B4%252C3-b%255Dindol-5%25282H%2529-yl%2529acetic%2520acid%2520%2528Setipiprant%252FACT-129968%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8011%26epage%3D8035%26doi%3D10.1021%2Facs.jmedchem.5b00824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wank, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kluge, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner-Redeker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingemanse, J.</span></span> <span> </span><span class="NLM_article-title">Disposition and metabolism of setipiprant, a selective oral CRTH2 antagonist, in humans</span>. <i>Drugs R&D</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">253</span>â <span class="NLM_lpage">269</span>, <span class="refDoi">Â DOI: 10.1007/s40268-013-0031-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1007%2Fs40268-013-0031-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=24214422" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=253-269&author=M.+Hochauthor=J.+Wankauthor=I.+Klugeauthor=W.+Wagner-Redekerauthor=J.+Dingemanse&title=Disposition+and+metabolism+of+setipiprant%2C+a+selective+oral+CRTH2+antagonist%2C+in+humans&doi=10.1007%2Fs40268-013-0031-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs40268-013-0031-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40268-013-0031-7%26sid%3Dliteratum%253Aachs%26aulast%3DHoch%26aufirst%3DM.%26aulast%3DWank%26aufirst%3DJ.%26aulast%3DKluge%26aufirst%3DI.%26aulast%3DWagner-Redeker%26aufirst%3DW.%26aulast%3DDingemanse%26aufirst%3DJ.%26atitle%3DDisposition%2520and%2520metabolism%2520of%2520setipiprant%252C%2520a%2520selective%2520oral%2520CRTH2%2520antagonist%252C%2520in%2520humans%26jtitle%3DDrugs%2520R%2526D%26date%3D2013%26volume%3D13%26spage%3D253%26epage%3D269%26doi%3D10.1007%2Fs40268-013-0031-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vickers, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinclair, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zollinger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glanzel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johanson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, V.</span></span> <span> </span><span class="NLM_article-title">Multiple cytochrome P-450s involved in the metabolism of terbinafine suggest a limited potential for drug-drug interactions</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1029</span>â <span class="NLM_lpage">1038</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10460803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaK1MXlslCqsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=1029-1038&author=A.+E.+Vickersauthor=J.+R.+Sinclairauthor=M.+Zollingerauthor=F.+Heitzauthor=U.+Glanzelauthor=L.+Johansonauthor=V.+Fischer&title=Multiple+cytochrome+P-450s+involved+in+the+metabolism+of+terbinafine+suggest+a+limited+potential+for+drug-drug+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple cytochrome P-450s involved in the metabolism of terbinafine suggest a limited potential for drug-drug interactions</span></div><div class="casAuthors">Vickers, Alison E. M.; Sinclair, John R.; Zollinger, Markus; Heitz, Francis; Glanzel, Ulrike; Johanson, Laurie; Fischer, Volker</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1029-1038</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Biotransformation pathways and the potential for drug-drug interactions of the orally active antifungal terbinafine were characterized using human liver microsomes and recombinant human cytochrome P-450s (CYPs).  The terbinafine metabolites represented four major pathways: 1. N-demethylation, 2. deamination, 3. alkyl side chain oxidn., and 4. dihydrodiol formation.  Michaelis-Menten kinetics for the pathways revealed mean Km values ranging from 4.4 to 27.8 Î¼M, and Vmax values of 9.8 to 82 nmol/h/mg protein.  At least seven CYP enzymes are involved in terbinafine metab.  Recombinant human CYPs predict that CYP2C9, CYP1A2, and CYP3A4 are the most important for total metab.  N-demethylation is primarily mediated by CYP2C9, CYP2C8, and CYP1A2; dihydrodiol formation by CYP2C9 and CYP1A2; deamination by CYP3A4; and side chain oxidn. equally by CYP1A2, CYP2C8, CYP2C9, and CYP2C19.  Addnl., characteristic CYP substrates inhibited pathways of terbinafine metabolite formation, confirming the involvement of multiple enzymes.  The deamination pathway was mainly inhibited by CYP3A inhibitors, including troleandomycin and azole antifungals.  Dihydrodiol formation was inhibited by the CYP1A2 inhibitor furafylline.  Terbinafine had little or no effect on the metab. of many characteristic CYP substrates.  Terbinafine, however, is a competitive inhibitor of the CYP2D6 reaction, dextromethorphan O-demethylation (Ki = 0.03 Î¼M).  In summary, terbinafine is metabolized by at least seven CYPs.  The potential for terbinafine interaction with other drugs is predicted to be insignificant with the exception that it may inhibit the metab. of CYP2D6 substrates.  Clin. trials are needed to assess the relevance of these findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlDKX8_KrMM7Vg90H21EOLACvtfcHk0liw6IKprftxAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlslCqsr0%253D&md5=c6a65bf93e3b416da1009bece3777e5a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVickers%26aufirst%3DA.%2BE.%26aulast%3DSinclair%26aufirst%3DJ.%2BR.%26aulast%3DZollinger%26aufirst%3DM.%26aulast%3DHeitz%26aufirst%3DF.%26aulast%3DGlanzel%26aufirst%3DU.%26aulast%3DJohanson%26aufirst%3DL.%26aulast%3DFischer%26aufirst%3DV.%26atitle%3DMultiple%2520cytochrome%2520P-450s%2520involved%2520in%2520the%2520metabolism%2520of%2520terbinafine%2520suggest%2520a%2520limited%2520potential%2520for%2520drug-drug%2520interactions%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1999%26volume%3D27%26spage%3D1029%26epage%3D1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gennaro, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelizzoni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bestetti, G.</span></span> <span> </span><span class="NLM_article-title">Production of substituted naphthalene dihydrodiols by engineered Escherichia coli containing the cloned naphthalene 1,2-dioxygenase gene from Pseudomonas fluorescens N3</span>. <i>Res. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">355</span>â <span class="NLM_lpage">364</span>, <span class="refDoi">Â DOI: 10.1016/s0923-2508(97)81591-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1016%2FS0923-2508%2897%2981591-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=9765814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A280%3ADyaK1cvjvV2msw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=1997&pages=355-364&author=P.+D.+Gennaroauthor=E.+Galliauthor=G.+Albiniauthor=F.+Pelizzoniauthor=G.+Selloauthor=G.+Bestetti&title=Production+of+substituted+naphthalene+dihydrodiols+by+engineered+Escherichia+coli+containing+the+cloned+naphthalene+1%2C2-dioxygenase+gene+from+Pseudomonas+fluorescens+N3&doi=10.1016%2Fs0923-2508%2897%2981591-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Production of substituted naphthalene dihydrodiols by engineered Escherichia coli containing the cloned naphthalene 1,2-dioxygenase gene from Pseudomonas fluorescens N3</span></div><div class="casAuthors">Gennaro P D; Galli E; Albini G; Pelizzoni F; Sello G; Bestetti G</div><div class="citationInfo"><span class="NLM_cas:title">Research in microbiology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-64</span>
        ISSN:<span class="NLM_cas:issn">0923-2508</span>.
    </div><div class="casAbstract">Naphthalene dioxygenase, a key enzyme in the dihydroxylation of naphthalene, is encoded by the plasmid pN3, responsible for naphthalene metabolism in Pseudomonas fluorescens N3.  The naphthalene dioxygenase, including all the sequences for its expression and the regulatory region, has been localized on the 4.3-kb HindIII-ClaI fragment and on the 3.5-kb HindIII fragment of the plasmid pN3, by Southern analysis using as probes nahA and nahR genes, the homologous genes of the plasmid NAH7 from Pseudomonas putida G7.  We cloned in Escherichia coli JM109 the dioxygenase gene and its regulatory region and developed an efficient bacterial system inducible by salicylic acid, able to produce dihydrodiols.  E. coli containing recombinant plasmids carrying the dioxygenase gene were analysed for their potential as a biocatalytic tool to produce dihydrodiols from different naphthalenes with the substituent on the aromatic ring at the alpha or beta position.  The dihydrodiols, identified by HPLC (high-performance liquid chromatography) and 1H-NMR (nuclear magnetic resonance) were produced with yields ranging from 50 to 94%.  The degree of bioconversion efficiency depends on the nature and the position of the substituent and indicates the broad substrate specificity of this dioxygenase and its potential for the production of a wide variety of fine chemicals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2kgk5L7LJi4xhnOQkIHOxfW6udTcc2eY2VZtlQxm6rrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1cvjvV2msw%253D%253D&md5=d9d99694dc8fb323f511653540ec8c4b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0923-2508%2897%2981591-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0923-2508%252897%252981591-4%26sid%3Dliteratum%253Aachs%26aulast%3DGennaro%26aufirst%3DP.%2BD.%26aulast%3DGalli%26aufirst%3DE.%26aulast%3DAlbini%26aufirst%3DG.%26aulast%3DPelizzoni%26aufirst%3DF.%26aulast%3DSello%26aufirst%3DG.%26aulast%3DBestetti%26aufirst%3DG.%26atitle%3DProduction%2520of%2520substituted%2520naphthalene%2520dihydrodiols%2520by%2520engineered%2520Escherichia%2520coli%2520containing%2520the%2520cloned%2520naphthalene%25201%252C2-dioxygenase%2520gene%2520from%2520Pseudomonas%2520fluorescens%2520N3%26jtitle%3DRes.%2520Microbiol.%26date%3D1997%26volume%3D148%26spage%3D355%26epage%3D364%26doi%3D10.1016%2Fs0923-2508%2897%2981591-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shindo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iba, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saotome, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misawa, N.</span></span> <span> </span><span class="NLM_article-title">Hydroxylations of substituted naphthalenes by Escherichia coli expressing aromatic dihydroxylating dioxygenase genes from polycyclic aromatic hydrocarbon-utilizing marine bacteria</span>. <i>J. Mol. Catal. B: Enzym.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">77</span>â <span class="NLM_lpage">83</span>, <span class="refDoi">Â DOI: 10.1016/j.molcatb.2007.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1016%2Fj.molcatb.2007.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1Sit7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=77-83&author=K.+Shindoauthor=A.+Osawaauthor=Y.+Kasaiauthor=N.+Ibaauthor=A.+Saotomeauthor=N.+Misawa&title=Hydroxylations+of+substituted+naphthalenes+by+Escherichia+coli+expressing+aromatic+dihydroxylating+dioxygenase+genes+from+polycyclic+aromatic+hydrocarbon-utilizing+marine+bacteria&doi=10.1016%2Fj.molcatb.2007.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxylations of substituted naphthalenes by Escherichia coli expressing aromatic dihydroxylating dioxygenase genes from polycyclic aromatic hydrocarbon-utilizing marine bacteria</span></div><div class="casAuthors">Shindo, Kazutoshi; Osawa, Ayako; Kasai, Yuki; Iba, Nobuko; Saotome, Ayako; Misawa, Norihiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Catalysis B: Enzymatic</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">77-83</span>CODEN:
                <span class="NLM_cas:coden">JMCEF8</span>;
        ISSN:<span class="NLM_cas:issn">1381-1177</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bioconversion expts. of various mono- or di-substituted naphthalenes such as dimethylnaphthalenes were carried out using the cells of Escherichia coli that expressed arom. dihydroxylating dioxygenase genes (phnA1A2A3A4 and phdABCD) from polycyclic arom. hydrocarbon-utilizing marine bacteria, Nocardioides sp. KP7 and Cycloclasticus sp. A5, resp.  We found that the former dioxygenase PhnA1A2A3A4 had broad substrate preference for these compds. and often was able to hydroxylate their Me groups.  Specifically, 1,4-dimethylnaphthalene was predominantly bioconverted into 1,4-dihydroxymethylnaphthalene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5lXj_CYG0wrVg90H21EOLACvtfcHk0ljmuDwCg6NQtA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1Sit7Y%253D&md5=a20882d7a9a13bb3b254b67ff9629a45</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.molcatb.2007.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcatb.2007.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DShindo%26aufirst%3DK.%26aulast%3DOsawa%26aufirst%3DA.%26aulast%3DKasai%26aufirst%3DY.%26aulast%3DIba%26aufirst%3DN.%26aulast%3DSaotome%26aufirst%3DA.%26aulast%3DMisawa%26aufirst%3DN.%26atitle%3DHydroxylations%2520of%2520substituted%2520naphthalenes%2520by%2520Escherichia%2520coli%2520expressing%2520aromatic%2520dihydroxylating%2520dioxygenase%2520genes%2520from%2520polycyclic%2520aromatic%2520hydrocarbon-utilizing%2520marine%2520bacteria%26jtitle%3DJ.%2520Mol.%2520Catal.%2520B%253A%2520Enzym.%26date%3D2007%26volume%3D48%26spage%3D77%26epage%3D83%26doi%3D10.1016%2Fj.molcatb.2007.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whited, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downie, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudlicky, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fearnley, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudding, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivo, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D.</span></span> <span> </span><span class="NLM_article-title">Oxidation of 2-methoxynaphthalene by toluene, naphthalene and biphenyl dioxygenases:structure and absolute stereochemistry of metabolites</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">727</span>â <span class="NLM_lpage">734</span>, <span class="refDoi">Â DOI: 10.1016/0968-0896(94)85024-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1016%2F0968-0896%2894%2985024-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=7858982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaK2MXitVOju78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1994&pages=727-734&author=G.+M.+Whitedauthor=J.+C.+Downieauthor=T.+Hudlickyauthor=S.+P.+Fearnleyauthor=T.+C.+Duddingauthor=H.+F.+Olivoauthor=D.+Parker&title=Oxidation+of+2-methoxynaphthalene+by+toluene%2C+naphthalene+and+biphenyl+dioxygenases%3Astructure+and+absolute+stereochemistry+of+metabolites&doi=10.1016%2F0968-0896%2894%2985024-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation of 2-methoxynaphthalene by toluene, naphthalene and biphenyl dioxygenases: structure and absolute stereochemistry of metabolites</span></div><div class="casAuthors">Whited, Gregory M.; Downie, J. Corey; Hudlicky, Tomas; Fearnley, Stephen P.; Dudding, Travis C.; Olivo, Horatio F.; Parker, Denise</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">727-34</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">2-Methoxynaphthalene was subjected to biooxidn. by whole cells of six organisms: Pseudomonas putida (contg. toluene dioxygenase), Escherichia coli (contg. recombinant toluene dioxygenase), Pseudomonas sp. (contg. naphthalene dioxygenase), E. coli (contg. recombinant naphthalene dioxygenase), E. coli (contg. recombinant naphthalene dioxygenase) and Beijerinckia sp. (biphenyl dioxygenase).  The major product of oxidn. by the naphthalene and biphenyl dioxygenases was isolated and identified as (1R,2S)-1,2-dihydroxy-7-methoxy-1,2-dihydronaphthalene.  A minor product, (1R,2S)-1,2-dihydroxy-6-methoxy-1,2-dihydronaphthalene, was detected.  Oxidn. by the toluene dioxygenase-contg. organisms led to the isolation of (1R,2S)-dihydroxy-6-methoxy-1,2-dihydronaphthalene as the major product.  Structural studies and dehydration of the diols to a mixt. of naphthols are described.  The abs. stereochem. of these new diols was detd. by correlation with known compds.  The organisms' potential in the prodn. of new metabolites as useful chiral synthons by biooxidn. of 2-substituted naphthalenes is indicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpg-seA617qLVg90H21EOLACvtfcHk0ljmuDwCg6NQtA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXitVOju78%253D&md5=0cbe64f39d19ca724d01e0341c4b5a04</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2F0968-0896%2894%2985024-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0968-0896%252894%252985024-0%26sid%3Dliteratum%253Aachs%26aulast%3DWhited%26aufirst%3DG.%2BM.%26aulast%3DDownie%26aufirst%3DJ.%2BC.%26aulast%3DHudlicky%26aufirst%3DT.%26aulast%3DFearnley%26aufirst%3DS.%2BP.%26aulast%3DDudding%26aufirst%3DT.%2BC.%26aulast%3DOlivo%26aufirst%3DH.%2BF.%26aulast%3DParker%26aufirst%3DD.%26atitle%3DOxidation%2520of%25202-methoxynaphthalene%2520by%2520toluene%252C%2520naphthalene%2520and%2520biphenyl%2520dioxygenases%253Astructure%2520and%2520absolute%2520stereochemistry%2520of%2520metabolites%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1994%26volume%3D2%26spage%3D727%26epage%3D734%26doi%3D10.1016%2F0968-0896%2894%2985024-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bestetti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Gennaro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leoni, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelizzoni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sello, G.</span></span> <span> </span><span class="NLM_article-title">Bioconversion of substituted naphthalenes to the corresponding 1,2-dihydro-1,2-dihydroxy derivatives. Determination of the regio- and stereochemistry of the oxidation reactions</span>. <i>Appl. Microbiol. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">306</span>â <span class="NLM_lpage">313</span>, <span class="refDoi">Â DOI: 10.1007/BF00169921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1007%2FBF00169921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaK28XitVersL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1995&pages=306-313&author=G.+Bestettiauthor=D.+Bianchiauthor=A.+Bosettiauthor=P.+Di+Gennaroauthor=E.+Galliauthor=B.+Leoniauthor=F.+Pelizzoniauthor=G.+Sello&title=Bioconversion+of+substituted+naphthalenes+to+the+corresponding+1%2C2-dihydro-1%2C2-dihydroxy+derivatives.+Determination+of+the+regio-+and+stereochemistry+of+the+oxidation+reactions&doi=10.1007%2FBF00169921"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Bioconversion of substituted naphthalenes to the corresponding 1,2-dihydro-1,2-dihydroxy derivatives. Determination of the regio- and stereochemistry of the oxidation reactions</span></div><div class="casAuthors">Bestetti, G.; Bianchi, D.; Bosetti, A.; Di Gennaro, P.; Galli, E.; Leoni, B.; Pelizzoni, F.; Sello, G.</div><div class="citationInfo"><span class="NLM_cas:title">Applied Microbiology and Biotechnology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">306-13</span>CODEN:
                <span class="NLM_cas:coden">AMBIDG</span>;
        ISSN:<span class="NLM_cas:issn">0175-7598</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A mutant (TTC1) derived from Pseudomonas fluorescens N3 has been obtained for use in bioconversion of several naphthalene derivs. to the corresponding optically active cis-dihydrodiols on a milligrams-to-grams scale.  All main compds. have been characterized, their relative and abs. configuration assigned, and their enantiomeric purity detd.  The regio- and stereoselectivity of the transformation has been established.  The procedure therefore represents a valid method for the convenient prepn. of a pool of valuable chiral syntons and auxiliaries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZZTpUrVz0HrVg90H21EOLACvtfcHk0lgiicLqU7Hs6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitVersL0%253D&md5=7609c6ad71611253272c7cca9c683d2d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2FBF00169921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00169921%26sid%3Dliteratum%253Aachs%26aulast%3DBestetti%26aufirst%3DG.%26aulast%3DBianchi%26aufirst%3DD.%26aulast%3DBosetti%26aufirst%3DA.%26aulast%3DDi%2BGennaro%26aufirst%3DP.%26aulast%3DGalli%26aufirst%3DE.%26aulast%3DLeoni%26aufirst%3DB.%26aulast%3DPelizzoni%26aufirst%3DF.%26aulast%3DSello%26aufirst%3DG.%26atitle%3DBioconversion%2520of%2520substituted%2520naphthalenes%2520to%2520the%2520corresponding%25201%252C2-dihydro-1%252C2-dihydroxy%2520derivatives.%2520Determination%2520of%2520the%2520regio-%2520and%2520stereochemistry%2520of%2520the%2520oxidation%2520reactions%26jtitle%3DAppl.%2520Microbiol.%2520Biotechnol.%26date%3D1995%26volume%3D44%26spage%3D306%26epage%3D313%26doi%3D10.1007%2FBF00169921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hudlicky, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endoma, M. A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butora, G.</span></span> <span> </span><span class="NLM_article-title">New chiral synthons from the microbial oxidation of bromonaphthalenes</span>. <i>Tetrahedron: Asymmetry</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">61</span>â <span class="NLM_lpage">68</span>, <span class="refDoi">Â DOI: 10.1016/0957-4166(95)00421-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1016%2F0957-4166%2895%2900421-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaK28XpsVWrsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1996&pages=61-68&author=T.+Hudlickyauthor=M.+A.+A.+Endomaauthor=G.+Butora&title=New+chiral+synthons+from+the+microbial+oxidation+of+bromonaphthalenes&doi=10.1016%2F0957-4166%2895%2900421-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">New chiral synthons from the microbial oxidation of bromonaphthalenes</span></div><div class="casAuthors">Hudlicky, Tomas; Endoma, Mary Ann A.; Butora, Gabor</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron: Asymmetry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-8</span>CODEN:
                <span class="NLM_cas:coden">TASYE3</span>;
        ISSN:<span class="NLM_cas:issn">0957-4166</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">1-Bromo- and 2-bromonaphthalene were subjected to biooxidn. with whole cells of Pseudomonas putida NCIB 9816-11.  The major metabolites were isolated and spectroscopically characterized as (+)-cis-(1R,2S)-dihydroxy-1,2-dihydro-8-bromonaphthalene and (+)-cis-(1R,2S)-dihydroxy-1,2-dihydro-5-bromonaphthalene from 1-bromonaphthalene and (+)-cis-(1R,2S)-dihydroxy-1,2-dihydro-7-bromonaphthalene from 2-bromonaphthalene.  The abs. stereochem. and enantiomeric excess were detd. by conversion of each metabolite to the known (-)-cis-(1R,2S)-dihydroxy-1,2,3,4-tetrahydronaphthalene diol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxZ4fVCDdjHrVg90H21EOLACvtfcHk0lgiicLqU7Hs6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XpsVWrsA%253D%253D&md5=d09b845ab702ec9b06cbeaea6fc5fc37</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2F0957-4166%2895%2900421-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0957-4166%252895%252900421-1%26sid%3Dliteratum%253Aachs%26aulast%3DHudlicky%26aufirst%3DT.%26aulast%3DEndoma%26aufirst%3DM.%2BA.%2BA.%26aulast%3DButora%26aufirst%3DG.%26atitle%3DNew%2520chiral%2520synthons%2520from%2520the%2520microbial%2520oxidation%2520of%2520bromonaphthalenes%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1996%26volume%3D7%26spage%3D61%26epage%3D68%26doi%3D10.1016%2F0957-4166%2895%2900421-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gawronski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">More OâFerrall, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudavalli, J. S.</span></span> <span> </span><span class="NLM_article-title">Toluene dioxygenase-catalyzed synthesis of cis-dihydrodiol metabolites from 2-substituted naphthalene substrates: assignments of absolute configurations and conformations from circular dichroism and optical rotation measurements</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">11500</span>â <span class="NLM_lpage">11511</span>, <span class="refDoi">Â DOI: 10.1002/chem.200801686</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1002%2Fchem.200801686" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=19006170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktV2gtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=11500-11511&author=M.+Kwitauthor=J.+Gawronskiauthor=D.+R.+Boydauthor=N.+D.+Sharmaauthor=M.+Kaikauthor=R.+A.+More+O%E2%80%99Ferrallauthor=J.+S.+Kudavalli&title=Toluene+dioxygenase-catalyzed+synthesis+of+cis-dihydrodiol+metabolites+from+2-substituted+naphthalene+substrates%3A+assignments+of+absolute+configurations+and+conformations+from+circular+dichroism+and+optical+rotation+measurements&doi=10.1002%2Fchem.200801686"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Toluene dioxygenase-catalyzed synthesis of cis-dihydrodiol metabolites from 2-substituted naphthalene substrates: assignments of absolute configurations and conformations from circular dichroism and optical rotation measurements</span></div><div class="casAuthors">Kwit, Marcin; Gawronski, Jacek; Boyd, Derek R.; Sharma, Narain D.; Kaik, Magdalena; More O'Ferrall, Rory A.; Kudavalli, Jaya S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">11500-11511</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Cis-Dihydrodiol metabolites have been isolated from naphthalene and six 2-substituted naphthalene substrates.  Their structures and abs. configurations have been detd. by a combination of calcd. (TDDFT) and exptl. based CD (CD) and optical rotation (OR) methods.  The "inverse" styrene helicity rule is shown to be incorrect for the interpretation of the CD spectra of cis-dihydrodiols.  A striking conclusion is that CD spectra correlate directly with the helicity of the styrene chromophore: i.e., the sign of the long-wavelength Cotton effect is identical with the sign of styrene torsion angle, whereas the OR sign is dependent on the abs. configuration of the allylic carbon atom.  The results demonstrate that a predictive model previously used for the detn. of preferred regio- and stereoselectivity assocd. with TDO-catalyzed cis-dihydroxylation of substituted benzene substrates can now be successfully extended to substituted naphthalene substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZy_Ti9kWyU7Vg90H21EOLACvtfcHk0lgiicLqU7Hs6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktV2gtg%253D%253D&md5=c4e0048e9a6b73494c33a46b25c6625e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fchem.200801686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200801686%26sid%3Dliteratum%253Aachs%26aulast%3DKwit%26aufirst%3DM.%26aulast%3DGawronski%26aufirst%3DJ.%26aulast%3DBoyd%26aufirst%3DD.%2BR.%26aulast%3DSharma%26aufirst%3DN.%2BD.%26aulast%3DKaik%26aufirst%3DM.%26aulast%3DMore%2BO%25E2%2580%2599Ferrall%26aufirst%3DR.%2BA.%26aulast%3DKudavalli%26aufirst%3DJ.%2BS.%26atitle%3DToluene%2520dioxygenase-catalyzed%2520synthesis%2520of%2520cis-dihydrodiol%2520metabolites%2520from%25202-substituted%2520naphthalene%2520substrates%253A%2520assignments%2520of%2520absolute%2520configurations%2520and%2520conformations%2520from%2520circular%2520dichroism%2520and%2520optical%2520rotation%2520measurements%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2008%26volume%3D14%26spage%3D11500%26epage%3D11511%26doi%3D10.1002%2Fchem.200801686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lautens, M.</span></span> <span> </span><span class="NLM_article-title">Rhodium(I)-catalyzed domino asymmetric ring opening/enantioselective isomerization of oxabicyclic alkenes with water</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5400</span>â <span class="NLM_lpage">5404</span>, <span class="refDoi">Â DOI: 10.1002/anie.201200390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1002%2Fanie.201200390" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BC38Xls1eltr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=5400-5404&author=G.+C.+Tsuiauthor=M.+Lautens&title=Rhodium%28I%29-catalyzed+domino+asymmetric+ring+opening%2Fenantioselective+isomerization+of+oxabicyclic+alkenes+with+water&doi=10.1002%2Fanie.201200390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Rhodium(I)-Catalyzed Domino Asymmetric Ring Opening/Enantioselective Isomerization of Oxabicyclic Alkenes with Water</span></div><div class="casAuthors">Tsui, Gavin C.; Lautens, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5400-5404, S5400/1-S5400/27</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Enantio-enriched 2-hydroxy-1-tetralones are formed from oxabicyclic alkenes through a novel RhI-catalyzed domino reaction.  The proposed mechanism involves water-induced asym. ring opening to generate chiral trans-1,2-diol intermediates and subsequent enantioselective isomerization (I â II â III).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmSvFWbDYA27Vg90H21EOLACvtfcHk0lgLc3aevtOp4A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xls1eltr0%253D&md5=16b4b24fe5d28bcf14aa0685f0decfd4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fanie.201200390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201200390%26sid%3Dliteratum%253Aachs%26aulast%3DTsui%26aufirst%3DG.%2BC.%26aulast%3DLautens%26aufirst%3DM.%26atitle%3DRhodium%2528I%2529-catalyzed%2520domino%2520asymmetric%2520ring%2520opening%252Fenantioselective%2520isomerization%2520of%2520oxabicyclic%2520alkenes%2520with%2520water%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D5400%26epage%3D5404%26doi%3D10.1002%2Fanie.201200390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, T. K.</span></span> <span> </span><span class="NLM_article-title">A diversity-oriented synthesis of bicyclic cis-dihydroarenediols, cis-4-hydroxyscytalones, and bicyclic conduritol analogues</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2472</span>â <span class="NLM_lpage">2475</span>, <span class="refDoi">Â DOI: 10.1021/ol100557f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol100557f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BC3cXls12js78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=2472-2475&author=P.+Mukherjeeauthor=S.+J.+Royauthor=T.+K.+Sarkar&title=A+diversity-oriented+synthesis+of+bicyclic+cis-dihydroarenediols%2C+cis-4-hydroxyscytalones%2C+and+bicyclic+conduritol+analogues&doi=10.1021%2Fol100557f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A Diversity-Oriented Synthesis of Bicyclic cis-Dihydroarenediols, cis-4-Hydroxyscytalones, and Bicyclic Conduritol Analogues</span></div><div class="casAuthors">Mukherjee, Parag; Roy, Soumya J. Singha; Sarkar, Tarun K.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2472-2475</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A common-intermediate-based enantioselective strategy has been developed aiming at bicyclic arene cis-dihydrodiols, cis-4-hydroxyscytalones, and bicyclic mimics of conduritol.  Key features of this protocol include Barrett's asym. hydroxyallylation, ring-closing metathesis (RCM), and completely regioselective Wacker oxidn. of internal cyclic olefins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWBs8kqnKFRLVg90H21EOLACvtfcHk0lgLc3aevtOp4A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXls12js78%253D&md5=c1eddd68011c639a33f4f2ad35db4b57</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fol100557f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol100557f%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DP.%26aulast%3DRoy%26aufirst%3DS.%2BJ.%26aulast%3DSarkar%26aufirst%3DT.%2BK.%26atitle%3DA%2520diversity-oriented%2520synthesis%2520of%2520bicyclic%2520cis-dihydroarenediols%252C%2520cis-4-hydroxyscytalones%252C%2520and%2520bicyclic%2520conduritol%2520analogues%26jtitle%3DOrg.%2520Lett.%26date%3D2010%26volume%3D12%26spage%3D2472%26epage%3D2475%26doi%3D10.1021%2Fol100557f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olesen, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linnet, K.</span></span> <span> </span><span class="NLM_article-title">Identification of the human cytochrome P450 isoforms mediating in vitro N-dealkylation of perphenazine</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">563</span>â <span class="NLM_lpage">571</span>, <span class="refDoi">Â DOI: 10.1046/j.1365-2125.2000.00298.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1046%2Fj.1365-2125.2000.00298.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=11136295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkvVyqtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2000&pages=563-571&author=O.+V.+Olesenauthor=K.+Linnet&title=Identification+of+the+human+cytochrome+P450+isoforms+mediating+in+vitro+N-dealkylation+of+perphenazine&doi=10.1046%2Fj.1365-2125.2000.00298.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the human cytochrome P450 isoforms mediating in vitro N-dealkylation of perphenazine</span></div><div class="casAuthors">Olesen, Ole V.; Linnet, Kristian</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">563-571</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">To identify the human cytochrome P 450 (CYP) isoforms mediating the N-dealkylation of the antipsychotic drug perphenazine in vitro and est. the relative contributions of the CYP isoforms involved.  The cDNA-expressed CYP isoforms were used to identify the isoforms that are able to mediate the N-dealkylation of perphenazine, which is considered a major metabolic pathway for the drug.  Using human liver microsomal prepns. (HLM), inhibition studies were carried out to establish the relative contributions of the CYP isoforms involved in the N-dealkylation reaction.  CYP isoforms 1A2, 3A4, 2C8, 2C9, 2C18, 2C19 and 2D6 were able to mediate the N-dealkylation of perphenazine.  Reaction velocities and their relative abundance in HLM suggested that CYP1A2, 3A4, 2C19 and 2D6 were the most important contributors to N-dealkylation.  Apparent Km values of CYP1A2 and CYP2D6 were in the range 1-2 Î¼M, and Km values of CYP2C19 and CYP3A4 were 14 Î¼M and 7.9 Î¼M, resp.  Ketoconazole inhibition of N-dealkylation mediated by a mixed HLM indicated that CYP3A4 accounted for about 40% of perphenazine N-dealkylation at therapeutically relevant concns.  The contribution of the CYP isoforms 1A2, 2C19 and 2D6 amounted to 20-25% each as measured by the percentage inhibition obtained by addn. of furafylline, fluvoxamine or quinidine, resp.  HLM-mediated N-dealkylation of perphenazine accounted for 57% of the total amt. of substrate consumed during incubation.  The present in vitro study suggests that CYP isoforms 1A2, 3A4, 2C19 and 2CD6 are primarily involved in the N-dealkylation of perphenazine.  The relatively modest role of CYP2D6 is at variance with in vivo studies, which indicate a greater contribution of this isoform.  Alternative metabolic pathways, corresponding to 43% of the HLM-mediated metab. of the drug, may depend more strongly on CYP2D6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2m5O_BqlM5bVg90H21EOLACvtfcHk0lgR8ZEhCYDDAA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkvVyqtA%253D%253D&md5=4dc579d66f4b4539d827d48bfa688047</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2125.2000.00298.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2125.2000.00298.x%26sid%3Dliteratum%253Aachs%26aulast%3DOlesen%26aufirst%3DO.%2BV.%26aulast%3DLinnet%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520the%2520human%2520cytochrome%2520P450%2520isoforms%2520mediating%2520in%2520vitro%2520N-dealkylation%2520of%2520perphenazine%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2000%26volume%3D50%26spage%3D563%26epage%3D571%26doi%3D10.1046%2Fj.1365-2125.2000.00298.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dierks, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelius, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ball, S. E.</span></span> <span> </span><span class="NLM_article-title">A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">23</span>â <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=11124225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BD3MXpvFGq" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=23-29&author=E.+A.+Dierksauthor=K.+R.+Stamsauthor=H.+K.+Limauthor=G.+Corneliusauthor=H.+Zhangauthor=S.+E.+Ball&title=A+method+for+the+simultaneous+evaluation+of+the+activities+of+seven+major+human+drug-metabolizing+cytochrome+P450s+using+an+in+vitro+cocktail+of+probe+substrates+and+fast+gradient+liquid+chromatography+tandem+mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry</span></div><div class="casAuthors">Dierks, Elizabeth A.; Stams, Karen R.; Lim, Heng-Keang; Cornelius, Georgia; Zhang, Honglu; Ball, Simon E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-29</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P 450s (CYP3A4, CYP2D6, CYP2C9, CYP1A2, CYP2C19, CYP2A6, and CYP2C8) was developed.  This method uses an in vitro cocktail of specific substrates (midazolam, bufuralol, diclofenac, ethoxyresorufin, S-mephenytoin, coumarin, and paclitaxel) and fast gradient liq. chromatog. tandem mass spectrometry.  The assay incubation time is 20 min, which is in the linear range for all of the substrates, and the anal. time is 4 min/sample.  Substrate specificity was confirmed by incubating Escherichia coli-expressed enzymes with the cocktail.  Potent specific inhibitors of the seven enzymes (ketoconazole, quinidine, sulfaphenazole, tranylcypromine, quercetin, furafylline, and 8-methoxypsoralen) were evaluated in cocktail and individual substrate incubations.  Five of these inhibitors were further studied to det. more precise IC50 values for inhibition of the seven enzymes.  The IC50 values obtained in both cocktail and individual incubations were in good agreement with published values.  This cocktail method offers an efficient, robust way to det. the cytochrome P 450 inhibition profile of large nos. of compds.  The enhanced throughput of this method greatly facilitates its use to assess CYP inhibition as a drug candidate selection criterion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgC8bpIeyGTLVg90H21EOLACvtfcHk0lgR8ZEhCYDDAA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXpvFGq&md5=923c36cb4476b965eabcfee26f974372</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDierks%26aufirst%3DE.%2BA.%26aulast%3DStams%26aufirst%3DK.%2BR.%26aulast%3DLim%26aufirst%3DH.%2BK.%26aulast%3DCornelius%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBall%26aufirst%3DS.%2BE.%26atitle%3DA%2520method%2520for%2520the%2520simultaneous%2520evaluation%2520of%2520the%2520activities%2520of%2520seven%2520major%2520human%2520drug-metabolizing%2520cytochrome%2520P450s%2520using%2520an%2520in%2520vitro%2520cocktail%2520of%2520probe%2520substrates%2520and%2520fast%2520gradient%2520liquid%2520chromatography%2520tandem%2520mass%2520spectrometry%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2001%26volume%3D29%26spage%3D23%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Donato, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Lechon, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castell, J. V.</span></span> <span> </span><span class="NLM_article-title">A microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatocytes cultured on 96-well plates</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>213</i></span>,  <span class="NLM_fpage">29</span>â <span class="NLM_lpage">33</span>, <span class="refDoi">Â DOI: 10.1006/abio.1993.1381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1006%2Fabio.1993.1381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=8238878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaK3sXlsFCmsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=1993&pages=29-33&author=M.+T.+Donatoauthor=M.+J.+Gomez-Lechonauthor=J.+V.+Castell&title=A+microassay+for+measuring+cytochrome+P450IA1+and+P450IIB1+activities+in+intact+human+and+rat+hepatocytes+cultured+on+96-well+plates&doi=10.1006%2Fabio.1993.1381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatocytes cultured in 96-well plates</span></div><div class="casAuthors">Donato, M. Teresa; Gomez-Lechon, M. Jose; Castell, Jose V.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-33</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    </div><div class="casAbstract">A sensitive and simple microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatocytes was developed.  The method is based on the metab. by cells cultured in microwells of appropriate substrates at noncytotoxic concns. (8 Î¼M 7-ethoxyresorufin and 15 Î¼M 7-pentoxyresorufin).  After incubation of the probes with the cells, the dealkylated resorufin formed and released into culture medium was quantified.  To ensure the hydrolysis of the resorufin conjugates eventually formed, culture supernatants were incubated in the microwells with Î²-glucuronidase and arylsulfatase.  The fluorescence was then read using a microplate fluoroescence reader.  A high correlation between the monooxygenase activity measured by this procedure and that measured by conventional procedures in the microsomal fraction of the same cells was found.  The major advantages of this method are: (1) the small no. of cells required; (2) a drastic redn. in assay time; (3) that the assay is performed in intact cells; and (4) the possibility of performing repeated assays with the same cell monolayer over a period of several days since no injury to cells is detectable during the assay.  This method proved to be very convenient for studying cytochrome P 450 induction by xenobiotics in primary cultures of human hepatocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvkbBymI3qW7Vg90H21EOLACvtfcHk0lhT6hP43i9gNA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlsFCmsLo%253D&md5=b0ad75f43217f05e9da8f78174310c51</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1006%2Fabio.1993.1381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.1993.1381%26sid%3Dliteratum%253Aachs%26aulast%3DDonato%26aufirst%3DM.%2BT.%26aulast%3DGomez-Lechon%26aufirst%3DM.%2BJ.%26aulast%3DCastell%26aufirst%3DJ.%2BV.%26atitle%3DA%2520microassay%2520for%2520measuring%2520cytochrome%2520P450IA1%2520and%2520P450IIB1%2520activities%2520in%2520intact%2520human%2520and%2520rat%2520hepatocytes%2520cultured%2520on%252096-well%2520plates%26jtitle%3DAnal.%2520Biochem.%26date%3D1993%26volume%3D213%26spage%3D29%26epage%3D33%26doi%3D10.1006%2Fabio.1993.1381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skaanild, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friis, C.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P450 sex differences in minipigs and conventional pigs</span>. <i>Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">174</span>â <span class="NLM_lpage">180</span>, <span class="refDoi">Â DOI: 10.1111/j.1600-0773.1999.tb00088.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1111%2Fj.1600-0773.1999.tb00088.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10563516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADyaK1MXmslarsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1999&pages=174-180&author=M.+T.+Skaanildauthor=C.+Friis&title=Cytochrome+P450+sex+differences+in+minipigs+and+conventional+pigs&doi=10.1111%2Fj.1600-0773.1999.tb00088.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 sex differences in minipigs and conventional pigs</span></div><div class="casAuthors">Skaanild, Mette T.; Friis, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Toxicology (Copenhagen)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">174-180</span>CODEN:
                <span class="NLM_cas:coden">PHTOEH</span>;
        ISSN:<span class="NLM_cas:issn">0901-9928</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">Minipigs have become a popular alternative to the traditional non-rodent species although little information is available on their P 450 system.  The total P 450, the enzyme activity and immunochem. levels of some of the most important drug metabolizing isoenzymes CYP1A2, CYP2A6, CYP2C19, CYP2D6, CYP2E1 and CYP3A4 were measured in liver microsomes from 8 minipigs and 12 conventional pigs of both sexes and castrate conventional pigs.  The mRNA expression was analyzed for 3 isoenzymes: CYP1A2, CYP2A6 and CYP2E1.  The total P 450 activity was slightly higher in minipigs compared to conventional pigs but no sex differences were detected.  CYP1A2 activity was 4 times higher in female than in male minipigs.  The activity of the male minipigs possessed the same activity as were identical to the conventional females, males and castrates.  The activity of CYP2E1 was 4 times higher in female than in male minipigs and 2 times higher in female than in male pigs.  No activity of CYP2D6 or CYP2C19 could be detected.  The CYP3A4 activity detected in minipigs was higher than the activity in conventional pigs.  A slight sex difference was seen in both strains.  Correlations between enzyme activity and immunochem. levels were found for CYP1A2, CYP2A6 and CYP3A4 but not for CYP2E1.  The mRNA concn. of CYP1A2, CYP2A6 and CYP2E1 was detd. because the activity of these enzymes showed marked sex differences.  A Spearman ranking correlation anal. between mRNA expression and enzyme activity showed a weak correlation for CYP2A6, but not for CYP1A2 and CYP2E1.  These results seem to indicate that CYP2A6 could be transcriptionally regulated, whereas CYP1A2 might be post-transcriptionally regulated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrodFDTcba_9rVg90H21EOLACvtfcHk0lhT6hP43i9gNA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmslarsbc%253D&md5=a49969afd2d11ded6418281a6084bebb</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0773.1999.tb00088.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0773.1999.tb00088.x%26sid%3Dliteratum%253Aachs%26aulast%3DSkaanild%26aufirst%3DM.%2BT.%26aulast%3DFriis%26aufirst%3DC.%26atitle%3DCytochrome%2520P450%2520sex%2520differences%2520in%2520minipigs%2520and%2520conventional%2520pigs%26jtitle%3DPharmacol.%2520Toxicol.%26date%3D1999%26volume%3D85%26spage%3D174%26epage%3D180%26doi%3D10.1111%2Fj.1600-0773.1999.tb00088.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairclough, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkes, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squire, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozzoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capogrosso, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wren, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Luca, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, K. E.</span></span> <span> </span><span class="NLM_article-title">Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e19189</span> <span class="refDoi">Â DOI: 10.1371/journal.pone.0019189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=10.1371%2Fjournal.pone.0019189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=21573153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFKjurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=J.+M.+Tinsleyauthor=R.+J.+Faircloughauthor=R.+Storerauthor=F.+J.+Wilkesauthor=A.+C.+Potterauthor=S.+E.+Squireauthor=D.+S.+Powellauthor=A.+Cozzoliauthor=R.+F.+Capogrossoauthor=A.+Lambertauthor=F.+X.+Wilsonauthor=S.+P.+Wrenauthor=A.+De+Lucaauthor=K.+E.+Davies&title=Daily+treatment+with+SMTC1100%2C+a+novel+small+molecule+utrophin+upregulator%2C+dramatically+reduces+the+dystrophic+symptoms+in+the+mdx+mouse&doi=10.1371%2Fjournal.pone.0019189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse</span></div><div class="casAuthors">Tinsley, Jonathon M.; Fairclough, Rebecca J.; Storer, Richard; Wilkes, Fraser J.; Potter, Allyson C.; Squire, Sarah E.; Powell, Dave S.; Cozzoli, Anna; Capogrosso, Roberta F.; Lambert, Adam; Wilson, Francis X.; Wren, Stephen P.; De Luca, Annamaria; Davies, Kay E.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e19189</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the muscle fibers leading to the gradual depletion of skeletal muscle.  There is significant evidence demonstrating that increasing levels of the dystrophin-related protein, utrophin, in mouse models results in sarcolemmal bound utrophin and prevents the muscular dystrophy pathol.  The aim of this work was to develop a small mol. which increases the levels of utrophin in muscle and thus has therapeutic potential.  Methodol. and Principal Findings: We describe the in vivo activity of SMT C1100; the first orally bioavailable small mol. utrophin upregulator.  Once-a-day daily-dosing with SMT C1100 reduces a no. of the pathol. effects of dystrophin deficiency.  Treatment results in reduced pathol., better muscle physiol. leading to an increase in overall strength, and an ability to resist fatigue after forced exercise; a surrogate for the six minute walk test currently recommended as the pivotal outcome measure in human trials for DMD.  Conclusions and Significance: This study demonstrates proof-of-principle for the use of in vitro screening methods in allowing identification of pharmacol. agents for utrophin transcriptional upregulation.  The best compd. identified, SMT C1100, demonstrated significant disease modifying effects in DMD models.  Our data warrant the full evaluation of this compd. in clin. trials in DMD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfaIHZ6ne-KrVg90H21EOLACvtfcHk0lgKL18w49IX7w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFKjurs%253D&md5=634efc4fcd4c7c591b82ab8142eb6085</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0019189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0019189%26sid%3Dliteratum%253Aachs%26aulast%3DTinsley%26aufirst%3DJ.%2BM.%26aulast%3DFairclough%26aufirst%3DR.%2BJ.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DWilkes%26aufirst%3DF.%2BJ.%26aulast%3DPotter%26aufirst%3DA.%2BC.%26aulast%3DSquire%26aufirst%3DS.%2BE.%26aulast%3DPowell%26aufirst%3DD.%2BS.%26aulast%3DCozzoli%26aufirst%3DA.%26aulast%3DCapogrosso%26aufirst%3DR.%2BF.%26aulast%3DLambert%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DF.%2BX.%26aulast%3DWren%26aufirst%3DS.%2BP.%26aulast%3DDe%2BLuca%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DK.%2BE.%26atitle%3DDaily%2520treatment%2520with%2520SMTC1100%252C%2520a%2520novel%2520small%2520molecule%2520utrophin%2520upregulator%252C%2520dramatically%2520reduces%2520the%2520dystrophic%2520symptoms%2520in%2520the%2520mdx%2520mouse%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0019189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i42"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01547">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_28271"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b01547">10.1021/acs.jmedchem.9b01547</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Additional tables, figures, schemes, graphs, experimental procedures, and copies of NMR spectra (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_001.pdf">jm9b01547_si_001.pdf (19.73 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01547/suppl_file/jm9b01547_si_002.csv">jm9b01547_si_002.csv (0.63 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01547&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-5%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01547" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01547" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799505b1abb3ca6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
